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Summary 
 
The development of resistance to multiple drugs is a major problem in treatment of number of 
infectious diseases and cancer. The phenomenon of multidrug resistance (MDR) is based on the 
synergetic interplay of a number of mechanisms such as target inactivation, target alteration, 
prevention of drug influx as well as active extrusion of drugs from the cell. The latter is mediated by 
over-expression of multidrug efflux pumps. The first discovered and the best characterized until now 
the human MDR transporter is P-glycoprotein. It is a member of the ATP binding cassette (ABC) 
superfamily and acts as an active transporter for a variety of anticancer agents using the energy 
released by ATP hydrolysis. The closest structure and functional homologue of P-glycoprotein found 
in bacteria is LmrA from Lactococcus lactis. 
The major goals of this work are to establish the selective isotope labelling of LmrA in Lactococcus 
lactis, to optimize LmrA sample preparation for solid-state NMR, and finally to perform first solid-
state NMR investigations on LmrA shedding light on its catalytic cycle and substrate binding. For a 
long time the solid-state NMR applications to biological science has been limited to investigation of 
small molecules mostly. Recently, the solid-state NMR methods have shown potential for structural- 
and non-perturbing, site directed functional studies of large membrane proteins as well as ligands 
bound to them. However, to our knowledge neither selective isotope amino acid labelling of any ABC 
transporter, nor NMR investigations on full-length ABC transporter have been reported to date. Solid-
state NMR experiments on a membrane protein require reconstitution of purified proteins into a 
membrane environment at a high density and either isotopic enrichment of the protein or bound drugs 
or inhibitors. Therefore, the large quantities of LmrA reconstituted at a high density in lipid 
membranes, sufficient for advanced NMR studies have been produced and its functional state in 
reconstituted form has been assessed. In the next step, a procedure for cost effective selective amino 
acids isotope labelling of LmrA in Lactococcus lactis has been established.  
Using this protocol deuterium alanine labelled LmrA reconstituted into E. coli liposomes has been 
prepared. Deuterium NMR has been used extensively to assess the proteins dynamics in past.   6
However, it has never been applied to ABC transporter. Here, we report 
2H NMR on selective alanine 
isotope labelled LmrA which has been used to shed light on the dynamics changes in the protein 
occurred under AMP-PNP, non-hydrolysable ATP analogue, binding and in ATP/ADP-Vanadate 
trapped state. It has been found that the major conformation changes affecting the protein motional 
characteristics occur in the ATP binding domains but not in the transmembrane domains.  
Additionally, the binding of several substrates to LmrA has been studied by fluorescence 
spectroscopy as well as by 
19F and 
31P solid-state NMR. The binding constants for several LmrA 
substrates have been obtained by fitting the concentration dependant tryptophan intrinsic fluorescence 
quenching curves. Based on the fluorescence studies and solid-state NMR data, the conformation 
changes in LmrA under substrate binding have been discussed. 
In addition, the preferable location of nine LmrA and P-glycoprotein substrates within the model 
membrane has been studied via 
1H-MAS-NOESY-NMR. The results have been interpreted with 
respect to LmrA and P-glycoprotein binding site accessibility from the membrane interface region.   7
 
Zusammenfassung 
 
Die Entstehung von Resistenzen gegenüber mehrerer Wirkstoffe ist ein großes Problem bei der 
Behandlung einiger ansteckender Krankheiten und Krebs.  
Multiwirkstoff Resistenzen (MDR) basieren auf einem synergetischen Zusammenspiel mehrerer 
Mechanismen wie der Inaktivierung oder Veränderung des Angriffziels, Verhinderung des 
Wirkstoffeinstroms ebenso wie der aktive Transport von Wirkstoffen aus der Zelle heraus. 
Der letzere wird durch die Überexpression von Multidrug Effluxpumpe vermittelt. Der erst entdeckte 
und am besten charakterisierte ist der menschliche MDR Transporter P-Glycoprotein. 
Er gehört zur Superfamilie der ATP Bindekassetten (ABC) und wirkt als aktiver Transporter für 
mehrere Anti-Krebs Stoffe. Die Energie wird durch ATP Hydrolyse gewonnen. Die ähnlichste 
Struktur und funktionelles Homolog von P-Glykoprotein, das in Bakterien gefunden wurde, ist LmrA 
von Lactococcus lactis. 
Das Hauptziel dieser Arbeit ist es, LmrA in Lactococcus lactis aminosäureselektiv mit Isotopen zu 
markieren, die Probenpräperation für Festkörper NMR zu optimieren und letztendlich erste Festkörper 
NMR Untersuchungen an LmrA durchzuführen, um den katalytischen Zyklus und die Substrat-
Bindung aufzuklären. 
Seit längerer Zeit waren die Anwendungen der Festkörper NMR im Bereich der Biologie meist auf die 
Untersuchung kleiner Moleküle beschränkt. Kürzlich haben die Methoden der Festkörper NMR 
Potential für strukturelle und nicht-störende ortsspezifische funktionale Studien großer 
Membranproteine sowie ihrer Liganden gezeigt. Es gibt bis jetzt jedoch nach unserem Wissen weder 
amonosäureselektive Isotopen-Markierung von ABC Transportern, noch NMR Untersuchungen an 
einem gesamten ABC Transporter. Festkörper NMR Experimente an einem Membranprotein erfordern 
die Rekonstitution mit einer hohen Konzentration und entweder Anreicherung von Isotopen des 
Proteins oder gebundener Wirkstoffe oder Inhibitoren. Deshalb wurden große Mengen von LmrA mit 
einer hohen Konzentration in Lipidmembranen für Festkörper-NMR rekonstituiert. Im nächsten 
Schritt wurde ein Verfahren für effiziente selektive Markierung von Aminosäuren von LmrA in   8
Lactococcus lactis etabliert. 
Unter Verwendung dieses Protokolles wurde LmrA, das mit deuteriertem Alanin markiert war und in 
E. coli Liposomen rekonstituiert war, hergestellt. 
Deuterium NMR wurde in der Vergangenheit umfangreich genutzt um die Dynamik der Proteine zu 
untersuchen. Sie wurde jedoch niemals auf ABC Transporter angewendet. Hier werden 
2H NMR 
experimente an Alanin-Isotopen markiertem LmrA vorgestellt, um die Veränderungen der Dynamik in 
dem Protein bei Bindung von AMP-PNP, einem nicht hydrolysierbares ATP Analogon, und in einem 
im ATP/ ADP-Vandat eingefangenen Zustand zu zeigen. Es stellte sich heraus, dass die wichtigsten 
Konformationsänderungen, die die Bewegung des Proteins beeinflussen, in der ATP-Binde-Domäne 
auftreten, nicht aber in den Transmembran-Domänen. 
Zusätzlich wurde die Bindung mehrerer Substrate an LmrA mit Fluoreszenz Spektroskopie untersucht 
als auch mit 
19F und 
31P Festkörper NMR. Die Bindungs-Konstanten für mehrere LmrA Substrate 
wurden mittels Tryptophan Fluoreszenz–Quenching erhalten. Bezogen auf die Fluoreszenz-
Untersuchungen und Festkörper NMR Daten wurden die Konformations-Änderungen von LmrA bei 
der Substrat Bindung diskutiert. 
Zusatzlich wurde die bevorzugte Lokalisierung von neun Substraten von LmrA und P-Glykoprotein 
innerhalb der Modell-Membran durch 
1H-MAS-NOESY-NMR untersucht. Die Ergebnisse wurden in 
Bezug auf die Zugänglichkeit der Bindungs-Stelle in LmrA und P-Glykoprotein von der 
Membranzwischenschicht interpretiert.   9
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1.    Introduction 
 
1.1. Multidrug resistance transporters 
 
1.1.1. MDR phenomenon  
Multidrug resistance (MDR) is typically defined as the ability of a living cell to show resistance to a 
wide variety of structurally and functionally unrelated compounds. In mammals, tumours, which are 
initially sensitive to cytotoxic agents, often develop resistance to a broad spectrum of structurally 
unrelated drugs. The widespread occurrence of MDR in tumour cells represents a major impediment 
to successful cancer chemotherapy. MDR has evolved as a protective mechanism whereby bacterial or 
tumor cells survive initial treatment and develop resistance against several structurally unrelated 
classes of compounds.  
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Figure 1.1: Drug resistance mechanisms of various origins: A) enzymatic (E) degradation or modification of 
drug (D); B) alteration of the drug target (T); C) active extrusion of drugs by transport proteins; D) prevention 
of drug entry. 
 
The primary mechanisms that give rise to MDR include: (1) modification of drugs, and hence their 
inactivation, by enzymes of the target cell; (2) alteration of the cellular target through mutation or   22
post-translation modification; (3) in bacteria, increased cell wall and outer membrane impermeability 
to drugs, which can be further amplified by the loss of one or more porins, and (4) active efflux 
transporters (Brennan, 2001) (Figure 1.1).  
Analysis of available genome sequences of various bacteria revealed that known and putative drug 
efflux transporters constitute between 6 % to 20 % of all transporters (Paulsen et al., 1998). In the 
genome of E. coli and Saccharomyces cerevisiae about 15-20 % of the genome may code for this type 
of proteins (Van Bambeke et al., 2003). A growing number of studies demonstrate that resistance to 
almost any antibiotic could be achieved through the activity of multidrug efflux pumps (Kumar and 
Schweizer, 2005; Paulsen, 2003; Blackmore et al., 2001). However, the connection between drug 
efflux and clinical examples of MDR is still not clear. Generally speaking, wild type expression of 
MDR pumps provides moderate increase in IC50 (the concentration of an inhibitor that is required for 
50% inhibition of an enzyme in vivo), which puts a question mark on their clinical relevance (Lynch 
and Martinez, 2002; Mazzariol et al., 2000). However, the concomitant expression of several efflux 
pumps has been shown to lead to apparently ‘high level’ resistance phenotypes (Van Bambeke et al., 
2003). There can be multiple reasons why these ‘high level’ resistance phenotypes appear. The first 
reason is the exposure of the targets to insufficient drug concentrations. The second reason is the 
ability of antibiotics to serve as inducers and regulators of some efflux pumps gene transcription or 
mRNA translation (treatment with rifampicin induces both cytochrome P450 and MDR expression in 
human whilst erythromycin, tetracycline and aminoglycosides lead to MexXY expression in P. 
aeruginosa (Li et al., 2000; Masuda et al., 2000; Roberts, 1996; Hebert et al., 1992)). The third reason 
for concomitant MDR pumps overexpression is dissemination. In several classes, the genetic elements 
encoding MDR pumps and their regulators are located on plasmids (such as Tet transporters in Gram-
positive bacteria), or on conjugative or transformable transposons located either on plasmids (Tet 
transporters also, in Gram-negative bacteria), or on the chromosome (mef genes in Streptococcus 
pneumoniae) (Del Grosso et al., 2002). 
So far, MDR transporters are found in almost every cell from bacteria to human. MDR has been 
reported in gram-negative bacteria including E. coli, S. typhimurium and Klebsiella pneumonia, in 
gram-positive bacteria such as Listeria monocytogenes,  Staphylococcus aureus,  Streptococcus   23
pneumonia (van Veen et al., 1998a). Besides bacteria, parasitic protozoa are also responsible for some 
of the most devastating and prevalent diseases of humans and domestic animals, such as malaria 
(Plasmodium spp.), mucocutaneous and visceral leishmaniasis (Leushmania spp.), African sleeping 
sickness (Trypanosoma brucei gambiense, Trypanosoma brucei rhodensiense), South-American 
Chagas' disese (Trypanosome cruzi), amoebic dysentery (Entamoeba spp.), and toxoplasmosis 
(Toxoplasma spp.) (van Veen et al., 1998). 
 
1.1.2. Families of MDR transporters 
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Figure 1.2: Representative members of the five characterized families of MDR transporters: the ATP-binding 
cassette superfamily (ABC), the resistance/nodulation/cell division family (RND), the multidrug and toxic 
compound family (MATE), the small multidrug transporter family (SMR), and the major facilitator superfamily 
(MFS).  
 
The families of MDR transporter include some members of the ATP binding cassette (ABC) 
transporters family which couple the hydrolysis of ATP to drug efflux, and five families of proteins, 
which use the proton motive force (pmf) to expel drugs primarily through drug:proton antiport. The 
latter include the major facilitator superfamily (MFS), resistance/modulation/division (RND), 
drug/metabolite transporters (DMT) and multi antimicrobial extrusion (MATE) proteins (Brennan, 
2001) (Figure 1.2, Table 1.1). A newly discovered superfamily, the multidrug endosomal transporters 
(MET), which is limited to the endosomal, late Golgi and lysosomal membranes has also been   24
described (Kumar and Schweizer, 2005). 
Multidrug efflux systems for gram-positive, gram-negative bacteria and eukaryotes are quite different. 
In gram-negative bacteria each efflux pump consists of three components: the inner membrane (IM) 
transporter, the outer membrane (OM) channel and the periplasmic accessory lipoprotein (Zgurskaya 
and Nikaido, 2000). In this arrangement, efflux complexes transverse both, the inner and the outer 
membranes and thus facilitate direct passage of the substrate from the cytoplasm or the cytoplasmic 
membrane into the external medium. Direct efflux of drugs into the medium is advantageous for 
gram-negative bacteria because, in order to come in again, the expelled drug molecules must cross the 
physical barrier that is the OM. The synergetic function of transporters and membrane barrier explains 
hypersusceptibility of gram-negative bacteria to various drugs. MDR pumps from gram-negative 
bacteria belong to several families of transporters (Nikaido, 2001).  
 
Family  Selected representatives  Organism  References 
 
MFS 
 
Bmr 
LmrP 
MdfA 
QuacA 
 
Bacillus subtilis 
Lactococcus lactis 
Escherichia coli 
Staphylococcus aureus 
 
(Neyfakh, 2002) 
(Bolhuis et al., 1996c) 
(Edgar and Bibi, 1999) 
(Mitchell et al., 1999) 
 
SMR 
 
EmrE 
QacE 
YkkC, YkkD 
 
Escherichia coli 
Gram-negative bacteria 
Bacillus subtilis 
 
(Rotem and Schuldiner, 2004) 
(Paulsen, 2003) 
(Jack et al., 2000) 
 
RND 
 
AcrB 
MexB 
YhiV 
 
Escherichia coli 
Pseudomonas aeruginosa 
Escherichia coli 
 
(Murakami et al., 2002) 
(Poole et al., 1993) 
(Ma et al., 1995) 
 
MATE 
 
NorM 
YdhE 
 
Vibrio parahaemolyticus 
Escherichia coli 
 
(Brown et al., 1999) 
(Brown et al., 1999) 
 
ABC 
 
LmrA 
PGP 
 
Lactococcus lactis 
Humans 
 
(van Veen et al., 1996) 
(Higgins, 1992) 
 
Table 1.1: Multidrug transporter families.   25
 
However, most of the efflux transporters that mediate resistance to relevant antibiotics belong to the 
resistance/nodulation/cell division family (RND). The best studied drug transporter complexes from 
gram-negative bacteria are AcrA-AcrB-TolC of E. coli and MexB-OprM of P. aeruginosa (Zgurskaya 
and Nikaido, 2000). They pump mostly lipophilic and amphiphilic compounds, including antibiotics, 
heavy metals, dyes, detergents, and solvents (Nikaido, 1996). 
Gram-positive bacteria lack the outer membrane and therefore rely mostly on expression of MDR 
pumps in order to protect themselves against multiple drugs. Gram-positive bacteria MDR pumps 
belong to at least three unrelated families: MFS, SMR, and ABC. According to substrate-specificity 
they can be subdivided into macrolide-specific (MefE, MefA), tetracycline-specific (TetK, TetL, and 
TetZ), and polyspecific (LmrA, LmrP) (Markham and Neyfakh, 2001).  
At present all known MDR transporters in eukaryotes belong to ABC family. The first described and 
the best characterized MDR ABC transporter in humans is P-glycoprotein (PGP). It provides 
resistance to a broad spectrum of compounds including anticancer chemotherapeutic agents 
(Ambudkar et al., 1999). 
 
1.1.3. MDR transporters of the ABC family  
ABC transporters have four core domains. Two transmembrane domains (TMDs) each consist of 
multiple membrane spanning α-helices, which together form the pathway for substrates, crosses the 
lipid bilayer. Two nucleotide binding domains (NBDs) contain the ATP binding sites and couple 
conformational changes induced by ATP binding, ATP hydrolysis and ADP release to the transport 
process (Higgins, 1986a).  
The ABC transporters family is large and diverse. What ties the family together is a number of highly 
conserved ABC cassette motifs, many of which are directly involved in the binding and hydrolysis of 
ATP (Geourjon et al., 2001). These conserved motifs are P-loop or Walker-A motif (GXXGXGKST, 
X denotes any amino acid), the Walker-B motif (hhhhD, h any hydrophobic amino acid), a glutamate 
residue in the Q-loop, and a histidine residue in the switch region. In addition, ABC cassettes 
invariably possess a D-loop with a short polypeptide stretch (…LSGG…), which is specific for all 
ABC cassettes. It is often referred as the ‘ABC signature sequence’. In general, NBD can be divided   26
into domain 1 (the catalytic domain, containing the Walker A and B motifs) and domain 2 (the so 
called signaling domain, containing the signature motif) (Figure 1.4). 
 
One of the best characterized MDR ABC transporter is undoubtfully P-glycoprotein and it is 
considered as a framework for the whole ABC MDR family. Therefore, the whole upcoming 
discussion will be held in relation to PGP. 
 
 
1.1.4. Structure investigations on ABC transporters 
 
Structure investigations of full length ABC transporters 
Membrane proteins are notoriously recalcitrant to purification and crystallization. Despite this, 
considerable progress has been achieved in structural analyses of ABC transporters. The past five 
years have seen several structures of the ABC transporter MsbA (Reyes and Chang, 2005; Chang, 
2003a; Chang and Roth, 2001) and the structure of BtuCD transporter of E.  coli (Figure 1.3). 
Additionally, the low resolution structures of PGP up to 8 Å, TAP at 35 Å, 22 Å MRP1, 20 Å CFTR, 
and YvcC at 25 Å are available (Rosenberg et al., 2005; Rosenberg et al., 2004; Chami et al., 2002; 
Lee et al., 2002; Rosenberg et al., 2001a; Rosenberg et al., 2001b; Rosenberg et al., 1997). 
The low (25 Å, single particle analysis) and medium (8-10 Å, electron microscopy) resolution 
structures showed that PGP has a shape of a cylinder, 10 nm in diameter and about 8 nm high. About 
half of the molecule resides in the membrane. The α-helices span the membrane a total of 12 times 
and organized in two TMDs. In the nucleotide bound state five of the α-helices from each TMD are 
related by a pseudo-two-fold symmetry, whilst the sixth breaks the symmetry (Rosenberg et al., 
2005). TMDs form an aqueous chamber in the membrane, open at the cytoplasmic leaflet. Gaps 
between two TMDs appear to form side-entrance into the chamber from the lipid phase, which may 
permit access of substrate to the chamber. Hydrophilic intracytoplasmic domains (ICDs) of the TMDs 
were observed at a resolution of 8 Å, which interact directly with NBDs. At the resolutions available 
for PGP not much can be concluded about NBDs arrangement. However, both structures of the   27
MJ0796 and the BtuCD NBDs can be modeled into PGP 3D structure obtained from 2D crystals 
(Rosenberg et al., 2005).  
The first MsbA (from E. coli) structure was solved in the absence of substrate and nucleotide. It 
shows a chamber in the membrane formed by two MsbA monomers (Figure 1.3 A). The α-helices of 
this chamber are arranged in the way so that chamber is open (~25Å) to the cytoplasmic side of the 
membrane. NBDs are placed relatively far from each other. TMDs are connected to NBDs by 
extensive helical intracellular regions (ICDs). In general, it is difficult to make any conclusions about 
NBDs organization, because the N-terminal region (residues 341-418) is not visible. So, the exact role 
and position of NBDs are obscure (Chang and Roth, 2001).  
A                             B                         C    D A                             B                         C    D
 
Figure 1.3: Structures of MsbA and BtuCD. Views of MsbA in the open (A) and closed (B) conformation, and 
LPS and ATP bound (C), and of BtuCD (D). The picture is made in VMD (Humphrey, W., Dalke, A. and 
Schulten, K., "VMD - Visual Molecular Dynamics", J. Molec. Graphics, 1996, vol. 14, pp. 33-38). 
 
The MsbA from Vibrio cholera was crystallized in the closed apo conformation (Figure 1.3 B). In this 
structure both the TMDs and NBDs are closely packed, a large internal chamber accessible from 
cytoplasm is formed between the interacting TMDs (Chang, 2003a).  
The crystal structure of MsbA of S. typhimurium was solved in complex with Mg·ADP·Vanadate and 
LPS (Figure 1.3 C). This structure when compared to closed MsbA structure exhibits a large rigid-
body rotation and translation that result in a ~15 Å opening toward the periplasmic ends and a ~15 Å 
closing of the NBD-associated ICD helices, which allow a chamber accessibility from the periplasm   28
but not from cytoplasm (Chang, 2003a). Additionally, in this latest MsbA structure, the bound LPS is 
seen on the outer membrane leaflet side. Interestingly, several conserved residues between MsbA and 
PGP map to the binding interface of the LPS, which suggests that this region could be a general 
binding site for other amphipathic compounds (Chang, 2003a). One more remarkable feature of this 
MsbA crystal structure is the NBDs architecture. It is better resolved in contrast to both early solved 
MsbA structures and its organization reminiscent of the dimer sandwich structures of the ABC 
transporter BtuCD and MJ0796 (Chang, 2003a). 
The three structures suggest significant helices tilting movement of the TMDs during the substrate 
transport, allowing accessibility to an internal chamber from the periplasm but not from the 
cytoplasm. This ‘tilting’ may impose a large amount of physical stress on both leaflets of the 
membrane and even require lipid reorganization to counterbalance the different space requirements of 
MsbA during the catalytic cycle (Schmitt, 2002). Interestingly, this arrangement of MsbA α-helices is 
consistent with site-directed spin labelling electron paramagnetic studies (EPR) (Dong et al., 2005; 
Buchaklian et al., 2004) on MsbA and inconsistent with PGP structures at low and medium resolution 
as well as with in vivo cross-linking data for the TMDs of PGP (Loo et al., 2003). These differences 
can reflect different conformation stages, different transport cycles (MsbA is a lipid flippase), or be an 
artifact of crystallization. Moreover, it has been proposed that the dimer interface has been wrongly 
observed and by the counter-clockwise rotation of both MsbA monomers the spiral MsbA has been 
obtained. This spiral MsbA dimer exhibits an interface between the two NBDs identical to that 
observed in BtuCD, the DNA repair protein Rad50, the homodimeric NBD of ABC transporter 
MJ0796. Additionally, the packing of TM helices and distances between the membrane spanning 
helices like in spiral MsbA similar to arrangement in PGP (Shilling et al., 2003).  
The E. coli BtuCD structure is different from all other available MsbA structures (Figure 1.3 D). All 
20 (not 12 like in MsbA, and PGP) BtuCD α-helices form the translocation pathway through the 
membrane that is closed to the cytoplasm by a gate region. The TMD helices tight packing 
reminiscent the one shown by multiple cross-linking studies on PGP (Loo and Clarke, 2005). 
Consequently, the NBDs of BtuCD are not separated; they are in contact with each other. In contrast 
to MsbA and PGP, no ICD was identified in BtuCD and the NBDs are in direct contact with the   29
TMDs via a cytoplasmic loop, which located between TM helices 6 and 7. The overall fold of ABC 
domain in BtuCD resembles that of HisP, MalK, TAP1, MJ1267, MJ0796, and the DNA repair 
enzyme Rad50 (Locher et al., 2002). The core consists of a six-stranded β-sheet that is surrounded by 
nine  α-helices, and a peripheral, three-stranded β-sheet. Each BtuCD ABC domain contains the 
nucleotide bound at the dimmer interface between ABC signature motif of one subunit and the P-loop 
of the other. At present, the BtuCD structure is considered as a framework for ABC family, whereas 
MsbA ‘open’ conformation structure is under debates. However, one should keep in mind that MsbA 
has the highest end-to-end sequence similarity with PGP and LmrA, whereas BtuCD has sequence 
similarity with these two MDR ABC transporters only in the NBDs. 
 
Structure investigations of the isolated nucleotide binding domains  
 
D2
D1
D2
D1
D2
D1 D2
D1
HisP Rad50
D2
D2
D1
D1
MalK
D2
D1
D2
D1
D2
D1 D2
D1
HisP Rad50
D2
D2
D1
D1
MalK  
Figure 1.4: NBDs association models. D1 and D2 are two domains of each ATP binding cassette. 
 
The first high resolution structure of an ABC domain – HisP, the NBD of histidine permease – was 
reported in 1998 (Hung et al., 1998). It shows a dimeric organization of HisP with a ‘back-to-back’ 
orientation. The dimer interface was formed by the outer β strand of domain 2 (D2), the ATP-binding 
sites are exposed, and the signature motifs were far way to interact with the bound nucleotide. The X-
ray structure of Rad50, a DNA repair enzyme, shows different dimeric organization. The nucleotide-
binding site in Rad50 is located in the dimeric interface and formed by the Walker A motif in 
monomer 1 and the C-loop of monomer 2, which resulted in a ‘head-to-tail’ orientation (Hopfner et 
al., 2000). One more dimer orientation has been shown for the ABC domain of MalK from 
Thermococcus litoralis (Diederichs et al., 2000). Here, the interface adopted a ‘head-to-head’ 
orientation, with the largest amount of buried surface area (Figure 1.4).    30
The following years brought a few more X-ray structures of other ABC domains (Karcher et al., 2005; 
Lewis et al., 2004; Schmitt et al., 2003; Gaudet and Wiley, 2001; Karpowich et al., 2001; Yuan et al., 
2001). So, in the crystal structure of a putative ABC domain MJ1267 of M. janaschii and RLI ABC 
ATPase RNase-L inhibitor of P. furiosus, the NBDs adopted a dimer interface that is identical to the 
one in Rad50 (Karcher et al., 2005; Smith et al., 2002). This NBDs organization is supported by 
biochemical data obtained for MalK (Fetsch and Davidson, 2002). Thus, it seems to be established 
that each monomer of ABC domain participate in ATP binding and sensing, thereby forming a dimer 
interface with a head-to-tail orientation (Schmitt and Tampe, 2002). 
A large body of biochemical studies, and computer simulations clearly demonstrated that ATP 
binding initiates NBDs dimerization (Zaitseva et al., 2005; Oloo and Tieleman, 2004). Interestingly, 
recent studies on Malk have shown that ATP promotes dimerization, whereas ADP does not (Lu et al., 
2005). The dimerization process seems to have two components. First, ATP binding to Walker A/B 
and Q loop motifs reorients the domain 1 and 2. Second, recognition of the ATP γ-phosphates by the 
signature motifs from the opposing NBD induces a clamp-like motion in the NBD to form a tight 
NBD-ATP-NBD sandwich (Karcher et al., 2005). However, whilst deriving the general model for 
NBDs dimerization, care should be taken, because ATPases from different families might have 
different dimerization mechanisms.  
At which stage of ABC domain catalytic cycle, nucleotide or nucleotides are hydrolyzed, is currently 
a matter of debate. Two models have been proposed. In the progressive clamp model, both 
nucleotides in the dimer are hydrolyzed, and the NBDs dissociate before reloading the ATP. In the 
alternative catalytic site model, hydrolysis occurs in the first catalytic site, followed by opening of this 
domain while the second catalytic site remains closed. After reloading of ATP in the first site, this site 
is closed, and hydrolysis takes place in the second catalytic site (for review see (van der Does and 
Tampe, 2004)).  
 
1.1.5. Conformational changes during substrate binding and transport 
Mechanism of ABC transporters is a puzzle despite a number of exhaustive studies performed by 
biochemists and structural biologists. Due to similarities in NBDs of different transporters, it is   31
generally accepted that all ABC cassettes bind and hydrolyze ATP in a similar fashion and therefore 
use a common mechanism to power the translocation of substrate through the membrane. Our 
understanding of mechanisms of ABC transporters function originates from the low resolution 
structures of PGP obtained at several conformation stages supported by a number of biochemical 
assays. Analysis of the two-dimensional crystals by cryo-electron microscopy revealed that major 
conformation changes within TMDs occur upon ATP binding, which significantly reduces the affinity 
for drug binding and opens a central pore along its length. These conformation changes can, 
potentially, facilitate movement of hydrophobic compounds from the lipid bilayer to the aqueous pore 
of the transporter (Rosenberg et al., 2003; Rosenberg et al., 2001b). Recently, the opening of ion 
channel in the TMDs was directly linked to NBDs dimerization using single-channel recording 
electrophysiological method on intact cystic fibrosis conductance regulator (CFTR) from the ABC 
family (Vergani et al., 2005). 
Biochemically, the putative conformation changes of PGP have been studied extensively via cystein-
scanning approach combined with oxidative cross-linking by Loo and Clarke. They have determined 
that the major conformation changes take place in TM 6, 11, 12 (Loo et al., 2003). Intrinsic 
fluorescence and MIANS quenching approaches have been used as an indication of conformation 
changes for PGP (Sharom et al., 2001) and LmrA (Vigano et al., 2002).  
On the bases of the limited structural information and the extensive available biochemical data two 
models of the ABC transporters mechanism were generated (Figure 1.5). The two-cylinder model and 
ATP switch model (Higgins and Linton, 2004; van Veen et al., 2000a). In the two-cylinder model 
proposed for LmrA, there is no transfer of substrate from one site to another; rather, substrate is 
translocated while bound to a single site whose affinity and orientation changes as a result of ATP 
hydrolysis. For PGP it has been proposed that drug initially binds to one side near cytoplasmic surface 
and transferred to a second (release) site when affinity of the first site is reduced as a result of ATP 
hydrolysis (Ramachandra et al., 1998; Dey et al., 1997). In any case, the power stroke for substrate 
translocation is provided by ATP hydrolysis. In contrast, the ATP switch model suggests the transport 
is initiated by substrate binding by facilitating ATP-dependant closed dimer formation. In the next 
step substrate release occurs followed by ATP hydrolysis aiming to restore transporter resting   32
conformation (Higgins and Linton, 2004) (Figure 1.5). 
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Figure 1.5: Contrasting transport models for ABC transporters. (A) Alternating two-site transport model 
proposed for LmrA. Step 1: binding of ATP to the NBD of one half of the transporter triggers drug binding to a 
high-affinity site. Step 2-3: ATP is hydrolyzed, occluding the drug-binding site. Step 3-4: release of the 
generated Pi leads to the exposure of the drug to an extracellular-facing, low-affinity drug-binding site. At this 
point drug can be released. One more ATP binds to the second NBD. Step 4-7: the transport cycle is repeated; 
the only difference is that the second NBD now powers the transport. Step 7: The original transporter 
conformation is restored. (B) ATP-switch model. Step 1: the transport cycle initiated by binding of substrate to 
its high-affinity site on the TMDs. The affinity to ATP is increased, effectively lowering the activation energy 
for closed dimer formation. Two ATP molecules bind and NBDs dimerization occurs. Step 2: the closed NBD 
dimer induces conformation changes in the TMDs such that the drug-binding site is exposed extracellularly and 
its affinity is reduced, releasing the bound drug. Step 3: ATP is hydrolyzed to form a transition-state 
intermediate. Step 4: hydrolysis of the two ATP molecules leads to restoring the resting protein state. Adapted 
from (Higgins and Linton, 2004; Borges-Walmsley et al., 2003). 
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Key questions: 
Although the large body of data on structural and functional aspects of ABC MDR transporters in 
general and on PGP in particular are accumulated, there are still many questions remain unclear. 
Among those questions are 1) what is a nature of substrate and ATP binding, 2) how many ATP 
molecules are hydrolyzed per transport of one substrate molecule, 3) how the conformation changes 
are transferred from NBDs to TMDs and the other way round, 4) what is a sequence in a transport 
cycle, and 5) how the transport cycle is regulated. In additional, crystal structures of ABC MDR 
transporter in open and closed states, as well with bound substrate are awaited to be determined. 
Mammalian proteins are hard to work on and it is often difficult to produce sufficient amount of 
material not only for crystallization trials but even for biochemical investigation. Therefore, a 
convenient model system to perform structural and functional investigation is a bacterial ABC MDR 
transporter like LmrA. 
   34
 
1.2. LmrA–a bacterial ABC MDR transporter as a model of P-glycoprotein 
At present, several different MDR-like transport systems in L. lactis strain MG1363 are known. These 
MDR transport systems vary in substrate specificity (anionic versus cationic substrates), and in their 
mode of energy coupling to drug transport (pmf – versus ATP-dependant). The secondary MDR 
transporter of L. lactis strain MG1363 is LmrP from MFS family. The ABC family in L. lactis strain 
MG1363 is represented by LmrA, the first identified bacterial MDR ABC transporter, and very 
recently described LmrCD (Lubelski et al., 2006; Lubelski et al., 2004; van Veen et al., 1996). 
LmrCD is a first known ABC MDR transporter with a heterodimeric composition. Interestingly, in 
LmrCD not only TMDs but also NBDs are structurally and functionally distinct (Lubelski et al., 
2006). A homologue of LmrA was found in a bacteriocin LsbA and LsbB producing strain of L. lactis 
(Mazurkiewicz et al., 2005). Evidence exists that L. lactis strain MG1363 also possesses anion 
transporter and anion-conjugate transporter (Mazurkiewicz et al., 2005; Yokota et al., 2000).  
LmrA, a 590-amino acids MDR transporter, belongs to the ABC family. LmrA confers resistance to 
several natural and synthetic chemotherapeutic drugs (Table 1.2). LmrA shares significant sequence 
similarity with the human MDR protein PGP (34 % identity and an additional 16 % similarity (van 
Veen et al., 1996)) and the lipid flippase MsbA from E. coli (28 % overall sequence identity (Chang 
and Roth, 2001)) (Figure 1.7). PGP and LmrA substrate specificity overlap remarkably. Moreover, 
LmrA, when expressed into insect and human lung fibroblast cells, is able to functionally complement 
PGP. LmrA is not only properly targeted to the plasma membrane but also confers multiple 
resistances in the human cells (van Veen et al., 1998b). 
The homodimeric organization of LmrA transporter has been shown by the experiments on dominant-
negative mutants mixed with wild-type protein (van Veen et al., 2000a). Each monomer in LmrA 
consists on six membrane spinning regions (putative α-helices) in the amino-terminal hydrophobic 
domain, followed by large hydrophilic domain containing ATP-binding site (van Veen et al., 1996) 
(Figure 1.6 - 1.8). The α-helical organization of TMDs has been determined by cystein scanning 
mutagenesis and Attenuated Total Reflection Fourier Transform Infrared spectroscopy (ATR-FTIR) 
studies (Poelarends and Konings, 2002; Grimard et al., 2001). Additionally, 
1H/
2H exchange ATR-  35
FTIR experiments revealed fast exchange implying that the transmembrane helical segments of LmrA 
are more flexible and accessible then any segments described before in the literature. This points out 
to large translation and rotation movements of the certain segments of transmembrane helices 
(Grimard et al., 2001). Electron microscopy analysis of purified and reconstituted LmrA revealed 
small, uniform particles with a diameter of 8.5 nm by 5 nm, similar to that previously observed for 
PGP (Poolman, unpublished results). 
 
Class Antibiotic  Increased  resistance  (fold) 
 
Aminoglycosides 
Gentamicin 
Kanamycin 
2 
3 
 
 
β-Lactams 
Ampicilln 
Ceftazidine 
Meropenem 
Penicillin 
2 
3 
1 
4 
Glycopeptides Vancomycin  1 
Lincosamides Clindamycin  14 
 
 
Macrolides 
Azithoromycin 
Clarithmomycin 
Dirithromycin 
Erythromycin 
Roxithromycin 
Spiramcin 
33 
23 
264 
53 
35 
35 
 
Quinolones 
Ciprofloxacin 
Ofloxacin 
2 
4 
 
Streptogramins 
Dalfopristin 
Quinupristin 
RP59500 
163 
31 
55 
 
 
Tetracyclines 
Chlortetracycline 
Demeclocycline 
Minocycline 
Oxytetracycline 
Tetracycline 
28 
12 
138 
8 
14 
 
Others 
Chloramphenicol 
Trimethoprim 
11 
1 
 
Table 1.2: Effect of LmrA expression on the resistance to antibiotics of E. coli CS1562, which is hypersensitive 
to drugs due to a deficiency of the TolC porin. Data obtained from (Putman et al., 2000).   36
 
On the basis of available crystal structures of V. cholera MsbA and monomeric TAP1, Ecker and co-
workers have built a homology model of LmrA. In this model, the TMDs are predicted to form a 
helical bundle, which lines a central aqueous pore open to the extracellular space. The central pore is 
lined by TM helices 1, 3, 5, and 6 of each monomer. TM helices 2 and 4 are shielded from the 
aqueous environment by other helices (Ecker et al., 2004; Pleban et al., 2004) (Figure 1.6). 
Using several analogues of the fluorescent membrane probe diphenyl-hexatrien (DPH), it has been 
shown that LmrA preferably transports cationic derivatives of DPH, whereas neutral and anionic DPH 
derivatives are not transported (Bolhuis et al., 1996a). This rule, however, is not strict to neutral 
substrates. LmrA as well as PGP can recognize a neutral acetoxymethyl ester derivative of 2′, 7′-bis-
(2-carboxyethyl)-5-(and-6)-caboxyfluorescein (BCECF-AM) (Bolhuis et al., 1996a; Homolya et al., 
1993). Based on the kinetics of the extrusion of 1-[4-(trimehylamino)phenyl]-6-phenylhexa-1,3,5-
triene (TMA-DPH) by LmrA, it has been concluded that drugs enter the protein from the inner 
membrane leaflet and are transported to the exterior (Bolhuis et al., 1996a).  
 
 
Figure 1.6: 3D atomic model of LmrA generated by the software package Insight II, using V. cholera MsbA 
(Ecker et al., 2004).   37
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Figure 1.7: Comparison of the amino acid sequence of LmrA from L. lactis, MsbA from E. coli, the N-, and C-
terminal halves of human PGP. MDR1-N and MDR1-C represent amino acid residues 1-640 and 641-1280 of   38
human PGP. The last residue in each row is numbered. The roman numbers refer to the predicted 
transmembrane α-helices of PGP. The ABC signature sequence and Walker A and B motifs are indicated. 
Different types of residues are highlighted with different colors, subsequently, acidic with blue, basic with 
magenta, hydroxyl, amine, basic-Q with green, small, hydrophobic with red, and others with grey. In alignment 
the following symbols denote the degree of conservation observed in each column: * - residues are identical in 
all sequences: - conserved substitutions have been observed, according to the colors above, . – semi-conserved 
substitutions are observed. Alignment is done with ClustalW (WWW Service at the European Bioinformatics 
Institute http://www.ebi.ac.uk/clustalw). 
 
Two binding sites, with a low and high affinity, allosterically coupled, have been demonstrated for 
LmrA (van Veen et al., 2000a). Only low-affinity, ouside-facing binding site is accessible in the 
vanadate-trapped state (van Veen et al., 2000a). On the basis of a detailed analysis of the LmrA drug 
binding sites, vinblastine equilibrium binding determinations, and photoaffinity labelling studies, an 
alternating two-site mechanism for drug transport was suggested. Accordingly to this model protein 
oscillates between two configurations, high-affinity, inside-facing, and low-affinity, outside facing 
(van Veen et al., 2000a).  
To generate a three-dimensional model of the substrate binding sites, LmrA in three different states 
(resting, with AMP-PNP, and ATP/ADP-Vanadate bound) were labeled with propafenone-type 
photoaffinity ligands, proteolyticly degradated and analyzed using matrix-assisted laser desorption 
ionization/time of flight mass spectrometry. Data revealed that propafenones bind to LmrA in certain 
regions within TM helices 3, 5, and 6 for all three protein states, meaning that these helices 3, 5, and 6 
are directly involved in drug binding and are accessible to the central cavity (Ecker et al., 2004). 
To obtain structural information of LmrA solute translocation pathway, a cystein scanning 
mutagenesis approach has been applied. Cystein mutations were introduced in each hydrophilic loop, 
and in TMD 6. In the next step their accessibilities were probed with fluorescein maleimide. The 
periodicity of cysteins accessibility showed that helix 6 has one face exposed to an aqueous cavity 
along its full length. Interestingly, cysteins in all loops external and internal were accessible to 
fluorescein maleimide. Taken all together it was concluded that under non-energized conditions the 
LmrA transporter forms an aqueous chamber within the membrane, which is open to the intracellular 
milieu (Poelarends and Konings, 2002). 
Recently it has been reported that LmrA can operate not only in unidirectional fashion, like it is   39
accepted to be the case for ABC transporter family members, but can mediate reverse transport 
(uptake) of ethidium with an apparent Kt of 2.0 μM in presence of an inwardly directed drug 
concentration. In analogy to ‘traditional’ drug efflux, ethidium uptake can be competively inhibited by 
the LmrA substrate vinblastine, and reduced under E314A and E512Q substitutions (Figure 1.8). 
Moreover, under ATP-depleted conditions LmrA has been shown to play a direct role in the ATP 
synthesis reaction (Balakrishnan et al., 2004). In the latter work, the same authors have further 
investigated the role of a conserved glutamate residue 314. It has been found that the transmembrane 
pH gradient has a dramatic influence on drug transport of E314D LmrA mutant. So, the active 
ethidium efflux by the E314D mutant of LmrA is hampered at pH 7.0 and can be almost rescued at 
pH 8 (Shilling et al., 2005). 
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Figure 1.8: Topology model for LmrA (monomer). Conserved residues mentioned in the text are highlighted 
with green, His-tag with yellow, Walker A, B, and C-loop with red. Picture is adapted from U. Hellmich. 
 
Additionally, it has been shown that LmrA-MD (LmrA mutant lacking NBDs) is able to mediate the 
uptake of ethidium in cells in co-transport with protons in a reaction driven by the ∆Ψ (interior   40
negative) and the transmembrane chemical proton gradient (∆pH, interior alkaline) (Venter et al., 
2003). It has been suggested that glutamate 314 for LmrA plays a role similar to carboxylates in 
proton translocation by protone-motive force–dependent transporters and primary pumps (Shilling et 
al., 2005; Abramson et al., 2003; Yerushalmi and Schuldiner, 2000). So, its protonation and 
deprotonation somehow facilitates conformation changes enabling substrate transport (Shilling et al., 
2005). Moreover, it has been shown that LmrA mediated Hoechst-33342 transport is sensitive to 
uncouplers that collapse the proton gradient, and to N,N′-dyclohexylcarbodiimide, an inhibitor of the 
FoF1-ATPase (van Berg van Saparoea et al., 2005).  
In support to function similarities of LmrA to secondary transporters, a significant sequence similarity 
has been observed between LmrA and MexB, a secondary transporter from RND family. The shares 
sequence corresponds to a harpin region of two membrane-spanning helices and the connecting loop 
between these helices (Venter et al., 2005).  
In addition to drugs, LmrA reconstituted into L. lactis lipids can transport specific lipids, namely 
fluorescent phosphatidylethanolamine, but not of fluorescent phosphotidylcholine (Margolles et al., 
1999). Recently, it has been shown that LmrA displays an ATP-dependent 
109Cd
2+ uptake stimulated 
by glutathione (Achard-Joris et al., 2005). 
Interestingly, the ABC transporter LmrA shares overlapping substrate specificity not only with PGP 
but with pmf-driven transporter of L. lactis LmrP (van Veen et al., 2000b). The expression of LmrA 
and LmrP is thought to be up-regulated, because the energy-dependant drug extrusion can be 
facilitated by growing bacteria in the presence of increasing concentrations of toxic compounds 
(Mazurkiewicz et al., 2005; Bolhuis et al., 1994). Although, the physiological role of LmrA and LmrP 
is not known, they are vital for L. lactis: all attempts to delete both lmrA and lmrP transporters genes 
were unsuccessful. Moreover, the deletion of one of the MDR transporters led to increased expression 
of the other (Bolhuis et al., 1994).  
   41
 
1.3. Solid-State NMR 
The nuclear magnetic resonance history started in December 1945 when Torrey and Pound detected 
weak radiofrequency signals generated by the nuclei of atoms in ordinary matter, namely paraffin. 
Almost in the same time Bloch and Packard independently observed radio signals from the atomic 
nuclei in water. These experiments gave life to nuclear magnetic resonance (NMR) (Levitt, 2001). 
These paragraphs briefly introduce the physical basis of the NMR phenomenon, emphasize 
difficulties faced by solid-state NMR and shortly explain the most common solid-state NMR 
(SSNMR) techniques. 
 
Nuclei, when placed in a strong external static and uniform magnetic field, Bo, start to precess around 
Bo with Larmor frequency ωo, which is related to Bo by the following equation (Levitt, 2001): 
[1]       ωo = -γBo ,  
where γ is the gyromagnetic ratio and is nucleus dependent, Bo is the applied magnetic field. 
In the absence of a magnetic field, spins have different orientations with the same energy. Therefore 
net magnetization can not be detected. To create a net magnetization a strong magnetic field has to be 
applied. In this case the quantization axis for nuclei coincides with the applied field direction. 
However, magnetic fields created by nuclei wished to be observed is negligibly small compared with 
the static Bo field applied to create net magnetization. For this reason, another magnetic field is 
applied in direction perpendicular to Bo called radiofrequency pulse (RF). This RF pulse rotates net 
magnetization in the plane perpendicular to Bo, where it can be detected. Apart from the external 
applied magnetic fields described above, there are more sources of magnetic fields, which are internal 
to the sample. The most important of those are chemical shift anisotropy, dipole coupling and 
quadrupole coupling. To describe the motions and interactions of all the nuclei and all the electrons 
the Schrödinger equation [2] is used. The Hamiltonian operator in the Schrödinger equation involves 
all the interactions between these particles (Levitt, 2001). 
[2]     d/dt  |  ψfull(t) > = - iĤfull | ψfull(t) >, 
where Ĥfull is the Hamiltonian of the system, | ψfull(t) > is a wave function containing information   42
about the positions, velocities, and spin states of all the electrons and nuclei. 
Equation 2 is complete, but only partly relates to our experiment. Considering only those interactions 
which are important for NMR, namely nuclear spin state, the spin Hamiltonian can be presented as 
follows (Levitt, 2001): 
 [3]    d/dt  |  ψspin(t) > = - iĤspin | ψspin(t) >.  
The nuclear spin Hamiltonian involves external (Ĥext(t)), internal electric and magnetic interactions 
(Ĥint(t)). The external part of the spin Hamiltonian is (Levitt, 2001): 
[4]     Ĥext (t) = Ĥstatic + ĤRF(t),  
where  Ĥstatic is the interaction of each spin with the longitudinal static field Bo, and ĤRF is the 
interaction of each spin with the transverse radiofrequency field BFR. The internal spin Hamiltonian in 
diamagnetic substances contains following contributions: chemical shift terms, ĤCS(t), quadrupolar 
coupling, ĤQ(t), direct dipole-dipole, ĤDC(t), coupling, j-coupling, spin-rotation interactions (Levitt, 
2001): 
 [5]    Ĥint (t) = ĤCS(t) + ĤDC(t) + ĤQ(t). 
 
1.3.1. Chemical shift 
Each nucleus within the molecule is surrounded by electrons, which induce an additional magnetic 
field. This additional magnetic field contributes to the total field and therefore changes the nuclei 
resonance frequency. This frequency shift is called the chemical shift. The shielding interactions have 
two main components: diamagnetic (opposite to the applied field) and paramagnetic (supports the 
applied field). The chemical shift shielding Hamiltonian operator acting on a spin I has the following 
form (Duer, 2002): 
 [6]    ĤCS = - γ ħ Î·σ·Bo,  
where Î is a nuclei I spin operator, σ is a second-rank tensor, called the chemical shift tensor, and Bo is 
the applied magnetic field generating the electron current and as a result the shielding magnetic field. 
A second rank tensor σ is used to describe the shielding properties associated with a nucleus due to 
the electron distribution around it, because the size of the electron current around the field, and hence 
the size of the shielding depend on the orientation of the molecule within the applied field Bo.    43
The NMR spectrum is affected only by the symmetric part of the shielding tensor, and the coordinate 
system can be chosen in a way that the shielding tensor becomes diagonal. This axis frame is called 
the principal axis frame (PAF), or x
PAF, y
PAF, z
PAF (Figure 1.9). The numbers along the resulting 
diagonal of σ
PAF are the principal values, which can be expressed as the isotopic value σISO, the 
anisotropy ∆CS, and the asymmetry value ηCS (Duer, 2002):  
 
[7]     σISO = 1/3 (σ
PAF
XX + σ
PAF
YY + σ
PAF
ZZ) 
∆cs = σ
PAF
ZZ - σISO 
ηCS = (σ
PAF
XX - σ
PAF
YY)/∆CS. 
 
The frequency of the observed NMR signal is composed of the nucleus Larmor frequency, and a 
chemical shift contribution. Because of a shielding tensor axial symmetry, σ
PAF
XX = σ
PAF
YY and ηCS = 0 
through the polar angles (θ and φ) (Figure 1.9.) the equation for the spectral frequency simplifies to 
(Duer, 2002): 
 [8]    ωCS (θ) = - ωo σ
PAF
ZZ ½ (3cos
2θ – 1). 
Bo
Z PAF
X PAF
θ
φ
Bo
Z PAF
X PAF
θ
φ
 
 
Figure 1.9: Chemical shift tensor. The polar angles, θ and φ, defining the orientation of Bo field in the principal 
axis frame (PAF) are defined.   44
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Figure 1.10: Effect of chemical shift anisotropy. (A) In a crystal, the chemical shift anisotropy depends on the 
solid with respect to the magnetic field. (B) Presence of different molecular orientations gives rise to a powder 
pattern.  
 
Equation 8 has a direct implication. In a powder sample all orientations are present, meaning all 
values of the angle θ are possible. Therefore, each different molecular orientation implies a different 
orientation of the principal axis frame with respect to the applied field Bo, and so has a different 
chemical shift associated with it. As a result the spectrum takes the form of a powder pattern with 
lines from the different molecular orientations covering a range of frequencies (Figure 1.10 B). So, 
the powder pattern has a so called centre of ‘mass’ or ‘mean value’, the isotropic frequency ωiso. 
 
1.3.2. Dipolar coupling 
Each nuclear spin possesses a magnetic moment; therefore spins can interact through space (Figure 
1.11). This interaction is called dipole-dipole coupling. The dipolar coupling may have intramolecular 
and intermolecular origin and be homonuclear (when the spins Ij and Ik are the same species) and 
heteronuclear (when spins Ij and Ik are different). 
The direct dipole-dipole interaction between spins Ij and Ik can be presented by the spin Hamiltonian 
which in angular frequency units can be expressed in Rad 
s-1 (Duer, 2002):   45
 
 [9]    Ĥdd = -(μ0/4π) γI·γk ħ ((Ij·Ik/r
3) – 3((Ij·r)· (Ik·r)/r
5)),  
where  r is the vector between point magnetic dipoles, r is the distance separating two magnetic 
dipoles spins Ij and Ik, Ij and Ik spin operators of nuclei Ij and Ik, μ0 is the magnetic permeability of 
free space, and γj and γk are the gyromagnetic ratios for nuclei j and k. 
 
j k j k
 
Figure 1.11: The magnetic moment of nuclear spin generates a magnetic field. Magnetic fields originating from 
different nuclei interact through space like bar magnets. This interaction is called dipole-dipole coupling. 
 
For the homonuclear dipolar coupling case, using the rotating frame formalism the Hamiltonian can 
be presented as follows (Duer, 2002): 
[10]     Ĥdd = -d(3cos
2θ-1)[ÎjzÎkz - ½(ÎjxÎkx + ÎjyÎky)],    
                                            Term        A       and         B 
where d is the dipolar coupling constant given as (Duer, 2002): 
[11]     d  =  ħ(μo/4π) (1/r
3)γjγk. 
The terms A and B in equation 10 cause a large range of transition frequencies (Duer, 2002). It results 
in very broad lines in NMR spectrum in case of homonuclear dipolar coupling. 
In the case of heteronuclear coupling between spins Ij and Ik the term B in equation 10 is absent, 
because it is associated with the transverse component of the local field due to spin Ik and it is 
important only if this component precesses at or near the resonance frequency of the other spin Ij. 
Therefore the effect of heteronuclear coupling on NMR spectrum is simpler and the general form of 
the lineshapes in found to be that shown in Figure 1.12.   46
 
 
Figure 1.12: Heteronuclear dipolar coupling results in the powder lineshape (pake pattern) of a NMR spectrum. 
The splitting of the 'horn' is equal to the dipolar coupling constant (d, eq. 11). 
 
 
1.3.3. Quadrupolar coupling 
About 74 % of NMR active nuclei have a spin greater then ½. In addition to a magnetic dipole 
moment, they possess an electric quadrupolar moment. Therefore, these nuclei interact not only with 
the applied magnetic field and all local magnetic fields, but also with any electric field gradient 
present. This interaction additionally affects the nuclear spin levels. The strength of the quadrupolar 
interaction depends on the orientation of a molecule with respect to the applied magnetic field Bo, 
even though this is not a magnetic interaction. The form of the quadrupolar Hamiltonian describing 
the interaction between a nuclear quadrupole moment of a nucleous with a spin I and an electric field 
gradient in tensorial form is (Duer, 2002): 
[12]       ĤQ = (eQ/6I(2I - 1)) I·eq·I 
where eq is a tensor describing the electric field gradient, and eQ is the electric quadrupolar moment, 
constant for a given nuclei and does not change with the chemical environment of the nuclei for 
instance (e is a proton charge).  
Figure 1.13 shows the first-order quadrupolar powder lineshape for a spin-1 nucleus at a site of axial 
symmetry. The term m is the z component of spin in the initial spin level of a transition, so can take 
values m = +1 to m = 0 and m = 0 to m = -1, which gives rise to mirror image powder pattern   47
lineshapes. The sum of these two powder patterns produces a ‘pake pattern’ like spectrum. The 
splitting of the ‘pake pattern’ is equal to three quarter of the quadrupolar coupling constant (Duer, 
2002): 
  [ 1 3 ]     χ = e
2qQ/ħ. 
¾ χ
 
 
Figure 1.13: The first-order quadrupolar powder lineshape for spin-1 at a site of axial symmetry. The splitting 
of the `horn` in the pattern is equal to ¾ χ, where χ is the quadrupolar coupling constant. The horns are created 
by crystallites in which the principal axis z of the quadrupolar coupling tensor is perpendicular to the applied 
field Bo. 
 
It is worth mentioning that the quadrupolar interaction for the majority of the quadrupolar nuclei is in 
the order of MHz and modern NMR spectrometers produce RF pulses in a range of 100 kHz, 
therefore in these cases the quadrupole coupling dominates through the whole experiment. However, 
fortunately, it is not the case for the most often used in SSNMR quadrupolar nuclei, deuterium. For 
2H 
the quadrupolar coupling constant is about 160-190 kHz, which simplifies experiments.   48
 
1. 4. Spectral resolution in solid-state NMR 
Experimental techniques strongly differ between solution and solid state NMR. In solid-state NMR 
the information may be extracted from the anisotropic interactions which are averaged in solution 
state NMR. However, exactly these interactions may cause line broadening and need to be removed 
and selectively introduced to obtain structural information (Duer, 2002).  
 
1.4.1. Magic-angle spinning  
Line broadening in SSNMR is caused mainly by chemical shift anisotropy and dipolar coupling. The 
symmetric chemical shift anisotropy (CSA) can be removed when the vector connecting two nuclei 
forms an angle 54.74
o with respect to Bo. This could be accomplished by using a single crystal in 
which the CSA ellipsoid is oriented at an angle 54.74
o with respect to Bo. However, it is hard to 
perform, because single crystals are hard to obtain. In reality, we often deal with the samples lacking a 
unique CSA axis orientation. In such cases rapid spinning of a polycrystalline sample at the angle 
54.74
o makes average CSA look like ellipsoid whose axis is aligned with the spinning axis. It happens 
because the angle θ (Figure 1.14) varies with time as the molecules rotate with the sample.  
θR
θ
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shielding tensor
rotor
 
Figure 1.14: The MAS experiment. The value for angle θR is at the magic angle with respect to the applied 
magnetic field and it is under control during the experiment. The chemical shift tensor is represented by an 
ellipsoid. The angle θ is the angle between Bo and the principal z-axis of the shielding tensor, β is the angle 
between the z-axis of the shielding tensor principal axis frame and the spinning axis. 
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The average orientation dependence of the nuclear spin is (Duer, 2002): 
 [14]    <3cos
2 θ – 1> = 1/2(3cos
2θR – 1) (3cos
2β – 1). 
The angle β is fixed for each nuclei and the angle θ can have all possible values in a powder sample. 
The angle θR is set to 54.74
o ((3cos
2θR – 1) = 0). Therefore, the molecular orientation dependence of 
the nuclear spin interactions (3cos
2θ – 1) is removed if the spinning speed is fast enough to average θ 
compared with the anisotropy of the interaction (Duer, 2002). This technique is known as magic-angle 
spinning (MAS). If the spinning frequency is not high enough to average the anisotropic interactions, 
the spectrum consists of a line of isotropic chemical shift and a pattern of sidebands that are spaced by 
the rotation frequency. The intensity distribution of the sidebands still contain the information about 
the chemical shift anisotropy and consequently about the molecular geometry in the sample. 
 
1.4.2. Cross polarization 
 
 
1H 
2H 
13C 
15N 
19F 
31P 
Nuclear Spin, I  1/2  1  1/2  1/2  1/2  1/2 
Nuclear magnetic 
Moment, μ 
2.793 0.857 0.702  -0.283  2.689  1.131 
Gyromagnetic ratio, 
γ (rad T
-1 s
-1) 
26.75 10 
7 4.11  10 
7 6.73  10 
7 -2.71  ×10
7 25.16  10 
7 10.83  10 
7 
Quadrupole moment    2.73 10 -31         
Relative sensitivity  1.00  9.65 10 
-3 1.59  10 
-2 1.04  10 
-3 0.83 6.63  10 
-2 
Natural abundance  99.985  0.015  1.10  0.37  100  100 
 
Table 1.3: Comparison of gyromagnetic ratios, natural abundance, and relative sensitivity of the most used 
nuclei in solid-state NMR (adapted from Mason J. A. PhD thesis 2001). 
 
Apart from the problem associated with anisotropic broadening and short transverse relaxation times 
characteristic for solid-state NMR, there is one more factor. SSMAS spectra are characterized by poor 
signal to noise ratio. The reasons for that are multiple. Signal-to-noise ratio roughly scales with the 
inverse of the linewidths, as the integral intensity of the whole line is constant. The linewidths in 
SSNMR are typically 10-100 times broader compared to solution-state NMR (Opella, 1982). Another   50
reason is given by the type of nuclei which are used in SSNMR. The most popular nucleus for 
solution state NMR, 
1H often can not be used in SSNMR because of its high abundance and 
significant homonuclear dipole-dipole coupling. Nuclei like 
13C, 
15N and 
31P are characterized by 
lower anisotropy but have a smaller gyromagnetic ratio and are less sensitive for NMR (Table 1.3). 
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Figure 1.15: Cross polarization for heteronuclear spin pairs. A) at different transition frequencies of two spins 
ω1 and ω2, no energy-conserving transitions occur; B) when ω1 = ω2, C) the spins can exchange magnetization 
through an energy-conserving ‘flip-flop’ interaction (Laws et al., 2002).  
 
The situation is further complicated by the fact that longitudinal relaxation times are longer in solid 
state than in solution. A smaller number of scans can be accumulated in a given time. Overall, it is 
clear that without techniques allowing us to enhance the signal, the experiments on such a nucleus like 
13C are close to impossible. 
To enhance the signals from rare nuclei such as 
13C and 
15N, many SSNMR experiments are today 
routinely performed involving the transfer of polarization from abundant nuclei (usually 
1H) by using 
a technique called cross polarization (CP). The process of CP occurs through the tendency of the   51
magnetization to flow from highly polarized nuclei to nuclei with lower polarizations when the two 
are brought into contact. For homonuclear spins, the magnetization can be exchanged through mutual 
energy conserving spin flips. For heteronuclear pairs such as 
1H and 
13C, these spins flips are not 
energy conserving at high magnetic fields (Figure 1.15). Therefore, the exchange of magnetization is 
driven externally by the application of RF fields. 
 
1H
X
decoupling
contact 
pulse
1H
X
900
decoupling
contact 
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1H
X
decoupling
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pulse
1H
X
900
decoupling
contact 
pulse
 
Figure 1.16: Pulse sequence for cross polarization experiment (Hediger et al., 1994; Metz et al., 1994; Peersen 
et al., 1993; Stejskal et al., 1977). 
 
Among the techniques for establishing a dipolar contact between two different spin systems, a 
particularly effective approach is that of Hartmann and Hahn. This approach involves the 
simultaneous application of two continuous RF fields, one at the resonance frequency of one spin and 
one at the resonance frequency of the other spin in a way that the Hartmann-Hahn condition is 
satisfied (Laws et al., 2002): 
  [ 1 4 ]     γCB1
C = γHB2
H 
then the magnetization can be exchanged between two nuclei in energy conserving way by spin flip-
flop. The carbon signal enhancement is proportional to γC/γH ≈ 1/4, which is comparable with the 
NOE enhancement in solution state NMR. Moreover, as the polarization required for the experiment 
comes from protons and its longitudinal relaxation time is much faster that of any other nucleus, the   52
experiment can be repeated more frequently. The cross polarization experiment in solid-state NMR is 
often combined with the MAS and proton decoupling during detection. The standard CP pulse 
sequence is shown in Figure 1.16. 
 
1.4.3. Decoupling techniques 
In solution, dipole-dipole couplings are averaged to their isotropic value by molecular tumbling. This 
is not the case in solids; here the spectra` quality is strongly influenced by homo- and heteronuclear 
dipolar coupling between the nuclei. As discussed previously, the dipolar coupling depends directly 
on the magnitude of the distance between the two spins. Therefore, it not only causes linebroadening 
but can also provide a means to obtain internuclear distances and as a result leads to determination of 
the molecule geometry and conformation. There are many pulse sequences designed to remove and to 
selectively reintroduce dipolar coupling.  
 
Heteronuclear decoupling 
In most cases, proton coupling is needed to be removed. The simplest technique to remove 
heteronuclear proton dipolar coupling is through continuous high-power decoupling (Figure 1.17).  
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Figure 1.17: High-power decoupling removes the effect of the effect 
1H dipolar coupling on the NMR spectrum 
of X nucleus.  
 
The method includes applying continuous irradiation (CW) of very high power (100-1000 Watts) at 
the frequency of the proton resonance. The effect of the close-to-resonance RF irradiation is that   53
proton spins undergo repeated transitions at a rate determined by the amplitude of the RF irradiation 
and 
1H Larmor frequency. Therefore, the time dependent z-component of the 
1H spin in the dipolar 
coupled spin pair, which is affecting the X spin spectrum, approaches zero. 
More sophisticated methods to achieve heteronuclear decoupling are via applying TPPM (Takegoshi 
et al., 2001; Bennet et al., 1995), SPINAL (Fung et al., 2000), SPARC (Yu and Fung, 1998), FMPM 
(Gan and Ernst, 1997), and C12 (Eden and Levitt, 1999) pulse sequences. They all have similar 
efficiency, so our detailed consideration will be limited to TPPM decoupling pulse sequence.  
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Figure 1.18: TPPM decoupling pulse sequence of alternating phase φP  + ΔφP, each of flip angle θP. 
 
The two pulse phase modulation (TPPM) pulse sequence consists of continuous irradiation with two 
pulses of flip angle θP and phases which differ by ΔφP (Figure 1.18). The used RF power is usually 
about 100-150 kHz. The optimal values of θP and ΔφP are determined for each particular case 
experimentally, θP is often close to 180
o and ΔφP is in a range of 10 - 70
o. 
 
Homonuclear decoupling 
In the simplest case, the effect of homonuclear dipolar coupling may be removed by magic-angle 
spinning. If MAS is not sufficient to remove homonuclear decoupling, special pulse sequences are 
designed to deal with it. One of the first implemented were WAHUHA (Haeberlen and Waugh, 1968) 
and MREV-8 (Rhim et al., 1973) (Figure 1.19). Although the WAHUHA sequence is not used any 
more, it still serves as a good illustrative example of how such techniques works (Laws et al., 2002).   54
Here, the pulses are placed in a cycle through the period of induction decay in such a way that there is 
one detection point per cycle until the magnetization decay completely. In comparison to TPPM, 
WAHUHA does not average the geometrical part of Ĥ
homo dd but deals with the spin factor Ĥ
homo dd. 
While implementing WAHUHA pulse sequences together with MAS, it is necessary to synchronize 
the pulse sequence and free induction decay collection. Synchronization is not needed if the 
decoupling pulse sequence is used in the t1 dimension of a 2D pulse sequence.  
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Figure 1.19: A) pulse sequence for one cycle of the four-pulse WAHUHA decoupling sequence. B) The Lee-
Goldburg sequence is the continuous analogue, in which spins undergo rotation about an axis inclined at the 
magic angle in spin space. 
 
One more homonuclear decoupling sequence worth mentioning is frequency-switched Lee-Goldburg 
(FSLG) (Bielecki et al., 1990; Bielecki et al., 1989) (Figure 1.19). In FSLG the pulses of 360
o are 
applied continuously when decoupling is needed. The pulses are off resonance by amount of Δω in a 
way that the effective field experienced by nuclei in the rotating frame is oriented at the magic angle 
with respect to Bo. As a result the spin magnetization precesses completely by one turn around the 
effective field and the average homonuclear dipolar coupling is zero.  
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1.4.4. Recoupling techniques 
The above sections of this Chapter address the questions how to remove undesirable effects of 
chemical shift anisotropy and dipolar coupling, and how to approach the resolution of SSNMR spectra 
close to the resolution of solution state NMR spectra. However, in doing so, we loose all the 
information about the environment of the nuclei contained in CSA and dipolar coupling. To 
reintroduce the dipolar coupling and CSA for selected periods of experiments the certain pulse 
sequences are designed. Using these techniques the distances can be measured and the correlations 
based on proximity can be established. 
 
Homonuclear dipolar recoupling 
One of the first dipolar homonuclear recoupling techniques (DRT) is DRAMA (dipolar recovery at 
the magic angle) (Tycko and Dabbagh, 1990). During this sequence, two π/2 pulses per rotation 
period toggle the reference frame interrupting the averaging producing by MAS. DRAMA recouples 
not only dipolar coupling but the CSA as well. Therefore, additional π pulses are included usually in 
the experiment to refocus the CSA (Figure 1.20). 
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Figure 1.20: Pulse sequence for one cycle of the DRAMA homonuclear dipolar recoupling sequence consisting 
of π/2 pulses only. τr is a rotor period (Laws et al., 2002). 
 
The alternative approach to observe homonuclear dipolar coupling is to use the rotational resonance 
phenomenon. If the sample spinning speed is equal to or n times chemical shift difference between the   56
two spins of interest, the term B in equation 10 is reintroduced (Duer, 2002). The rotational resonance 
condition is achieved only between two spins, whose the dipolar coupling is measured (Raleigh et al., 
1988). In addition to DRAMA and rational resonance, a plethora of homonuclear recoupling 
sequences have been developed. In practice the most and commonly used DTR seem to be is RFDR 
(radiofrequency driven recoupling) and C7 (Brinkman et al., 2000; Carravetta et al., 2000). 
 
Heteronuclear dipolar recoupling 
 
180º 90º
I
180º
S
rotor
0            1            2             3              4
180º 90º
I
180º
S
rotor
0            1            2             3              4  
Figure 1.21: REDOR experiment sequence. 
 
A number of experiments have been designed to measure the heteronuclear dipolar coupling, based on 
the same principle and similar to the well known rotation-echo double resonance experiment 
(REDOR) (Figure 1.21) (Gullion and Schaefer, 1989). The general idea of this experiment is that 
magnetization of spin I, which is created by a simple 90
o pulse, is left to refocus under the influence 
of S spin. The refocusing of dipolar coupling is prevented by a series of rotor-synchronized 180
o 
pulses applied to spin S. To obtain the value of dipolar coupling between spin I and S, the extent of I 
dephasing is monitored as a function of the number of rotor periods for which the dephasing is 
allowed.  
As the strength of the heteronuclear dipolar coupling approaches ~ 25Hz, it becomes very difficult to   57
determine distances by using REDOR. This corresponds to a 
15N – 
13C distance of ~ 5 Å and 
13C – 
31P 
distance of ~ 7.5 Å. These distances exceed those typically studied by solution-state NMR and they 
can provide useful constrains in structural studies of solids. This approach is, unfortunately, not 
suitable for large dipolar couplings, because in this case the magnetization is completely dephased in 
one or two rotor periods. Under these circumstances, there are not enough data points to perform a 
careful analysis (Laws et al., 2002).   58
 
1.5. Solid-state NMR in application to membrane transporters 
As stated previously, high-resolution structures of membrane transporters as well as of high molecular 
weight complexes are rare. Membrane transporters are difficult to crystallize; membrane proteins are 
surrounded by lipids and may aggregate when removed from their normal environment. The same 
characteristics also hinder solution spectroscopy which is also not suitable for very large complexes 
due to the lack of fast isotropic tumbling needed for good spectral resolution.  
Solid-state NMR is not limited by these problems and, in principal, can be readily applied to almost of 
those systems. The molecular weight limit that can be studied by solid state NMR is almost 
unreachable and the field has seen a number of publications on high molecular weight proteins 
(Basting and Lehner, 2006; Luca et al., 2005; Creemers et al., 2004; Williamson et al., 2001; Glaubitz 
et al., 2000; Spooner et al., 1998; Watts et al., 1998; Opella, 1982).  
For the first time SSNMR has been applied to transporters by Watts and co-workers who have 
detected the substrate glucose bound to GalP transporter (Spooner et al., 1994). First SSNMR 
investigations on GalP transporter were followed by studying E. coli FucP (Spooner et al., 1998) 
GusB, NupC transporters (Patching et al., 2004b; Patching et al., 2004a), and EmrE MDR pump 
(Glaubitz et al., 2000), as well as Streptococcus thermophilus LacS transporter (Spooner et al., 1999). 
These and some other studies aiming to obtain structural information on substrate binding are listed in 
introduction to Chapter 5.  
Interestingly, in all cases the studies have been limited to drug-protein interaction with labeled 
substrate and in no cases isotope labeled proteins were used.  
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Aims of the thesis 
 
ABC transporters compose a facility of membrane proteins that is associated with many genetic 
disorders as well as with the resistance to antibiotics and cancer chemotherapy. The latter is mediated 
by over expression of multidrug efflux pumps. The first discovered and the best characterized until 
now the human MDR transporter ABC transporter is P-glycoprotein. The closest structure and 
functional homologue of P-glycoprotein found in bacteria is LmrA from Lactococcus lactis.  
ABC transporters are extremely difficult for structural analysis and whilst a number of advances have 
been made, progress in this field remains relatively slow. Solid-state NMR is a powerful technique for 
obtaining structural constrains and in the past years SSNMR had showed its potency for getting those 
constrains for membranes, relatively small proteins and peptides. As SSNMR can deal with 
membrane embedded and/or membrane associated proteins and peptides, it has a potential to produce 
high-resolution information for such proteins like membrane transporters. 
This thesis aims to approach ABC MDR transporters for characterization at atomic level with 
SSNMR. In doing so, several goals have to be achieved.  
1. It will be demonstrated how large quantities of functionally active and selectively isotope labeled 
LmrA reconstituted at a high density in lipid membranes, sufficient for advanced NMR studies can be 
produced.  
2. Using selectively CD3 alanine labeled LmrA reconstituted into E. coli liposomes, it will be 
investigated if LmrA undergos conformational changes affecting the dynamics protein properties 
upon AMP-PNP binding and in ATP/ADP-Vanadate tapped state. 
3. Using isotope non-labelled protein reconstituted into proteoliposomes, the ligand binding will be 
explored via intrinsic tryptophan fluorescence quenching approach and solid-state NMR spectroscopy. 
4. The membrane preferential location of nine LmrA and P-glycoprotein substrates will be 
investigated via 
1H-NOESY NMR spectroscopy and the results will be correlated with existing ABC 
MDR transporters binding sites models.   60
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2. Development of defined media for isotope labelling of LmrA from 
Lactococcus lactis 
 
Abstract 
The aim of this chapter is to present a cost efficient procedure for biosynthetic selective amino acids 
labelling of the ABC MDR transporter LmrA expressed in L. lactis for SSNMR. A variety of 
techniques have been established for biosynthetic uniformly and selective amino acid labelling of 
proteins expressed in E. coli. However, to our knowledge isotope labelling has never been shown for 
proteins expressed in L. lactis.  
The results of this Chapter have been partially published: Mason A.J., Siarheyeva A., Haase W., 
Lorch M., van Veen H., Glaubitz C., Amino acid type selective isotope labelling of the multidrug 
ABC transporter LmrA for solid-state NMR studies, FEBS Letters  568 (1-3): 117-121 June 18 2004. 
 
2.1. Introduction 
Unlike in solution-state NMR, the proton resonance alone is not sufficient for resonance assignment 
of large biomolecules in solid-state NMR, because even sophisticated resolution enhancement 
techniques such as combined rotation and multiple pulse sequences are not able to reduce the 
linewidths to achieve the resolution needed. Therefore, problems associated with direct 
1H 
observation in solid-state NMR has made isotope labelling an absolute requirement. Commonly stable 
isotopes such as 
13C, 
15N, 
19F and 
2H are enriched. In particular low-γ nuclei, like 
13C or 
15N are 
commonly used, primarily because they have relatively large chemical shift ranges and small dipolar 
couplings. The combined labelling approach opens a door to the development of higher dimensional 
experiments and allows larger proteins to be studied (Straus, 2004; Lian and Middleton, 2001b). The 
labels can be introduced into the protein and peptide structure by chemical modifications or 
biosynthetically. Solid-phase synthesis is widely used to directly synthesize polypeptides with length 
that are between 2 to 40 residues long. The chemical modification strategy includes such methods as   62
methylation of the lysine side groups, covalent modification of cysteine sulfhydryl groups or 
15N 
tyrosine nitration (Lian and Middleton, 2001a; Goto and Kay, 2000; Danielson and Falke, 1996b). 
The biosynthetic approach includes usage of 
15N and 
13C labeled precursors as the sole nitrogen or 
carbon sources, or selectively labeled amino acids as a source of nutrients during protein expression. 
As an example, extensive 
13C labelling in E. coli can be achieved by substitution of glucose or acetate 
in a growth medium by their fully labeled analogues or by adding fully labeled glycerol as the only 
carbon source (Lian and Middleton, 2001a; Goto and Kay, 2000; Hong and Jakes, 1999; Stryer, 
1988). To achieve full 
15N labelling, 
15N-labelled ammonia can be used as the sole nitrogen source 
(Castellani et al., 2002). An alternative approach is to apply selective extensive labelling. Selective 
labelling can be achieved using partly labeled glucose or glycerol (Lian and Middleton, 2001b; 
LeMaster, 1994). In a similar manner, sample deuteration can be obtained, when the deuteration is 
needed to simplify NMR spectra aiming to improve relaxation properties of the remaining protons. 
This is used mainly in solution state NMR to increase the protein molecular mass limit (Goto and 
Kay, 2000; Morgan et al., 2000). Amino acid type selective isotope labelling can be used to observe 
selected amino acids (Goto and Kay, 2000). For this purpose the amino acids of interest are replaced 
by their isotope labeled analogues in the growth media. This biosynthetic approach can be 
complicated however by cross-labelling and isotopic dilution. The problems can be solved by using 
the appropriate auxotrophic strains. For the case of E. coli a complete library of auxotrophic strains 
exists in the genetic Stock Centre at Yale University (Lian and Middleton, 2001b). For protein 
production in quantities suitable for NMR experiments the strain auxotrophy must be further 
combined with over expression of the desired protein. Examples of multi-domain membrane proteins 
that can be heterologously expressed at levels suitable for structural studies are rare and examples 
where such proteins have been labeled for NMR purposes are even rarer (Creemers et al., 1999; Eilers 
et al., 1999). 
Whilst the bacterium E. coli is one of the most popular systems in which to overexpress membrane 
proteins (Drew et al., 2003; Lian and Middleton, 2001b), recently protocols have been developed to 
express membrane proteins in alternative protein expression systems including Pichia pastoris, 
Chinese hamster ovary cell, SF9 cells, and Semliki forest virus cells (Chen et al., 2006; de Lamotte et   63
al., 2001; Goto and Kay, 2000; Morgan et al., 2000). Cell free synthesis has been successfully applied 
to membrane proteins (Klammt et al., 2004) but may not be capable of producing such large proteins 
as ABC transporters in a correctly folded and functional state.  
For this reason, we have sought to take advantage of the ability to produce large amounts of 
functional LmrA in L. lactis to prepare samples for NMR experiments. The L. lactis expression 
system has many advantages, (1) the organism is easy and inexpensive to culture; (2) the expressed 
membrane proteins are normally targeted to the cytoplasmic membrane, (3) it has a single membrane 
and (4) relatively mild proteolitic activity (to date only two proteinases are known) and (5) methods 
for genetic manipulations as well as a nisin induction system are established and available (Mierau 
and Kleerebezem, 2005). To create the nisin-controlled expression system (NICE), the auto-induction 
properties of nisin were used. So, the signal transduction system nisK and nisP were isolated from the 
nisin gene cluster and inserted into the chromosome of L. lactis strain MG1363 (nisin-negative), 
creating the strain NZ9000. When the gene of interest is subsequently placed behind the inducible 
promoter PnisA on a plasmid (pNZ8048), expression of that gene can be induced by addition of sub-
inhibitory amounts of nisin (0.1 – 5 ng/ml) to the culture medium (Mierau and Kleerebezem, 2005). 
Lactococci lack various biosynthetic pathways when compared with E. coli for example, so that they 
require certain nutrients, especially amino acids and vitamins (Konings et al., 2000). The strain used 
here, pNH LmrA NZ9000 is Glu (or Gln), Leu, Ile, Val, His and Met auxotrophic (Kunji et al., 2003). 
This multiple auxotrophy, allows efficient isotopic labeled amino acid incorporation, but eliminates 
the possibility of uniformly labelling using minimal medium. The use of the L. lactis expression 
system for NMR studies on selectively and uniformly labeled membrane proteins is complicated by 
the fact that to date, knowledge about both carbon and nitrogen metabolism of L. lactis bacterium for 
growth in chemically defined media is limited.  
Earlier attempts to define the composition of chemically defined medium for Lactococcus or 
Lactobacillus strains allowed the basic components and the composition of this medium for L. lactis 
strain 2118 to be highlighted (Novak et al., 1997; Cocaign-Bousquet et al., 1995a; Poolman and 
Konings, 1988; Otto et al., 1983). The general outcome of many studies made on Lactococcal species 
is that with respect to specific requirements for nutrient this group is heterogeneous (Mierau et al.,   64
2005; van Niel and Hahn-Hagerdal, 1999) and for each strain the nutrients requirements must be 
considered separately. For L. lactis strain pNZ9000 used for LmrA over expression neither the 
components nor the concentration of the various components of defined medium has been previously 
optimized. 
In this chapter the development of the chemically defined medium for L. lactis strain pNZ9000 has 
been demonstrated. Using L. lactis expression system large quantities of selectively 
13C-glycine 
labeled LmrA (ca. 1mg LmrA/liter culture), sufficient for solid-state NMR experiments are produced. 
First solid-state NMR spectra are presented showing the suitability of this system for further studies of 
LmrA structure and function. In so doing, a large (64 kDa) ABC transporter becomes accessible, for 
the first time, to NMR techniques previously restricted to much smaller proteins. In addition, attempts 
to enhance the labelling efficiency and protein yield are described.  
 
 
2. 2. Materials and methods 
 
2.2.1. Optimization of defined media composition 
 
Materials 
L. lactis strains pNH LmrA NZ9000 and NZ9700 was a gift from H.W. van Veen (University of 
Cambridge). Difco Laboratories’ M17 medium was obtained from BD, Sparks, MD; n-dodecyl-β-D-
maltoside (DDM) from Glycon Biochemicals GmbH, Luckenwalde, Germany; Ni
2+ nitriloacetic acid 
(Ni-NTA) resin from Qiagen Inc. All other materials were reagents of analytical grade. 
 
Microorganism and media 
L. lactis strain NZ9000 was used as a host for expression vector pNH LmrA, strain 8048 non over 
expressing LmrA was used as a control whilst NZ9700 was used as a nisin producing strain 
(Margolles et al., 1999) Cells were cultured overnight at 30˚C in M17 medium or defined medium, 
both supplemented with 0.5 % (w/v) glucose and 5 µg/mL chloramphenicol, and used to start large 
scale cultures grown at 30˚ without shaking.   65
 
Nisin production 
L. lactis NZ9700 was grown in M17 medium until OD660 ~ 0.9 and then the cells were harvested. The 
nisin contained in the supernatant was stored in 1 ml aliquots at -20
oC. To induce LmrA expression it 
was diluted 1000 fold in the growth medium. 
 
Preparation of a defined medium 
 
Amino acids, g/L 
Alanine 
Arginine 
Asparagine 
Aspartic acid 
Cysteine 
Glutamic acid 
Glutamine 
Glycine 
Histidine 
Isoleucine 
Leucine 
Lysine 
Methionine 
Phenylalanine 
Proline 
Serine 
Threonine 
Tryptophan 
Tyrosin 
Valine 
Adenine 
Guanine  
Uracil 
 
0,3 
0,36 
0,48 
0,04 
0,12 
0,48 
0,48 
0,12 
0,12 
0,36 
0,84 
0,72 
0,20 
0,36 
0,6 
0,12 
0,36 
0,09 
0,24 
0,6 
trace 
trace 
trace 
Salts, g/L 
NH4CL 
KH2PO4 
K2HPO4 
MgSO4 
NaCL 
 
 
 
 
Vitamins, g/L 
Thiamine 
Riboflavine 
Niacine 
Pyridoxal HCL 
Aminobenzoic acid 
Folic acid 
Biotin 
 
 
3,75 
2,5 
3,25 
0,87 
0,525 
 
 
 
 
 
0,0001 
0,001 
0,001 
0,0023 
0,0001 
0,001 
0,0001 
 
Table 2.1: Chemically defined medium. 
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The medium (Table 2.1) was prepared as follows. Phosphates, magnesium, ammonium salts and all 
amino acids were dissolved and autoclaved separately. Glucose was prepared as a 20 % stock 
solution, chloramphenicol as a 30 mg/ml stock solution in ethanol, vitamins as a 100-fold stock 
solution, stored at 4
oC (Phan-Thanh and Gormon, 1997). The pH of the medium was 6 – 6.5 and was 
maintained without further adjustments. The bacterial growth was followed by measuring the culture 
optical density at wavelength 660 nm every 40 minutes on a UV-550 Jasco spectrophotometer. Over 
expression of LmrA was achieved by induction with 1 % nisin at OD660 0.7. 
Optimization of a chemically defined medium was done by comparing L. lactis growth with different 
concentrations of amino acids. The concentration of amino acids was increased in 20 % steps starting 
with 80 % of the original recipe (Table 2.1). To examine the auxotrophy for selected amino acids, L. 
lactis strain NZ9000 over expessing LmrA was grown on the chemically defined media (CDF) 
lacking glycine, tryptophan, serine, or both serine and glycine.  
 
Preparation of inside out vesicles 
Preparation of inside-out vesicles was done as described preciously (van Veen et al., 2000a). L. lactis 
cells were harvested by centrifugation, washed with 100 mM Tris, 50 mM KCl buffer, pH 7 and 
resuspended in approximately 20 mL of the same buffer. 1 mL of lysozyme stock solution (200 
mg/mL) was then added to digest the cell walls. The dissolved pellets were incubated for 30 minutes 
at 30
oC and the cells were lysed by passage through a cell disrupter (1.5 kPa). 20 µl (100 µg/mL) 
DNase I and 200 µL of 1 M MgSO4 were added to the cell suspension, which was further incubated 
for 15 min at 30
oC. Unbroken cells and cell debris were removed by centrifugation 10000 rpm for 20 
minutes at 4
oC. The vesicles were harvested by ultracentrifugation for 30 minutes at 50000 rpm. The 
protein concentrations in the vesicles were measured using the Bio-Rad DC protein assay kit as 
adapted from Lowry (Lowry et al., 1951). 
 
Purification of LmrA 
Purification of histigine-tagged LmrA ISOVs were solubilised on ice with the solubilization buffer 
(100 mM Tris, 50 mM NaCl, 10 % (v/v) glycerol, 3 % (w/v) DDM, pH 8.0) for an hour. The   67
unsolubilised fraction was removed by ultracentrifugation (55000 rpm, 40 minutes). The supernatant 
was incubated with Ni-NTA agarose for one hour on ice. Ni-NTA agarose was preliminarily 
preequalibrated with buffer A (100 mM Tris, 50 mM NaCl, 10 % (v/v) glycerol, 0.05 % (w/v) DDM 
and 10 mM Imidazole, pH 8.0). After the incubation, the resin was loaded on a column (Pharmacia) 
attached to an ÄKTA prime HPLC. Non-histidine tagged proteins were washed from the column with 
buffer A an B (100 mM Tris, 50 mM NaCl, 10 % (v/v) glycerol, 0.05 % (w/v) DDM and 10 mM 
Imidazole, pH 8. 0 and 7.0) respectively. When no further protein was detected in the flow (OD 
monitored at 280 nm), LmrA was eluted with buffer B supplemented with 250 mM Imidazole. All 
handlings were carried out at 4
oC. 
 
Hoechst-33342 transport in membrane vesicles 
20 µL inside-out membrane vesicles (about 6 mg/mL) were diluted to 2 mL volume with 100 mM 
Tris, 50 mM KCl buffer, pH 7, containing 2 mM MgSO4. After 1 minute incubation at 30
oC 10 µL 1 
mM Hoechst-33342 was added. 20 µL 100 mM ATP was added when the intensity of the 
fluorescence reached a plateau. The experiment was repeated with ADP in place of ATP. All 
measurements were carried out with excitation and emission wavelengths of 355 and 457 nm 
respectively and a slit width of 3 nm on the Jasco FP-6300 spectrophotometer (Kamihira et al., 2005; 
Shapiro and Ling, 1995). 
 
2.2.2. Metabolic labelling of LmrA ISOVs with 
13CO labeled amino acids 
The amino acid selective labelling has been probed using 
13C labeled glycine and tyrosine. Glycine 
was chosen to be the amino acid of interest because there are 49 glycines in LmrA sequence and it is 
one of the cheapest amino acids making it a good candidate to perform first NMR experiments aiming 
to reveal the amenability of LmrA to isotopic labelling. As a next candidate for selective amino acid 
labelling, tyrosine was chosen. There 14 tyrosines in LmrA sequence and several of them can be 
involved in substrate binding.  
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2.2.3 Attempts to enhance protein yield and labelling efficiency 
 
Attempts to enhance protein yield 
1. L. lactis NZ9000 were grown to OD660 1.44, harvested, washed with 100 mM Tris, 50 mm KCl, pH 
7 buffer. In three series of experiments equal amounts of cells (from 1 liter of M17 media) were 
transferred into different volumes of defined media. The defined media volumes were equal, half, and 
one fourth of the initial rich medium volumes. In the fresh defined media the cells were left to adapt 
for 20 minutes and finally induced with nisin. The L. lactis cells growths were followed by measuring 
the OD660. After 2.5 hours the cells were harvested. LmrA expression was monitored with SDS-
PAGE.  
2. The cells were initially grown on the chemically defined media containing 50 % of the initial 
concentration of non labeled amino acid (tyrosine). The 
13C isotope labeled tyrosine (50 % of the 
optimum concentration) was added at the induction stage. 
 
Attempts to inhibit aromatic amino acids synthesis 
L. lactis strain pNZ9000 over expressing LmrA was grown on the chemically defined medium 
containing 
13CO phenylalanine in place of unlabeled phenylalanine and in the presence of glyphosate 
(1 g/L) (Kim et al., 1990). Prior to addition, glyphosate has been dissolved in 1 M NaOH. 
 
Solid-state NMR measurements 
All experiments were performed on a Bruker Avance 600 spectrometer equipped with a 4 mm MAS 
DVT probe. The measurements were performed at 150.9 MHz for 
13C, 70.9 MHz for 
15N using a 
CPMAS pulse program employing a 80-100% ramped Hartmann-Hahn condition, two pulse phase 
modulated (TPPM15) heteronuclear 
1H decoupling at a field of 62.5 kHz and a 49 ms acquisition 
time. CP contact times and recycle delay times were respectively 1.5 ms and 2 s. Spectra were zero 
filled to 16K points and 100 Hz exponential line broadening was applied during processing. Spectra 
were referenced externally to the carbonyl resonance of glycine at 176.03 ppm (
13C), (
15NH4)2 SO4 27 
ppm. For each 
13C spectrum between 20k to 30k scans were accumulated.   69
2. 3. Results  
 
2.3.1. Optimization of defined media composition 
Figure 2.1A shows that the L. lactis growth curve was not significantly affected by varying the amino 
acids concentrations. Therefore, increasing the amino acid concentration would more likely lead in 
future to a waste of expensive isotopic labeled amino acids. The usage of the defined medium, 
composed of variety amino acids, implies that an excess of amino acids facilitates amino acids 
incorporation, preventing their biosynthetic degradation. For this reason, lowering the amino acid 
concentration in the chemically defined medium should be done with caution. The optimal 
concentrations of amino acids are listed in the Table 2.1.  
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Figure 2.1: (A) Growth of L. lactis with different amino acid concentrations, accordingly, 80, 100, 120, 140, 
160, 180 % amino acids when comparing with the amounts listed in the Table 2.1. Total protein concentrations 
in all cases were ca. 3 mg/L. (B) L. lactis growths in the chemically defined media with either serine (black line) 
or glycine (red line) missing; CDF media with complete amount of amino acids (green line) (Table 2.1). 
 
L. lactis growth was not essentially altered when glycine and tryptophan were missing in the defined 
media, moderate inhibition of L. lactis growth was noticed in case of serine (Figure 2.1B, 2.2) as well 
as when both glycine and serine together were removed from the defined media (Figure 2.2).  
Figure 2.3A compares typical L. lactis growth curves for the optimized defined medium versus M17 
medium. L. lactis grow in the chemically defined medium approximately with the same rate as in the 
M17 medium until OD660 reaches 0.8 where the bacteria enter stationary phase in defined media but 
continued their growth in the rich media. LmrA yield in the defined medium was ca. 1 mg/L which is   70
three times less when compared with the M17 medium (ca. 3 mg/L). The protein over production and 
its reproducibility in the chemically defined medium and the M17 is conformed by SDS-PAGE 
(Figure 2.3B).  
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Figure 2.2: L. lactis growths in the chemically defined media with either no tryptophan (red line), or no serine 
and glycine, (green line) defined media with complete amount of amino acids (black line) (Table 2.1). 
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Figure 2.3: (A) L. lactis growth in the M17 (ca. 10 mg/L total protein) and in the chemically defined medium 
(CDF) (ca. 3 mg/L total protein). L. lactis grew in CDF approximately to half of the cell density when 
comparing with the M17 medium and this difference in cell densities is reflected in total protein concentration. 
(B) SDS - PAGE analysis with 40 % acrylamide gel shows LmrA overexpression in L. lactis: 1, 8 -- standards; 
2, 3 – L. lactis ISOV, M17 media; 4 - 7 – ISOV, the defined medium. 
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Hoechst transport assay in ISOVs 
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Figure 2.4: Hoechst-33342 transport in the membrane vesicles. LmrA – mediated transport was measured by 
fluorescence Hoechst-33342 assay. Dye was added after 1 minute of incubation at a room temperature. When 
intensity of fluorescence reached plateau ATP or ADP was added.  
 
To examine the functional state of LmrA overexpressed in the chemically defined medium a Hoechst 
transport assay was performed. Hoechst-33342 has been shown to be a substrate for LmrA and P-
glycoprotein (Shapiro and Ling, 1995). The Hoechst transport assay is based on the well known fact 
that Hoechst-33342 dye is fluorescent in lipid environment and non-fluorescent in aqueous 
environment. Addition of Hoechst-33342 to ISOVs results in a steep increase in fluorescence intensity 
due to the rapid partitioning of dye into the vesicles (Figure 2.4). Hoechst-33342 binding to the 
liposomes was essentially complete within 30 seconds, as judged by the fluorescence increase. It has 
been shown earlier  that about 90 % of the Hoechst-33342 added became bound to the lipids (Shapiro 
and Ling, 1995). At the point when Hoechst-33342 fluorescence reaches equilibrium distribution 
between the vesicles and buffer environment ATP is added. A 5-10 % fluorescence drop immediately 
after ATP addition is caused by dilution. Slow fluorescence intensity decrease follows ATP addition 
because of Hoehst-33342 pumping out of the lipid layer. An ATP regeneration system consisting of 
creatinine kinase and creatinine phosphatase maintains constant ATP concentration which allows 
observing pumping on a time scale of up to 1000 seconds. Control experiments are made with ADP 
place ATP. No changes in Hoechst-33342 fluorescence intensity are observed after addition of ADP. 
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2.3.2. Metabolic labelling of LmrA ISOVs with 
13CO labeled amino acids 
CPMAS spectra of 
13C LmrA ISOVs natural abundance and 
13CO glycine labeled LmrA ISOVs were 
recorded at temperature as low as 253K (Figure 2.5). Together with the signal from lipids, the spectra 
showed increased intensity in the amino acid carbonyl resonance region. Subtraction of CPMAS 
spectra of 
13C LmrA ISOVs natural abundance from 
13CO glycine labeled LmrA ISOVs (Figure 2.5) 
revealed the presence of the labeled LmrA in the sample manifested as a peak at 172.4 ppm. 
The large number of glycine residues and low chemical shift separation precludes the extraction of 
information from the spectra in Figure 2.5. Less abundant amino acid is tyrosine, there are 14 tyrosine 
residues in LmrA sequence compared with 49 glycines and several tyrosines are located in the 
transmembrane helices 5 and 6 which are proposed to be involved in the drug binding and transport 
(Ecker et al., 2004). It is widely thought that aromatic amino acids like tyrosine might form the 
binding sites for drugs (Dougherty, 1996). Hence, labeled tyrosines might provide a valuable reporter 
on LmrA function.  
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Figure 2.5: 
13C CPMAS spectra of LmrA ISOVs A) 
13CO labeled glycine LmrA ISOV, B) 
13C natural 
abundance LmrA ISOVs, C) spectral subtraction (A from B) revealing contribution from protein. Spectra 
recorded at 8 kHz MAS spinning frequency and at temperature of 253K.   73
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Figure 2.6: 
13C CPMAS spectra of LmrA ISOVs A) 
13CO labeled tyrosine LmrA ISOVs, B) 
13CO labeled 
ISOVs prepared from L. lactis strain 8048, C) spectral subtraction (A from B) revealing contribution from 
LmrA. Spectra recorded at 8 kHz MAS spinning frequency and at temperature of 243K. 
 
The CPMAS spectrum of 
13CO tyrosine labeled LmrA ISOVs was compared with the CPMAS 
spectrum of 
13CO tyrosine labeled ISOVs produced by L. lactis strain 8048 which does not over 
express LmrA. Both spectra were recorded at 243K. The subtraction of the first spectrum from the 
second (Figure 2.6) confirmed the presence of 
13CO tyrosine labeled LmrA. However the chemical 
shift resolution of spectrum for fourteen 
13CO tyrosines is not any better when compared to 
13CO 
fourty nine glycines. The reasons for this may include high background signal from other labeled 
proteins in ISOVs and from 
13C natural abundance.  
 
2.3.3. Attempts to enhance protein yield and labelling efficiency 
 
Attempts to enhance protein yield 
A simple procedure to increase the yield of isotopically labeled proteins presented by Marley (Marly 
et al., 2001) was applied. The idea is to grow the cells predominantly on unlabelled rich medium   74
allowing rapid growth to high cell densities and then at induction point to transfer the cells into 
isotopically labeled defined medium. This method aims for more efficient and targeted incorporation 
of often expensive isotope labeled amino acids into the protein of interest. 
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Figure 2.7: SDS-PAGE analysis with 40 % acrylamide gel as the evidence of LmrA over expression in L. lactis 
grown in 1 liter (2), half liter (3), and one forth liter (4) of the defined media, transferred from 1 liter of M17 
media, standards (1).  
 
 
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
0 50 100 150 200 250 300 350
0.0
0.5
1.0
1.5
2.0
2.5
3.0
O
D
 
6
6
0
time (min)
M17
equal CDF
half CDF
one fourth CDF
transfer point
 
Figure 2.8: L. lactis growth in the chemically defined medium. The L. lactis cells were grown in the M17 media 
(black line) and further transferred in equal (red line), half (green line), and one forth (blue line) volume of the 
defined media comparing to initial M17 media volume. The growths were followed by measuring OD660. 
 
The bacterial growths were followed before and after transferring from the M17 into equal, half and 
one fourth volume of the chemically defined media compared with the initial volume of rich media, as 
described in the methods (Figure 2.8). The total protein yields determined for all three cases were 
accordingly 28, 44 and 144 mg per liter of the defined media. The increased cell densities and total 
protein concentrations reflect mainly different cells densities at the initial point of cell growth in the   75
defined media; the real increase in protein expression level is not that high. The LmrA over 
expression is shown on SDS-PAGE (Figure 2.7). In the next step the 
13CO tyrosine incorporation with 
the method described above was compared for the strain 8048 (not over expressing LmrA) and pNH 
LmrA. The CPMAS spectra for both cases were recorded at 243K (Figure 2.9). The spectrum shows 
the signal in the protein carbonyl region confirming efficient 
13CO tyrosine incorporation. Subtraction 
of the spectra allows an estimate that LmrA comprises approximately 20 % of the total protein. The 
13C tyrosine resonances overlap on the spectra (Figure 2.9) and the resonances from different residues 
can not be resolved.  
LmrA his-tagged purification was performed as described in the methods. Unfortunately, it was not 
possible to purify LmrA although LmrA over expression in ISOVs was clearly shown by SDS PAGE 
electrophoresis (Figure 2.7). Prolonged protein solubilization time (up to 3 hours) led to the same 
results. 
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Figure 2.9: 
13C CPMAS spectra of LmrA ISOVs A) 
13CO labeled tyrosine LmrA ISOVs, B) 
13CO labeled 
tyrosine 8048 ISOVs. In both cases cells are grown on the M17 medium until OD660 0.9 and transferred into the 
isotope enriched medium. To prepare LmrA enriched ISOVs, cells were inducted after transferring. C) spectral 
subtraction (A from B) revealing increased signal from 
13CO tyrosine labeled LmrA. Spectra recorded at 8 kHz 
MAS spinning frequency and 243K. 
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Figure 2.10: Hoechst-33342 transport assay result obtained for the membrane ISOVs performed for L. lactis 
cells transferred from M17 media into equal, half and one fourth volumes of defined media versus initial M17 
media volume. Dye was added after 1 minute of incubation at room temperature. When intensity of fluorescence 
reached plateau ATP or ADP was added.  
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Figure 2.11: 
13C CPMAS spectra of LmrA ISOVs A) 
13CO labeled tyrosine LmrA ISOVs prepared from 
L.lactis cell grown on the chemically defined medium containing full amount of 
13C tyrosine from the beginning 
B) 
13CO labeled tyrosine ISOVs prepared from the cells grown on the chemically defined medium enriched with 
half amount of labeled tyrosine at the induction point. C) spectral subtraction (A from B) revealing reduced 
13C 
tyrosine incorporation Spectra recorded at 8.5 kHz MAS spinning frequency and at 260K.   77
 
In addition, Hoechst transport assays on ISOVs performed from L. lactis cells transferred from M17 
media into equal, half and one fourth volumes of defined media versus initial M17 media volume 
were unable to detect the active protein. Figure 2.10 shows typical Hoechst-33342 transport assay 
results.  
The trial to reduce cost of labels was done using the protocol developed by Cai (Cai et al., 1998) for 
protein expressed in E. coli. For this purpose L. lactis cells were grown on the defined media in which 
half the required amount of the isotope labeled amino acid was added after induction. The 
13C 
spectrum of ISOVs prepared from the cells grown in this way is compared with the spectrum of 
ISOVs prepared from bacteria cells cultured on defined medium containing the whole amount of 
isotope labeled tyrosine from the beginning (Figure 2.11). The spectral subtraction reveals that 
13CO 
tyrosine incorporation is slightly reduced when only half amount of labeled amino acid is added after 
induction point; however the signal in carbonyl region from 
13CO tyrosine remains strong.  
 
Attempts to inhibit aromatic amino acids synthesis 
A method to achieve more efficient incorporation of labeled aromatic amino acids has been 
previously introduced for E. coli (Kim et al., 1990). The idea of this approach is that the glyphosate 
inhibits 5-enolpyruvylshikimic acid-3-phosphatesynthase reaction needed for aromatic amino acids 
biosynthesis. In this way aromatic amino acid synthesis is hampered and bacteria are obliged to 
incorporate endogenous amino acids. In principle, by applying this method, any aromatic amino acids 
might be incorporated with similar efficiency to auxotrophic strains (Kim et al., 1990). 
Figure 2.12 shows the comparison of 
13C spectra of L. lactis ISOVs containing 
13C labeled 
phenylalanine. The cells were grown on the chemically defined media with and without glyphosate 
inhibitor; however the spectra did not show the expected increase label incorporation when inhibitor 
is used. 
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Figure 2.12: 
13C CPMAS spectra of 
13CO labeled phenylalanine LmrA ISOVs, the bacteria were grown in the 
presence of glyphosate A) and in the absence of inhibitor B), spectral subtraction C) (A from B) revealing no 
difference in 
13CO phenylalanine incorporation. Spectra recorded at 8 kHz MAS spinning frequency and 255K. 
 
 
2. 4. Discussion 
 
2.4.1. Optimization of defined media composition 
A rational medium for S. cremoris and S. lactis growth was first reported nearly 20 years ago 
(Poolman and Konings, 1988). Based on this work the nutritional requirements for L. lactis strain 
2118 have been assessed (Cocaign-Bousquet et al., 1995a). However, it is known that each L. lactis 
strain differs in its nutritional requirements, meaning the results obtained for strain 2118 cannot be 
simply accepted for strain pNZ9000. The optimal conditions must be reconsidered to achieve 
maximal labelling efficiency along with minimal label scrambling and label cost. Special care was 
taken checking the amino acid requirement. For biosynthetic labelling, selected amino acids are 
replaced with their expensive isotope labeled analogues. Therefore, for cost efficient labelling we 
needed to find optimal concentrations of amino acids allowing sufficient cell growth. In Figure 2.1 the   79
growth of L. lactis with different amino acids concentrations is shown. The optimal amino acids 
concentrations were obtained (Table 2.1). 
To characterize individual amino acids requirements, the LmrA over expressing strain pNZ9000 was 
grown on the defined medium from which either tryptophan, or serine, or glycine, or both serine and 
glycine were removed. Glycine and serine was chosen because for strain 2118 their absence in 
defined media led to important decrease in the growth rate (60 %) and because cheap 
13C labeled 
glycine was planned to be used as a first labelling reporter (Cocaign-Bousquet et al., 1995a). In our 
case only a moderate decrease in the growth rate was observed when either serine, or glycine, or both 
serine and glycine were removed. This growth rate decrease was attributed to serine, because its 
addition to growth medium restored almost correct growth (Figure 2.1B, 2.2). It has been shown for L. 
lactis strain 2118 that serine is normally consumed at a high level and is used for ammonia 
metabolism (Novak et al., 1997). It is likely that only a moderate growth inhibition is observed in 
medium lacking serine because the experimental medium contains NH4Cl as an addition source of 
ammonia. Our observations together with existing knowledge lead us to think that uniformly 
15N 
labelling might be possible in a medium containing a 
15N labeled nitrogen source and 
15N labeled 
serine (Novak and Loubiere, 2000; Otto et al., 1983). Considering uniform 
13C labelling, it is known 
that a small but significant part of glucose is converted into the cell structural material serving as a 
carbon source giving the totality of nearly all amino acids (Mahmound et al., 2004; Novak and 
Loubiere, 2000; Otto et al., 1983). Therefore uniform 
13C LmrA labelling might be considered in 
future as well. For this purpose glucose must be replaced by its 
13C analogue in the chemically defined 
medium. 
To probe the effect of the aromatic amino acid, tryptophan, on bacterium growth, LmrA expressing L. 
lactis were grown on media lacking tryptophan (Figure 2.2). The absence of tryptophan in defined 
medium did not lead to any significant growth rate suppression. Comparing the data obtained for 
serine, glycine and tryptophan for the strain pNZ9000 with results reported for strain 2118 (Cocaign-
Bousquet et al., 1995a), we conclude that both strains behave in similar way in respect to these three 
amino acids. The only difference is that the dramatic suppression of the bacterium growth rate 
reported for the strain 2118 in case of serine absence is much more pronounced when compared with   80
the LmrA over expressing strain. Summing up all the results it can be concluded that apart from 
amino acid concentration all the other components (vitamins and salt) do not need further 
considerations and their concentrations can be used as defined for strain 2118. Taking into account the 
importance of serine for ammonia metabolism, we clearly would not be able to label serine with this 
biosynthetic approach.  
L. lactis growth has been further compared in the optimized defined and complex organic (M17) 
media. L. lactis grew with similar rate in both media; however the bacterium entered the stationary 
phase earlier when grown on the defined medium (Figure 2.3A). The reasons why the cells growth is 
limited in the defined medium are obscure. As pH remains fairly constant during cell growth (Otto et 
al., 1983), it can not effect the growth (Mierau et al., 2005). It has been reported that accumulation of 
H2O2 and lactate by Lactococci occurred in synthetically defined media. Both H2O2 and lactate are 
toxic and retards growth above certain concentration. For H2O2 it is considered that the primary lack 
of catalase causes destruction of cell components and several of the potentially glycolytic enzymes 
(glucokinasa, glyceraldehydes–3 phosphate dehydrogenase and fructose-1, 6-dophoshate) are known 
to be inhibited by H2O2 (van Niel et al., 2002). This would also explain the fact that enhancement of 
amino acids concentration does not increase protein yield (Figure 2.1A) as it would be expected if the 
medium was simply exhausted at OD660 0.8. SDS-PAGE analysis with 40 % acrylamide gel shows 
that over expression of L. lactis LmrA protein in the defined and in M17 media are comparable 
(Figure 2.3A).  
Nevertheless sufficient cell densities for L. lactis growth on defined media can be obtained. The 
chemically defined medium was tested by selective labelling of LmrA with 
13CO tyrosine and glycine 
(Figure 2.5, 2.6). The efficiency of labelling is difficult to estimate. Estimation of labelling levels 
often relies on mass spectrometry (Cai et al., 1998). However, despite progress made recently in the 
mass spectroscopy field, a number of technical issues remain to be addressed. Among them are the 
relationships between the amount of analyzed sample and obtained signal intensity, which is complex 
and incompletely understood, and technical difficulties in membrane proteins ionization (Meng et al., 
2004; Aebersold and Mann, 2003). As a result, the examples of mass spectroscopy on membrane 
proteins are rare (Venter et al., 2002).    81
 
2.4.2. Metabolic labelling of LmrA ISOV with 
13CO labeled amino acids 
The spectra presented on Figure 2.5 and 2.6 show the incorporation of labeled amino acids anologues 
into the protein sequence. 
13CO tyrosine and glycine resonances from labeled LmrA overlap on MAS 
NMR spectra due to the relatively high natural abundance of 
13C (1 %) and possible labels 
incorporation into other then LmrA L. Lactis proteins. Subtraction of 
13CO CPMAS spectrum of 
labeled ISOVs produced from L. lactis strain 8048, which does not over express LmrA, from a 
spectrum of labeled ISOVs containing 30 % of over expressed LmrA could potentially remove the 
natural abundance background. However the resolution of the difference spectrum is not sufficient to 
resolve individual residues. The internal MAS rotor volume is not big enough to increase signal to 
noise ratio simply by taking more material for measurements. One possible solution could be to 
enhance the protein concentration in the ISOVs and this way to make signal from labeled protein 
dominant. 
To examine the function state of LmrA overexpressed in the chemically defined medium the Hoechst 
transport assay was performed (Figure 2.4). Hoechst-33342 is shown to be substrate for LmrA and P-
glycoprotein (Shapiro and Ling, 1995). The slow rate of Hoechst-33342 pumping represents the 
difference between the rate of substrate transport out of the membrane and the rate of rebinding of 
transported Hoechst-33342 to the membrane.  
 
2.4.3. Attempts to enhance protein yield and labelling efficiency 
 
Attempts to enhance protein yield 
An approach to enhance the production of isotope labeled protein was applied accordingly to (Marly 
et al., 2001). The idea of this method is to generate cell mass using unlabeled rich media followed by 
exchange into a smaller volume of labeled media. Thus, the consumption of costly isotope labels is 
reduced, by-products inhibiting cell growth are removed and, finally, a high yield of isotope labeled 
protein can be achieved. It was shown that a higher level of protein production (Figure 2.7) and 
labelling (Figure 2.9) can be achieved. Unfortunately, it was not possible to purify protein from the   82
cells and the over expressed protein in ISOVs was found to be inactive (Figure 2.10).  
Apart from the possibility that the protein over expressed under such media exchange condition is not 
fully matured at the stage of biosynthesis, it is possible that the protein is stably folded, but it adopted 
a fold which is not the native conformation of the protein. Such misfolding can occur at some point 
during the protein solubilization or even purification leading to hampered accessibility of the His-tag. 
The presence of this problem is difficult to detect and solve. There are methods known to correct 
membrane protein misfolding during solubilization and purification. The usage of protein denaturants 
(urea, for example) in the presence of detergent can potentially unfold misfolded protein bound to an 
affinity column, the further removal of denaturant on the column is suggested to lead to protein 
refolding in to a native-like conformation (Rogl et al., 1998). A second method, known as 
‘reconstitutive refolding’ includes protein purification into dodecylphosphocholine (DPC) micelles 
followed by mixing with POPC lipids and dialytic removal of DPC (Gorzelle et al., 1999). 
Unfortunately, both methods could not be applied to LmrA; because the protein is not stable under 
denaturing conditions and, in our experience, aggregates quickly while dialyzing.  
Degradation of membrane proteins can be also an important factor which abolishes the protein 
production. The mechanism of membrane protein degradation is not well studied, but a couple of 
examples, such as SecY translocase component, are known. SecY needs to be over expressed together 
with SecE component, otherwise it is prone to degradation (Kihara et al., 1995). Moreover, protein 
over production can trigger stress responses and thus degradation of the target protein in the cell 
(Mierau et al., 2005) 
One further way to reduce labelling cost is to add the expensive labeled amino acids after induction 
and in smaller amounts. The idea is that after induction the cells are mainly involved in expression of 
the target protein and therefore expensive isotope labels amino acids will be incorporated mostly in 
the over expressed protein (Lian and Middleton, 2001b). In this way site specific label incorporation 
can be achieved and theoretically label scrambling might be minimized. In Figure 2.11, reduced but 
still essential labeled amino acid incorporation is shown, when this method is applied.  
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Attempts to inhibit aromatic amino acids synthesis 
In the next step the trial has been done to improve efficiency of aromatic amino acid incorporation by 
inhibiting these amino acids synthesis. For this purpose glyphosate, an inhibitor of 5-
enolpyruvylshikimic acid-3-phosphate synthase, was added in the defined growth medium. Figure 
2.12 shows that the level of 
13C phenylalanine incorporation is not altered when glyphosate is added. 
It is known that L. lactis biosynthetic pathways are simpler in comparison with E. coli. The result of 
this simplicity is that the bacterium prefers to consume amino acids rather then to synthesize them 
(Konings et al., 2000). This way the amino acid incorporation is very efficient and addition of any 
amino acid synthesis inhibitors has no influence. An alternative explanation could be that glyphosate 
inhibition is not valid for L. lactis. L. lactis biosynthetic pathways are less well understood than those 
of E. coli and the effect of different enzyme inhibitors is difficult to predict.  
 
Conclusion 
The chemically defined medium needed to perform biosynthetical selective amino acid labelling of 
ABC transporter LmrA in L. lactis for NMR purposes is developed. The first spectra of inside-out 
vesicles containing 30 % of over expressed and 
13CO glycine/tyrosine labeled LmrA conform 
successful labelling. The method to half reduce isotope labeled amino acid quantities in comparison 
with amounts listed in Table 2.1 is successfully applied to L. lactis system. The functional state of 
LmrA over expressed in the chemically defined medium was demonstrated with fluorescence 
Hoechst-33342 assay.    84
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3. Purification and reconstitution of LmrA in various lipids for solid-state 
NMR 
 
Abstract 
SSNMR imposes strict constrains on a sample preparation with respect to protein purity, 
reconstitution at high protein lipid ratio, and sample homogeneity. As soon as large quantities of 
selectively isotope labeled LmrA can be produced in L. lactis, the next large problem to overcome 
prior SSNMR experiments is the concentration of liposomes reconstituted with the protein in a NMR 
rotor. To achieve a decent signal-to-noise ratio while doing SSNMR measurements, the protein 
incorporations into liposomes has to be of a ratio of about 1:100 mol/mol (protein/lipid). This protein 
lipid ratio exceeds the ratios used typically for functional assays in approximately 3-5 times. 
Therefore, the procedure for reconstitution of LmrA into E. coli and synthetic lipids at a high protein 
lipids ratio (1:300 mol/mol) has been established. The homogeneity of reconstitution and protein 
function state in reconstituted form has been probed subsequently with freeze-fracture microscopy, 
sucrose gradient, and functional assay. 
The results of this Chapter have been partially published: Mason A.J., Siarheyeva A., Haase W., 
Lorch M., van Veen H., Glaubitz C., Amino acid type selective isotope labelling of the multidrug 
ABC transporter LmrA for solid-state NMR studies, FEBS Letters  568 (1-3): 117-121 June 18 2004. 
 
3.1. Introduction 
As it has been observed, some model membrane system better mimic the structural, dynamic and 
morphological properties of native bilayers than others. In general, the resemblance to native 
membrane decreases in the order: vesicles > bicelles > mixed micelles > micelles >amphipoles 
(Sanders and Oxenoid, 2000). The membrane protein are extremely difficult to study, therefore every 
advantage should be taken in preparation of the model system. For a number of membrane proteins 
satisfactory resolution can be obtained in detergent, however the liposomes surely provide better   86
interactions that integral proteins require (Krueger-Koplin et al., 2004). The fact that most membrane 
proteins are fully active only when they are correctly inserted in a lipid bilayer is well known and 
accepted. Accordingly, in many instances the ability to investigate membrane proteins is limited by 
the necessity to functionally reconstitute these proteins into liposomes.  
Despite the fact that many proteins have been functionally reconstituted into artificial lipid membrane, 
the molecular mechanisms of membrane reconstitution with integral membrane proteins are still 
poorly understood and the methods often lack reproducibility. The situation with ABC transporters is 
even more complicated. In recent years, the purification and reconstitution of only a few members of 
the ABC transporter family in a functionally active form has been achieved (Hagmann et al., 2002; 
Mao et al., 2000; Callaghan et al., 1997a; Shapiro and Ling, 1995). For biochemical investigation the 
proteins are usually reconstituted at high lipid protein ratio to ensure the protein’ function state. So, 
typical protein lipid ratio in proteoliposomes in this case is usually kept in the order of 1:1000 
mol/mol. Current solid-state NMR techniques are insufficiently sensitive to this amount of labeled 
protein and good quality spectra are difficult to obtain. Usually, the amount of nuclear spins in the 
sample has to be in the order of μM for decent signal-to-noise ratio to obtain. With the rotor active 
volume of 20-90 μL, the protein concentration must be in the order of 3-20 mM. For ABC transporter 
with a molecular mass of 64 kDa, this means that at least 10-15 mg of protein need to be inserted into 
a small MAS rotor container. In the units of protein to lipid ratio, it means approximately 1:100 
mol/mol. In this case, anyway, four-fifths of the sample volume in the rotor is still taken by lipids. 
Further increase of protein to lipid ratio is dangerous, because it can be associated with protein 
aggregation or lead to 2D crystals formation. In general, 2D crystals are suitable for SSNMR 
investigations but unfortunately it is not possible to monitor proteins activity in 2D crystal form. 
Four basic strategies of membrane protein insertion into liposomes can be outlined: mechanical 
means, freeze-thawing, organic solvents and detergents (Rigaud and Levy, 2003). The first three 
methods find very rare applicability because they cause membrane protein degradation. The 
amphiphilic nature of most membrane proteins requires detergents, not only in the initial step of their 
solubilization, but also as a mean of keeping the protein in a non-denaturing environment during 
further purification and even storage. The standard detergent-mediated method of protein   87
reconstitution contains the following steps: preforming of liposomes, incubation of detergent 
solubilised protein with liposomes and finally, removing of detergents (Figure 3.1).  
 
preformed liposome
solubilization
increasing detergent concentration
Rsat Rsol
protein addition followed by detergent removed
preformed liposome
solubilization
increasing detergent concentration
Rsat Rsol
protein addition followed by detergent removed
 
 
Figure 3.1: The standard reconstitution strategy: preparation of liposomes, step-by-step detergent addition, 
protein addition and detergent removal. 
 
The liposomes can be preformed in a number of ways, the details can be found elsewhere (Knol et al., 
1998). Here lipids are extruded through polycarbonate filters of 100, 200 and 400 nm. The specific 
internal volumes of liposomes after extrusion through 400 nm filters are 0.90 ± 0.05 µL/mg of lipids. 
Subsequent extrusion through 200 nm filters yields a specific volume of 0.73 µL/mg of lipids. The 
diameter and morphology of liposomes depend on the filters as well. Extrusion through 400 nm filters 
yields liposomes with average diameter of ~ 350 nm, with only a relatively small fraction being multi-
lamellar. Extrusion of these liposomes through 200 nm filters yields lower amounts of multi-lamellar 
liposomes, whereas the size is reduced to ~ 150 nm. Subsequent extrusion through 100 nm filters 
reduces the size even further to ~ 100 nm. The latter preparations exhibit irregular shapes and a large   88
fraction appeared as collapsed structures. In our studies we prepared liposomes exclusively by 
extrusion through 400 nm filters, as these preparations yield highest level of protein uptake (Knol et 
al., 1998; Paternostre et al., 1988). This might be especially important in reconstituting such a large 
protein as LmrA.  
The next step in any detergent-mediated reconstitution is solubilization of preformed liposomes. The 
processes of membrane solubilization can be subdivided into three stages. First, the detergent 
incorporates into the lipid bilayer (stage 1), which results in a peak of the turbidity at the onset of 
solubilization Rsat (Rsat is a maximal detergent concentration at which preformed liposomes are not 
disturbed by detergent addition). Subsequently the liposomes disintegrate (Stage 2) and a translation 
takes place from bilayer structures to mixed micelles. Finally, at Rsol (Rsol is a minimal detergent 
concentration at which preformed liposomes are solubilised) the liposomes are completely solubilised 
(Stage 3) and further increase in detergent concentration only affects the ratio of detergents to lipids in 
micelles. The membrane reconstitution of an integral membrane protein can often be optimized by 
following the insertion of the protein into preformed liposomes, destabilized by detergents in the 
range Rsat to Rsol (Figure 3.1).  
The turbidity measurements systematically performed as a function of detergent concentration is a 
simple and effective technique to qualitatively evaluate the lamellar to micellar transitions and the 
amounts of detergent bound either to the bilayer or to the micelles (Paternostre et al., 1988). This 
makes the whole procedure well controlled and highly reproducible. 
The association of a protein with lipid detergent mixtures has been shown to be a time dependant 
process, which depends on the nature and the concentration of detergents used for reconstitution. 
Depending of the nature of the detergent, proteins can either be incorporated directly into detergent-
saturated liposomes at the onset of solubilization (mechanism 1), transferred from mixed micelles to 
detergent-saturated liposomes (mechanism 2), or participate in proteoliposomes by micellar 
coalescence (mechanism 3). The final protein orientation depends on the mechanism of association. 
Dodecylmaltoside (DDM)-mediated reconstitution performed here leads usually (Rigaud and Levy, 
2003) to direct protein incorporation into detergent-saturated liposomes (Putman et al., 1999). 
Theoretically DDM could mediate reconstitution in both directions however, the hydrophilic ATP   89
domain, which is comparable in size with transmembrane part, may prevent a random insertion of the 
protein into the membrane and lead to a symmetric distribution of orientations (Knol et al., 1997; 
Paternostre et al., 1988).  
The last step of reconstitution is the removal of detergent from the equilibrated lipid-detergent 
mixtures. Although there are various methods (dialysis, gel filtration and dilution) in use, absorption 
of detergent molecules on Bio-beads SM-2 has been demonstrated to be the most efficient.  
To date, the existing protocol allows LmrA reconstitution with a large excess of lipids. This protocols 
allows only very limited amount of LmrA, less then 0.1 mg of LmrA, to be placed into a NMR rotor. 
In an afford to overcome this limitation, the reconstitution LmrA into E. coli liposomes has been 
optimized for a protein lipid ration of 1:300 mol/mol. The function state of LmrA reconstituted at 
such a high protein to lipid ratio was confirmed by ATPase assay. In addition to E. coli liposomes, 
LmrA has been reconstituted into several synthetic lipids systems at high lipid protein ratio. 
 
 
3.2. Materials and methods 
 
Materials 
Bio-beads, SM-2 from Bio-Rad Laboratories Inc; E. coli,  1-Palmitoyl-2-Oleoyl-sn-Glycero-3-
Phosphoethanolamine (PE), 1-Palmitoyl-2-Oleoyl-sn-Glycero-3-Phosphocholine (PC), 1-Palmitoyl-2-
Oleoyl-sn-Glycero-3-Phospho-rac-(1-glycerol) (PG) lipids from Avanti Polar lipids, Alabaster. 
 
3.2.1. Solubilization and purification of LmrA 
LmrA purification was performed as described under Materials and Methods in Chapter 2. Directly 
from the column the purified LmrA was passed through the analytical gel filtration column. Gel 
filtration analysis was performed using ÄKTA HPLC system (Amersham Pharmacia) at a flow rate of 
0.08 mL/min. 50 μL of the purified LmrA (approximately 1 mg/mL) directly from the Ni
2+-NTA 
column was loaded into a Superose 6 3.2/30 column (Amersham Pharmacia) previously equilibrated 
with 50 mM Tris, 150 mM NaCl, 0.02 % (w/v) DDM pH 8 buffer.    90
 
3.2.2. Reconstitution of LmrA 
 
Bio-beads preparation 
Bio-beads preliminarily were washed 3 times with methanol, 5 times with 100 mM Tris 50 mM KCl 
buffer (pH 7), incubated with E. coli lipids suspension (30 µg lipids per 20 mL 100 mM Tris 50 mM 
KCl pH 7 buffer) for at least 40 minutes and finally washed 3 times with the same buffer. This 
procedure aims to reduce loss of lipids during the reconstitution procedure. 
 
Detergent solubilization method  
E. coli total lipid extract was resuspended in 100 mM Tris 50 mM KCl buffer (pH 7) to a final 
concentration 4 mg/mL and the suspension were clarified by drop-wise addition of 10 % (w/w) DDM 
solution. Purified LmrA protein in solution taken directly from the column was added to solubilised E. 
coli lipids. The solution was incubated for 40 minutes and finally 1.5 g bio beads were added per 100 
mg DDM in solution. The mixture was placed on a rocking table and became cloudy within 2 hours. 
The molar ratio of protein to lipids was about 1 to 100.  
 
Liposome destabilization method  
Lipids at a starting molar ratio of 200 lipids per protein were suspended in 100 mM Tris, 50 mM KCl 
buffer at pH 7 to a concentration of 4 mg/mL. The lipid suspension was vortexed briefly and then 
extruded (Northern Lipid Extruder) 11 times through a 400 nm filter. The liposome suspension was 
then titrated with a 0.02 M DDM solution as described (Fang et al., 1999; Cocaign-Bousquet et al., 
1995b) and mixed with detergent solubilised LmrA. The destabilized liposomes and protein were 
incubated for 30 minutes on a rocking table at room temperature before bio beads (80 mg/mL) were 
added. The mixture was incubated for a further 30 minutes on a rocking table at room temperature and 
then overnight at 4ºC. After incubation, the increased turbidity of the solution indicated vesicle 
formation. After removal of bio beads, the protein-lipid vesicles were pelleted by centrifugation 
(55000 rpm for 40 min) and layered over a discontinuous sucrose gradient (10-20-30 %). Bands were   91
collected from the sucrose gradient and washed with 100 mM Tris, 50 mM KCl, 10 mM EDTA buffer 
at pH 7 before being pelleted and loaded into 4 mm MAS rotor (Bruker GmbH, Kahlsruhe, Germany). 
Protein concentrations were measured using the Bio-Rad DC protein assay kit (Lowry et al., 1951).  
 
Reconstitution into PE/PG and PC/PG/cardiolipin mixtures 
For both reconstitutions the lipids were dissolved in methanol chlorophorm mixture 1:1 (v/v). Organic 
solvents were removed under rotor evaporation. Remaining organic solvents were removed under 
vacuum for at least 4 hours. Dry lipid film was then resuspended in reconstitution buffer (100 mM 
Tris, 50 mM KCl, pH 7). The following reconstitution was applied as described for detergent 
liposome destabilization method above. The molar lipid ratio in PC/PG/cardiolipin mixture was 
approximately 5:3:2. The molar ratio in PE/PG mixture was 7 to 3. 
 
Electron microscopy 
For freeze-fracturing, reconstituted membrane vesicles in suspension were placed between two small 
copper blades and frozen by plunging into ethane cooled to –180
oC by liquid nitrogen. Samples were 
fractured in a freeze-fracture (400T from Balzers, Lichtenstein) and shadowed with platinum/carbon 
at an angle of 45 degrees. Replicas reinforced by pure carbon shadowing at an angle of 90 degrees 
were cleaned from organic material in chromo-sulfuric acid and later analyzed by electron microscopy 
(EM208S, Philips, Eindhoven, The Netherlands). 
 
Solid-state NMR  
All experiments were performed on a Bruker Avance 600 equipped with a 4 mm MAS DVT probe. 
Experiments were performed at 150.9 MHz and 60.8 MHz for 
13C and 
15N using a CPMAS pulse 
program employing an 80-100% ramped Hartmann-Hahn condition, two pulse phase modulated 
(TPPM15) heteronuclear 
1H decoupling at a field of 62.5 kHz and a 49 ms acquisition time. CP 
contact times and recycle delay times were respectively 1.5 ms and 2 s for 
13C experiments. Spectra 
were zero filled to 16K points and 100 Hz exponential line broadening was applied during processing. 
Spectra were referenced externally as described in Chapter 2. Number of scans accumulated for each   92
measurement varied and indicated in subsequent figure legend. 
 
Enzyme assay 
The ATPase assay of reconstituted LmrA was based on a colorimetric ascorbic acid/ammonium 
molybdate assay to measure the liberation of Pi from ATP. 50 mM ATP and 10 mM vanadate stock 
solutions were freshly prepared. Reconstituted LmrA was washed twice with 20 mM K-HEPES (pH 
7), 5 mM MgSO4 buffer and resuspended at a final concentration of 2.5 mg/mL. ATPase assays were 
performed at 30
oC in a reaction volume of 20 mL. Following incubation of reconstituted LmrA and 
ATP (final concentration 5 mM) for 10 minutes, the ATPase reactions were terminated by addition of 
40 mL of a freshly prepared acidic solution consisting of 0.48 % (w/w) ammonium heptamolybdate 
tetrahydrate, 6.6 % (v/v) concentrated sulfuric acid, 0.01 % (w/w) potassium antimonyl tartrate and 
0.42 % (w/w) ascorbic acid. Following the addition of 140 mL H2O and 30 min of incubation at 30
oC 
in the dark, the absorbance was measured at 690 nm. ATPase activity measurements in the presence 
of 1 mM orthovanadate were obtained in parallel and subtracted from the reading. 
 
Hoechst 33342 assay  
Hoechst-33342 assay on LmrA reconstituted liposomes was performed as described under section 
Materials and Methods in Chapter 2. 
 
 
3. 3. Results 
 
3.3.1. Solubilization and purification of LmrA  
Solubilization of LmrA was performed essentially as described in (Margolles et al., 1999). It has been 
shown that 1 % (w/v) DDM solubilises 91 % of LmrA, whereas other detergents showed clearly 
worse results (Margolles et al., 1999). In agreement with Margolles and co-workers, SDS-PAGE 
analysis revealed that almost all protein is solubilised from ISOVs (Figure 3.3).  
The purification was carried out in a single affinity chromatography step as described in (Margolles et   93
al., 1999). The eluted fraction containing his-tagged LmrA was typically at a concentration of 1 
mg/mL, and the procedure yielded about 1 mg of LmrA from 15 mg of total membrane protein. 
Fractions collected at different steps of the purification procedure, and purified protein was analyzed 
by SDS-PAGE. Analysis of SDS-PAGE gels showed that LmrA is isolated at high purity (Figure 3.3). 
In addition, van Veen and co-workers have analyzed SDS-PAGE gels and immunoblots with the 
purified protein using densitometry. It was shown that LmrA can be isolated at levels of 
approximately 97 % of purity (Margolles et al., 1999). 
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Figure 3.2: Analysis of the purified LmrA (approximately 1 mg/mL) performed by gel filtration on Superose 6 
(3.2/30). The 64 kDa LmrA was eluted as a single peak.  
 
In addition, to probe the protein purity, LmrA was loaded into a gel filtration column. The gel 
filtration showed that purified LmrA in DDM detergent micelles elutes as a single peak, no evidences 
of aggregated proteins as well as of contaminations from other proteins were visible on gel filtration 
chromatogram (Figure 3.2). 
 
3.3.2. Reconstitution of LmrA  
In both the detergent lipids solubilised and detergent liposome destabilized methods of protein 
reconstitution, detergent DDM and E. coli lipids extracts were used. Polar lipid extracts from E. coli   94
are commonly used in membrane protein reconstitution (White et al., 2000), and they are good model 
biological membrane. DDM was chosen for liposomes solubilization and destabilization because this 
detergent is used for protein purification and possible detergent exchange could extend the 
reconstitution procedure.  
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Figure 3.3: Analysis of the purified LmrA (approximately 1 mg/mL) performed by SDS-PAGE analysis with 
40 % acrylamide (1) standards, (2) ISOVs containing over expressed LmrA, (3) 3 % DDM solubilised LmrA, 
(4) Unsolubilised material, (5) wash prom the purification column, (6) LmrA purified. 
 
Detergent solubilization method 
Detergent solubilised LmrA, eluted from the Ni-NTA column was used immediately for reconstitution 
at high protein to lipid ratios. Lipids (4 mg/mL) were dissolved completely in the presence of DDM, 
and mixed with purified LmrA (1 mg/mL). In the next step, detergent was removed rapidly over the 
course of a few hours with polystyrene beads. The resulting protein-lipid vesicles were collected by 
centrifugation and the presence of LmrA in the vesicles was confirmed by SDS-PAGE gel analysis 
(Figure 3.4). In addition, the presence of the labeled LmrA in the sample was confirmed by comparing 
the spectrum for the reconstituted sample with that of E. coli lipids (Figure 3.4). However, electron 
microscopy revealed that reconstitution is not efficient. The freeze-fracture microscopy showed the 
liposomes contain no or rare protein incorporations. A substantial amount of protein is simply 
aggregated (Figure 3.5). Moreover, the sucrose gradient confirmed that the reconstitution is not 
homogenous. For visual inspection it is clear that LmrA in all three bands is mostly in aggregated 
form (Figure 3.5).    95
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Figure 3.4: A) 
13C CPMAS spectra of E. coli lipids vesicles reconstituted LmrA by detergent solubilization 
method; a) protein free lipid vesicles, b) 
13CO glycine labeled LmrA reconstituted in lipid vesicles, c) spectral 
substraction (a from b) revealing contribution from protein. Spectra recorded at 8 kHz MAS spinning frequency 
and 253K. B) SDS-PAGE analysis with 40 % acrylamide 1) standards, 2) LmrA purified, 3) LmrA reconstituted 
into  E. coli liposomes using detergent liposome solubilization method. Approximately 30k scans were 
accumulated per each spectrum. 
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Figure 3.5: The freeze fracture electron micrographs of E. coli lipid reconstituted LmrA by detergent lipids 
solubilization method. A) Free lipid vesicles with limited protein incorporation, B) protein aggregates. The 
freeze-fracture microscopy was performed by Dr. W. Haase for MPI of Biophysics, Frankfurt. The freeze-
fracture micrographs are shown in 16K magnification. C) The 10-20-30 % sucrose gradient of LmrA 
reconstituted into E. coli liposomes using detergent liposome solubilization method. LmrA aggregates are 
clearly visible in all three bands.  
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Liposome destabilization method 
LmrA was reconstituted by mixing the purified protein with preformed DDM destabilized liposomes, 
followed by the slow detergent removal. The onset of solubilization (liposomes saturated with 
detergent) was reached at a concentration of 1 µmole of DDM /mg of lipid. SDS gel showed (Figure 
3.6D) that protein efficiently reconstituted into liposomes and its presence can not be detected in 
supernatant left after reconstitution. Analysis of proteoliposomes reconstituted LmrA using detergent 
liposome destabilization method by freeze fracture microscopy showed the presence of protein free 
liposomes, LmrA aggregates as well as liposomes containing reconstituted LmrA (Figure 3.7A, B, C). 
The aggregated protein can potentially hamper NMR lineshapes. To clarify how much of protein is 
actually aggregated the 10-20-30% sucrose gradient was performed. The protein free liposomes were 
clearly separated from LmrA reconstituted liposomes but not the aggregated protein. The aggregates 
are kept on the liposomes surface by some kind of interactions, possibly electrostatic. To disturb the 
electrostatic interactions, the reconstitution buffer was supplemented with 10 mM EDTA. This way 
the aggregated protein was separated from free and LmrA reconstituted liposomes as it can be seen on 
a sucrose gradient (Figure 3.7).  
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Figure 3.6: The freeze-fracture micrographs of E. coli reconstituted LmrA by liposomes destabilization method 
after 10-20-30% sucrose gradient. A) empty liposomes, B) the liposomes with sufficient LmrA incorporation, 
and C) aggregates separated from the liposomes. The freeze-fracture microscopy was performed by Dr. W. 
Haase for MPI of Biophysics, Frankfurt. The corresponding freeze-fracture micrographs are shown at 10K, 16K, 
and 20K magnification respectively. (D) SDS - PAGE analysis with 40 % acrylamide (1) LmrA purified, (2) 
LmrA E. coli liposomes reconstituted, (3) supernatant from reconstitution, and (4) standards.  
 
To further analyze the quality of reconstitution, LmrA was labeled with 
13CO glycine how it is   97
described in Chapter 2, purified and reconstituted into E. coli liposomes by detergent destabilization 
approach in presence of 10 mM EDTA, and loaded on the 10-20-30% sucrose gradient.  
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Figure 3.7: 
13C CPMAS spectra of E. coli lipids vesicles reconstituted LmrA by detergent destabilization 
method; a) protein free lipid vesicles, b) 
13CO glycine labeled LmrA reconstituted in lipid vesicles, c) 
aggregated protein. Spectra recorded at 8 kHz MAS spinning frequency and 253K. 62K (b) and 56K (a, c) 
transients were acquired for each spectrum. The 10-20-30 % sucrose gradient of LmrA E. coli liposomes 
reconstituted in buffer supplemented with 10 mM EDTA. A) Free liposomes (9 % sucrose); B) liposomes 
reconstituted LmrA (17 % sucrose); C) aggregated protein (28 % sucrose). Approximately 30 K scans were 
accumulates per each spectrum. 
 
Three bands were collected and analyzed by 
13C CPMAS NMR. The lowest density band (9 % 
sucrose) contained only protein free liposomes. The spectrum of this band was characterized by 
natural abundance signals from lipids and a lack of any intense signal in the carbonyl region from 
13CO glycine labeled LmrA. The second band (17 % sucrose), an increased intensity at 172.4 ppm 
indicated the presence of 
13CO glycine labeled LmrA. Comparison of resonance intensity of the 
carbonyl resonance (172.4 ppm), from 49 labeled glycine resonances, with that of the lipid CH2 
natural abundance resonance (30.8 ppm) yields an approximate protein lipid ratio of 1/6 (w/w). The   98
aggregated protein was found to accumulate in the third band (28 % sucrose). The 
13CO CPMAS 
spectrum of this sample was characterized by low intensity and was composed largely of signal from 
aggregated protein (175.8 ppm) with some associated lipids (Figure 3.7). All presented spectra were 
recorded with similar numbers of scans allowing us to estimate contribution from aggregated protein 
and free liposomes. The contribution from the aggregated protein is not high.  
Unfortunately, using ATPase assay, it was found out that E. coli liposomes reconstituted LmrA after 
sucrose gradient is not active. So, taking into account that contribution from aggregated protein is not 
dramatic and free liposomes resonances do not affect with protein resonances it was decided to use 
reconstituted LmrA without sucrose gradient step. 
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Figure 3.8: A) The freeze-fracture micrographs. The freeze-fracture microscopy was performed by Dr. W. 
Haase for MPI of Biophysics, Frankfurt. The freeze-fracture micrographs are shown in 16K magnification. B) 0-
10-20-30 % sucrose gradient of E. coli reconstituted LmrA by liposomes destabilization method under detergent 
exchange condition. Both bands (18 % and 21 % sucrose) visible on sucrose gradient contain LmrA.  
 
In the next step, detergent destabilized reconstitution of LmrA in E. coli liposomes was probed under 
detergent exchange conditions. Meaning the protein was purified as always in DDM micelles, but the 
liposomes were destabilized by step-by-step addition of ocyl glycoside place DDM. In Figure 3.8 the 
freeze-fracture of LmrA reconstituted into E. coli liposomes shows that under detergent exchange 
conditions the protein incorporation is even higher. So, this way the quality of reconstitution is further 
improved. Moreover, the sucrose gradient shows that the reconstitution is more homogenous, there is   99
no protein aggregations on the bottom of the tube and two bands (18 % and 21 % sucrose), both from 
liposomes reconstituted LmrA are close (Figure 3.8B). 
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Figure 3.9: The colorimetric ATPase assay performed on A) ISOV containing overexpressed LmrA (red and 
purple lines show ATP hydrolysis accordingly without and with vanadate, blue line is the difference between 
red and purple line, corresponding to LmrA vanadate sensitive activity, B) functionally reconstituted LmrA (in 
proteoliposomes) compares inorganic phosphate turnover with increasing amounts of LmrA over 10 minutes. 
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Figure 3.10: Hoechst-33342 transport assay result obtained for proteoliposomes reconstituted LmrA. Dye was 
added after 1 minute of incubation at room temperature. When intensity of fluorescence reached plateau ATP or 
ADP was added.  
 
Compared with previously published results (Vigano et al., 2002) the enzyme function assay detecting 
ATP turnover showed much reduced activity when protein was reconstituted by detergent liposome   100
solubilization method and slightly reduced activity of NBDs for LmrA reconstituted by detergent 
destabilization method. The vanadate sensitive ATP activity for detergent liposome destabilization 
method was determined to be 47 nmole/min/mg of protein (Figure 3.9B). Interestingly, the vanadate 
sensitive ATP activity in ISOV was determined to be in the same ranges as reconstituted system – 40 
nmole/min/mg of protein (Figure 3.9A). Lower activity in ISOVs can be contributed to variation in 
LmrA over expression level.  
Hoechst-33342 transport by proteoliposomes reconstituted LmrA was measured as described in 
Chapter 2. No Hoechst-33342 transport was detected (Figure 3.10). 
 
13CO tyrosine LmrA
250 200 150 100 50 0 ppm
13CO tyrosine LmrA
250 200 150 100 50 0 ppm 
Figure 3.11: 
13C CPMAS spectra of 
13CO tyrosine labeled LmrA reconstituted in lipid vesicles. Spectra 
recorded at 8 kHz MAS spinning frequency and 253K. Approximately 40 K scans were accumulates per 
spectrum. 
 
To probe the selective amino acid labelling approach and reconstitution using liposome 
destabilization method, 
13C tyrosines were incorporated into LmrA. Figure 3.11 shows that 14 LmrA 
tyrosine signals can not be resolved on a MAS carbon spectrum. 
13C carbon has better sensitivity then 
15N, however 
15N has advantage of very low natural abundance (0.36 %) in contrast to 
13C (1.11 %). 
Therefore, in the next step 
15N labeled tyrosines were incorporated into LmrA (Figure 3.12). 
However, due to low 
15N sensitivity, no statements can be made about resolution of individual LmrA 
sites (Figure 3.12).    101
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Figure 3.12: 
15N CPMAS NMR spectra of 
15N tyrosine labeled LmrA reconstituted in lipid vesicles. Spectra 
recorded at 8 kHz MAS spinning frequency and 253K. Approximately 250 K scans were accumulates per 
spectrum. 
 
LmrA reconstitution in synthetic lipid mixtures 
 
AB AB
 
Figure 3.13: The freeze-fracture micrographs of A) PC/PG/cardiolipin, B) PE/PG lipids mixture reconstituted 
LmrA by liposomes destabilization method. The molar lipid ratio in PC/PG/cardiolipin mixture was 
approximately 5:3:2. The molar ratio in PE/PG mixture was 7 to 3. The freeze-fracture microscopy was 
performed by Dr. W. Haase for MPI of Biophysics, Frankfurt. The freeze-fracture micrographs are shown in 
16K magnification. 
 
LmrA reconstitution was probed for lipids mixtures PE/PG and PC/PG/cardiolipin. These lipids 
mixtures were chosen for reconstitution because PE/PG mimics E. coli membrane and   102
PC/PG/cardiolipin mixture resembles eukaryotic membrane. The freeze-fracture micrographs for both 
lipid mixtures are presented in Figure 3.13. For PE/PG lipids mixture freeze-fracture micrographs 
shows well formed liposomes and sufficient reconstitution. For PC/PG/cardiolipin the liposomes are 
replaced by long lipids sheets containing sufficient protein incorporation.  
 
 
3.4. Discussion 
 
3.4.1. Solubilization and purification of LmrA 
The solubilization of membrane proteins requires that the proteins are taken from their natural 
environment and that lipid bilayer is replaced by the detergent micelle. The choice of the detergent 
used for protein solubilization is crucial and to a large extent determines the quality of purification.  
LmrA solubilization and purification was performed essentially as described in (Margolles et al., 
1999). van Veen and co-workers have examined several detergents on their ability to solubilised 
LmrA. The best results were obtained for DDM and Triton-100, they solubilised respectively 91 % 
and 87 % of LmrA from ISOVs. However, due to often inhibition of the transport activity of 
membrane transporters by Triton-100, DDM was selected for the purification of LmrA (Margolles et 
al., 1999; Putman et al., 1999; Callaghan et al., 1997b). The solubilization of LmrA was probed by 
SDS-PAGE analysis. The results revealed that almost all protein is solubilised from ISOVs (Figure 
3.3).  
The purification of LmrA was achieved by applying a single nickel-chelate affinity chromatography 
step. The eluted fraction containing his-tagged LmrA (1 mg/mL) was loaded on a gel filtration 
column and on SDS gel. Gel filtration and SDS-PAGE analysis showed that LmrA is isolated at high 
purity (Figure 3.2 and Figure 3.3). Slight broadening of a peak from the purified LmrA on the gel 
filtration chromatogram can be associated with non homogeneous size distribution of DDM detergent 
micelles (Figure 3.2). 
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3.4.2. Reconstitution of LmrA 
The method of LmrA reconstitution into preformed liposomes by detergent liposome destabilization 
method was found to yield a lot higher protein incorporation in comparison with liposome 
solubilization method (Figure 3.3-3.7). The final protein lipids ratio was estimated to be 1 to 6 (w/w). 
This ratio is sufficient to provide high enough protein concentration in NMR rotor needed for NMR 
measurements. The further increase in protein lipid ratio we considered dangerous because aberrant 
oligomerization could take place. 
As it was shown by electron microscopy the fraction of liposomes after reconstitution is not 
homogenous. Together with LmrA reconstituted liposomes, there are some free liposomes and 
aggregated protein. Presence of free liposomes is harmful for NMR measurements in case when 
13C 
experiments are performed (high natural 
13C abundance 1 %) and when critical amount of free 
liposomes competes with proteoliposomes for the place in small MAS NMR rotor. More problems 
come from aggregated protein, because the contribution from aggregated protein broadens resonances. 
To estimate contribution from free liposomes and aggregated protein, 
13CO glycine isotope labeled 
LmrA reconstituted into E. coli lipid liposomes were separated on a sucrose gradient. 
13C MAS NMR 
spectra of all the three bands (Figure 3.7), corresponding to empty liposomes, proteoliposomes and 
aggregated protein, were compared (Figure 3.7). From the spectra comparison it was concluded that 
the contribution from free liposomes and aggregated protein is not dramatic. So, keeping in mind 
ABC transporters instability, the gradient step was excluded in further experiments. 
From detergents used for membrane protein solubilization and purification, the most popular 
candidate is DDM. It is relatively mild detergent and is usually well tolerated by membrane proteins. 
It has been previously reported that its long alkyl chain protect the hydrophobic portion of integral 
membrane proteins better than shorter detergents like octylglyside (Callaghan et al., 1997a). DDM 
was applied for solubilization and reconstitution of number of membrane proteins including LmrA 
and LmrP from L. lactis (van Veen et al., 2000a; Putman et al., 1999). However, considering 
liposome formation DDM is clearly not the best choice. It has been shown that it is difficult to remove 
DDM from liposomes because of its low CMC. Presence of detergent in liposomes add unnecessary 
lipid dynamics, initiates proteoliposomes leakage and as a result complicates activity assays,   104
determines swelling of liposomes and formation of multilamellar vesicles (Otten et al., 2000). In 
particular cases, the presence of detergent molecules leads to liposomal disintegration, followed by 
formation of small micelles, which can not maintain protein incorporation. In addition, prolonged 
contact with detergent facilitates slow protein degradation. Therefore, we considered the possibility to 
exchange detergent during the reconstitution procedure. For reasons mentioned before, DDM can not 
be excluded from LmrA purification procedure but its usage can be avoided in case of liposome 
destabilization.  
In contrast to DDM, the complete detergent removal from the proteoliposomes, as well as smoother 
liposome morphology distribution has been shown in case of ocylglycoside (OG) usage (Fang et al., 
1999; Knol et al., 1997). Functional octylglycoside mediated reconstitution as well as lower OG 
detergent induced protein ATPase activity and drug binding inhibition in comparison to DDM have 
been shown for P-glycoprotein (Callaghan et al., 1997a). The liposomes were destabilized by OG. 
The efficiency of LmrA reconstitution was assessed by migration profiles of liposomes and protein 
through sucrose gradients and by freeze-fracture microscopy (Figure 3.8). The sucrose gradient 
reveled two major bands: at 21 % and 18 % (w/v) sucrose (Figure 3.8B). Surprisingly, both bands 
contained protein. Existence of two bands corresponding to proteoliposomes can be addressed to two 
main peaks in liposomes size distribution profile. In comparison to DDM mediated reconstitution, no 
band corresponding to aggregated protein was found. Taken together, octylglycoside mediated LmrA 
reconstitution allows an optimized reconstitution procedure. The freeze-fracture microscopy revealed 
sufficient protein incorporation into liposomes (Figure 3.8A). This novel detergent liposomes 
destabilization approach can be advantages if the protein dynamics is studied.  
As soon as successful reconstitution is confirmed by electron microscopy, the functional state of the 
protein must be assessed. Available methods to check the protein function state depends on both the 
protein and on the model membrane system used. For example, the enzymatic activity can typically be 
measured regardless of the model system (Vinogradova et al., 1998). For some classes of proteins in 
some media, functional assays are not possible. For example, the channel activity can not be assessed 
in micelles (Sanders and Oxenoid, 2000). In this case evidence for native protein structure must be 
obtained by indirect methods such as measurements of ligand binding capacity, and protein   105
thermodynamic stability (Sanders and Oxenoid, 2000; Lau and Bowie, 1997), additional information 
can be acquired using so called ‘finger-print’ methods like near- and far-UV circular dichroism, amide 
H-D exchange measurements, and fluorescence. Once this data are obtained the comparison between 
the structural data obtained under conditions known to provide correctly folded protein and the data 
received for tested conditions can be done.  
The ATPase turnover was estimated using a colorimetric assay, the reported activity (47 
nmole/min/mg) is lower then earlier reported activity for LmrA in ISOVs (150 nmol/min/mg) (Vigano 
et al., 2002) (Figure 3.9). It is interesting to note, that for P-glycoprotein the reported activity varies 
from 6 to 900 nmol/min/mg (Ambudkar et al., 2003; Ambudkar et al., 1999; Callaghan et al., 1997a). 
The activity in reconstituted system may be underestimated, since many ATP binding sites can be 
buried in the vesicles lumen and are not accessible to ATP. Moreover, low ATPase activities are 
typically observed before for proteins reconstituted at a high protein lipids ratio (Poolman, personal 
communications). 
Hoechst-33342 was used to assess the functional state in studies of several reconstituted membrane 
proteins, including MDR transporters LmrP, P-glycoprotein and LmrA (van Veen et al., 2001; 
Putman et al., 1999; Shapiro and Ling, 1995). Our study unfortunately showed no ATP mediated 
Hoechst-33342 transport in LmrA reconstituted proteoliposomes (Figure 3.10). The Hoechst-33342 
transport assay requires well formed and sealed liposomes. In the case of reconstitution of LmrA into 
E. coli lipids (Figure 3.6) we observed a broad distribution of vesicles size, including some fused 
liposomes, and high protein density in majority of the vesicles. It is known that such a high density of 
protein in membrane changes the membrane bilayer properties a lot. As a result, the vesicles are not 
stable and leaky. The additional liposome fusion and aggregation can be caused by Hoechst-33342 
itself (Shapiro and Ling, 1995). Overall, these facts suggest that the proteoliposomes can be 
significantly leaking. To detect Hoechst-33342 transport the rate of transport must be much higher 
than the rate of rebinding of Hoechst-33342 to the membrane. In addition, significant detergent 
retention during the reconstitution procedure (approximately 1 mol of DDM per 15-20 mol of 
phospholipids) can affect transport. The detergent can potentially affect the passive drug flip-flop 
from one membrane leaflet to the other and thereby interfere with net drug transport indirectly.   106
Taking all together it is not surprising that we were not able to detect Hoechst-33342 transport even 
when the protein is active as the ATPase assay presented here shows. 
As soon as functional reconstitution is confirmed, the selective 
13CO glycine and tyrosine labelling of 
LmrA were performed as described in Chapter 2. The quality of spectra of 
13C as well as 
15N tyrosine 
and glycine labeled LmrA reconstituted into E. coli liposomes do not allow us to resolve individual 
components (Figure 3.11, 3.12). Such spectra quality deterioration can be due to many reasons. 
Firstly, we certainly meet frequent problem of the frozen membrane samples: conformational micro 
heterogeneity of the protein of interest where each component yields its own distinct spectrum, and 
the spectra of many individual conformers overlap. The possible solution could be preparation of 
microcrystals or protein with careful precipitation with agents as ammonium sulphate or polyethylene 
glycole (Sanders and Oxenoid, 2000). However, crystallization of MDR ABC transporters is difficult 
if not impossible and in both cases (crystallization and precipitation) we would deal with not 
functional protein. 
 
Reconstitution of LmrA in synthetic lipid mixture 
A number of NMR measurements were planned in our laboratory in future to assess the protein lipid 
interactions. For this purpose, the reconstitution trials were extended to include not only E. coli lipids 
but also mixture of synthetic lipids. In Figure 3.13 the freeze-fracture micrographs of PE/PG and 
PC/PG/cardiolipin reconstituted LmrA are shown. PE/PG reconstitution case resembles E. coli lipid 
reconstitution; well formed liposomes with essential incorporation are shown. PC/PG/cardiolipin 
reconstitution is appeared to be different, with the protein incorporation occurring not in liposomes 
but in lipid sheets.  
 
Conclusion 
LmrA has been successfully reconstituted into natural E. coli lipids and mixture of synthetic lipids 
(PE/PG, and PC/PG/cardiolipin) using detergent liposome destabilization approach at high protein 
lipid ratio (1:6 w/w). For comparison, the previously established protocol allowed to reconstitute 
LmrA into lipids at 1:100 w/w ratio (Margolles et al., 1999). The quality of reconstitution and the   107
protein function state in reconstituted form have been assessed subsequently by freeze-fracture 
microscopy, sucrose gradient, SDS-PAGE, ATPase assay, and Hoechst 33342 transport assay. The 
first spectra of 
13C and 
15N tyrosine labeled LmrA reconstituted into E. coli liposomes revealed good 
signal to noise ratio and confirm that the amount of selectively isotope labeled LmrA sufficient for 
SSNMR experiments are produced. This makes for the first time the 64 kDa membrane protein LmrA, 
and therefore the ABC transporter superfamily accessible to NMR analysis.  
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4. LmrA dynamics as studied by deuterium NMR line shape analysis and 
relaxation measurements 
 
Abstract 
As it is well accepted that the conformation changes in ABC MDR transporters leading to substrate 
transport are driven by ATP binding and hydrolysis, it is a question of great importance to investigate 
ATP binding to MDR pumps. In this chapter dynamics changes in ABC MDR transporter LmrA 
under ATP and ATP/ADP-Vanadate binding have been followed by deuterium solid-state NMR.  
 
4.1. Introduction 
The existence of a structural cooperation between membrane and cytosolic domains propose 
significant conformation rearrangements within these domains. These rearrangements might be 
associated with altering of the proteins NBDs and TMDs dynamics behaviour. Therefore, the 
dynamics information is an important complement to static structural data and studying of the protein 
internal dynamics is of fundamental interest. The dynamic information for large membrane proteins 
like ABC transporter is difficult to extract. Recently, long-time dynamics of BtuCD ABC-transporter 
and AcrB MDR transporter were approached using B-factor analysis. However, only qualitative 
dynamics description was obtained in both cases (Lu et al., 2006; Tanizaki and Feig, 2006). 
Concerning MDR ABC transporters, to our knowledge, there were no reports on any studies 
concerning their dynamics.  
There are several methods to investigate the proteins internal dynamics (Stopar et al., 2005). One of 
the most powerful approach is solid-state 
2H NMR (Tiburu et al., 2004; Sparrman and Westlund, 
2003; Millet et al., 2002; Palmer, 1997; Bienvenue et al., 1982). It allows studying molecular 
dynamics of membrane embedded proteins spanning a wide range of time scales extending over many 
orders of magnitude (Tiburu et al., 2004; Rozovsky and McDermott, 2001; Keniry et al., 1984b; 
Davis, 1983; Batchelder et al., 1982; Bienvenue et al., 1982). Indeed, several pulse sequences for 
measuring of fast and intermediate rate processes, as well as two-dimensional chemical exchange   110
experiments for measuring slow rate processes allow following molecular dynamics in motional 
frequencies from 10 to 10
10 Hz (Palmer, 2004; Siminovitch, 1998). In doing so, the correlation time of 
5 10
5 Hz and a three-jump rotation at 10
8 Hz were estimated subsequently for (ε-
2H2) tyrosine ring 
and (β-
2H3) alanine in selectively labelled photosynthetic bound protein (Kikuchi et al., 2000). 
Deuterium is a convenient probe of macromolecular dynamics. The relaxation of this nucleus is 
completely dominated by the quadrupolar interaction. This is characterized by the quadrupole 
coupling constant χ and the asymmetry parameter ηQ. For deuterons the quadrupolar coupling 
constant is known to be relatively small (χ ~ 160 - 190 kHz) and because the quadrupolar interaction 
is dominated by intramolecular contributions from the axially symmetric deuterons bond the 
asymmetry parameter is close to zero (Beshah et al., 1987). These features result in relatively simple 
spectra and lineshapes that are sensitive to both molecular structure and motions (Hologne and 
Hirschinger, 2004; Kristensen et al., 1999). Therefore, the interpretation of the 
2H relaxation data is 
straight forward in contrast to the case for relaxation data from other nuclei, for example with spin ½. 
For spin half nuclei the relaxation rates contain the contributions from interactions like dipolar 
coupling, and chemical shift anisotropy (Muhandiram et al., 1995; Torchia, 1984). These interactions 
are negligible in 
2H spectra. Moreover, the angular dependence of the NMR frequency is the same for 
the chemical shift and quadrupole interactions, therefore molecular motions affects chemical shift and 
2H powder patterns in essentially the same way (Torchia, 1984).  
Additionally, concerning proteins internal dynamics studies, solid-state NMR has an advantage over 
solution state NMR. In solids, in contrast to liquids the orientation-dependent NMR parameters of 
protein motion are not covered by the rapid overall motion of the protein (Torchia, 1984).  
For our study we have selected CD3 alanine groups as a probe of internal protein dynamics for variety 
of reasons. These reasons are 1) alanine high frequency occurrence in proteins coupled with their 
distribution at various positions; 2) methyl groups in alanine are directly attached to the α-carbon 
allowing to look at the backbone dynamics; 3) methyl groups reorientation is sensitive to local 
environment and information on the actual rate of motion as well as on type of motion can be deduced 
directly from the line shape analysis and relaxation measurements (Leo et al., 1987; Smith and 
Oldfield, 1984).    111
In the past, several proteins and peptides have been extensively studied on a subject of their 
macromolecular dynamics using 
2H solid-state NMR. Among those are gramicidin, collagen, the coat 
protein of bacteriophage fd, bacteriorhodopsin in the purple membrane of Halobacterium halobium, 
egg white lysozyme, pancreatic A2 phospholipase, triosephospate isomerase, and photosynthetic 
membrane-bound protein (Rozovsky and McDermott, 2001; Kikuchi et al., 2000; Mack et al., 2000; 
Prosser and Davis, 1994b; Allerrini et al., 1985; Torchia, 1984; Jelinski et al., 1980a).  
The main goal of this study is to shed light on dynamic properties of membrane and cytoplasmic 
LmrA domains and to investigate how the ATP binding and hydrolysis affect these protein 
characteristics. Because of relatively high basal ATP hydrolysis rate, 47 nmole/min per mg of protein, 
ATP is not a good candidate for 
2H SSNMR measurements which can last up to several days. 
Therefore, to investigate dynamic properties of LmrA under ATP binding, non-hydrolysible ATP 
analogue AMP-PNP was used place ATP. This analogue has been used extensively to trap several 
ABC transporters including PGP and LmrA in pre-hydrolysis state (Ecker et al., 2004; Rosenberg et 
al., 2003). To trap the protein in post-hydrolysis state in addition to ATP vanadate was added to the 
reconstituted LmrA. It is well know that vanadate traps ADP at one of the two nucleotide-binding 
sites by mimicking the transition state of the γ-phosphate of ATP during ATP hydrolysis. In addition, 
vanadate trapping at one site inhibits ATP hydrolysis at the second site (Fetsch and Davidson, 2002; 
Loo and Clarke, 2002; van Veen et al., 2000a).  
In our study we used deuterium solid-state NMR approach. Severe line distortions of the static spectra 
of selectively alanine CD3 labeled LmrA with AMP-PNP and ATP/ADP-Vanadate bound when 
compared to LmrA resting state spectra were interpreted as an evidence of restricted motions of the 
cytosolic and membrane spanning protein domains.  
 
 
4.2. Materials and methods  
 
Materials 
L-(3, 3, 3-d3) alanine (98 % atom 
2H) was obtained from Sigma Aldrich. Deuterium-depleted water   112
was purchased from Aldrich Chem. Proteinase K was from Sigma and phenylmethylsulfonyl fluoride 
(PMFS) from Serva. All the other reagents were of analytic grade.  
 
Labelling  
LmrA and LmrA-MD were labeled with L-(3, 3, 3-d3) alanine biosynthetically following the protocol 
adapted from Cai (Cai et al., 1998) (Chapter 2). For this purpose L. lactis cells were grown on the 
defined media in which half the required amount of the isotope labeled amino acid was added after 
induction point. After induction the bacteria were left to overexpress LmrA or LmrA-MD and 
incorporate L-(3, 3, 3-d3) alanine for 2.5 hours.  
 
Expression, purification and reconstitution  
 
Full-length LmrA 
Purification and reconstitution of full length LmrA have been done how it was described in Chapter 2 
and 3. 
The LmrA reconstituted proteoliposomes were washed with a total of 10 mL of 100 mM Tris 50 mM 
KCl pH 7 buffer made on deuterium depleted water by suspension and centrifugation. Samples of 
LmrA were trapped respectively with ATP non-hydrolysable analogue AMP-PNP, and ATP/ADP -
Vanadate. For this purpose AMP-PNP or ATP 20 mM, and MgSO4 5 mM were solubilised in 100 
mM Tris 50 mM KCl pH 7 buffer made in deuterium depleted water, added into the LmrA 
reconstituted vesicles up to total volume of 5 mL, incubated for 20 minutes on a rocking table at a 
room temperature, and harvested at 55000 rpm for 40 minutes.  
 
LmrA-MD 
LmrA-MD (N-terminally His6-tagged LmrA truncated in the linker region (His 353) that connects the 
MD to the NBD) expression strain NZ9000 was a gift from H. van Veen, University of Cambrige, UK 
(Venter et al., 2003). Truncated LmrA (LmrA-MD) was detected as a 36 kDa protein by 
SDS−polyacrylamide-gel electrophoresis (SDS−PAGE) (Figure 4.1). Purification and reconstitution   113
of LmrA-MD has been performed as it is described for full-length LmrA (Chapter 2, and 3).  
 
Proteolysis of LmrA 
As an alternative to LmrA-MD, NBDs were removed from LmrA full length by proteolysis. To do 
that and thus to isolate the membrane–embedded domain together with loops connecting 
transmembrane segments of LmrA, the proteoliposomes (3 mg of LmrA /mL) were incubated with 
proteinase K (4 mg/mL) at a room temperature on a rocking table for 30 minutes. The proteolitic 
digestion was stopped by addition of phenylmethylsulfonyl fluoride to a final concentration of 1 mM.  
The proteoliposomes containing LmrA-MD and LmrA without proteinase K cleaved NBDs were the 
diluted in 100 mM Tris, 50 mM KCl, pH 7, pelleted by centrifugation for 40 minutes at 50000 rpm, 
and subsequently washed twice with 100 mM Tris 50 mM KCl buffer made on deuterium depleted 
water. Sample was analysed by SDS-PAGE (Figure 4.1).  
 
E. coli lipid liposomes 
The liposomes for 
31P measurements were prepared as described in Chapter 3 for detergent liposomes 
destabilization method, including extrusion, detergent destabilization, and final detergent removal and 
harvested by centrifugation for 30 minutes at 50000 rpm. 
 
2H NMR measurements  
All 
2H NMR experiments were performed on a Bruker Avance 600 spectrometer equipped with a 4 
mm MAS DVT probe. The measurements were done at 92.123 MHz. For all static measurements a 
solid echo experiment pulse program was used with the acquisition time of 8.123 ms, the 90
o pulse of 
4 μs, the recycle delay time was 0.4 s, and the echo delay of 50 μs. The spectral width for 
2H was set 
to 303030 Hz. Spectra were zero filled to 4892 points and 2500 Hz exponential line broadening was 
applied during processing. The number of scans collected for each measurement was approximately 
400K. Each experiment took ca. 48 hours. 
For MAS 
2H NMR measurements a rotor synchronized Hahn echo experiment with the 90
o pulse of 4 
μs, recycling delay of 1 s, spectral width of 303030 Hz, data size of 8K, and acquisition time of 12.99   114
ms were used. Hahn echo experiment was used because it solves the problem of a dead time better 
then starting Fourier transformation at the first rotor echo. The number of scans collected for each 
measurement was approximately 50K. Each experiment took ca. 6 hours. The linebroadening of 200 
Hz was applied during processing. 
For the T1 measurements the inversion-recovery technique has been used. In the inversion recovery 
pulse sequence, the spin system is first inverted with a 180 degree pulse (of 10 μs). It is then allowed 
to evolve during a variable delay (0 - 200 ms) and finally detected the magnetization is detected with 
a 90 degree observe pulse (of 5 μs) and acquired with the acquisition time of 8.123 ms. The relaxation 
delay must be at least 5T1. Typically, 15 – 20 points were obtained for each experiment. Experimental 
data were fitted to the following equation (Claridge, 1999) 
 [4.1]    M (t) = (M (0) – Mo) exp (-t/T1) + Mo  
where Mo is magnetization at thermal equilibrium, M (t) is +z magnetization at a time point t, and T1 
is the longitudinal relaxation. Data conversion, calculations and fitting were done with the help of the 
open source software packages Tcl/Tk (Welch, B.B., http://dev.scriptics.com), SIMPSON ((Bak et al., 
2000), http://nmr.imsb.au.dk/bionmr/software/simpson.php), and GNUPLOT (version 4.0, Thomas 
Williams and Colin Kelley, http://www.gnuplot.info). Each experiment took ca. 60 hours. 
The 
31P measurements were performed on a Bruker Avance 400 spectrometer equipped with a 4 mm 
MAS DVT probe. The measurements were performed at 161.923 MHz. The 
31P spectra were acquired 
using a Hahn echo pulse sequence, with echo delay of 15 μs and 
31P excitation pulse with a length of 
3 μs. The continuous wave homonuclear 
1H decoupling was applied during the acquisition. The line 
broadening of 250 Hz were applied to all spectra. The number of scans collected for each 
measurement was approximately 4K. Each experiment took ca. 3 hours. 
The temperature was regulated by a Bruker temperature control. All spectra were processed and 
analysed using routines in TOPSPIN. The low temperature experiments were run first to minimize the 
sample degradation. 
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4.3. Results 
 
2H static spectra of LmrA in a resting state  
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Figure 4.1: SDS acrylamide gel: 1) LmrA-MD (36 kDa), 2) LmrA after proteolysis without cytoplasmic 
domain (35 kDa), 3) NBD left in supernatant after isolating the membrane-embedded LmrA domain with 
proteinase K, 4) full-length LmrA (65 kDa), and 5) standards. 
 
Characteristic quadrupolar echo spectra of selectively alanine CD3 labelled LmrA in a resting state are 
shown in the Figure 4.2A as a function of temperature. Examination of Figure 4.2A reveals that at low 
temperature 
2H spectra of LmrA in a resting state have a typical powder pattern lineshape. The 
2H 
alanine selective labelled LmrA quadrupolar coupling of 49 kHz is close to quadrupolar coupling 56 
kHz know for crystalline form of CD3 alanine, how it was found by SIMPSON simulations (Figure 
4.3) (Beshah et al., 1987). Increasing the temperature causes dramatic changes in the LmrA spectra. 
Namely, at increasing temperatures an isotopic component appears in the spectra. For this isotopic 
component the quadrupolar coupling constant has collapsed to an apparent value of 159 Hz from 49 
kHz, how it was found by SIMPSON simulations (Figure 4.3). Such a dramatic motion narrowing can 
be associated with correlation times of ca. 10
-4 s and be originated from deuterons’ orientation over a 
wide angular range in a time several-fold less that the inverse of the frequency of the rigid 
quadrupolar splitting, that is << 10
-5 s (Leo et al., 1987). 
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Figure 4.2: 
2H NMR spectra of 
2H alanine selective labelled LmrA reconstituted E. coli liposomes in a resting 
state (A) and trapped with AMP-PNP (B). The spectra recorded at increasing temperatures 235K, 260K, 270K, 
and 280K and arise from 48 alanines in the LmrA (~ 147 deuterons). The spectrum of powder CD3 labelled 
alanine recorded at 280K is shown for comparison (C).  
 
It is known that T1 is sensitive to motions with broad range of correlation times. Table 4.1 shows the 
spin-lattice relaxation times of LmrA as a function of temperature. A continuous increase of the   117
values with increasing temperatures is found. This T1 behaviour is consistent with the results observed 
for DPPC with incorporated peptide and without (Prosser et al., 1992) and for hydrochloride form of 
L-CD3–alanine (Keniry et al., 1984b). However, no general conclusion can be drawn since the limited 
measurement time did not allow following the T1 temperature behaviour any longer and 
systematically analyse the relaxation data as a set of temperature–dependant parameters.  
 
Temperature T1, ms: TMDs 
Rigid (R) 
T1, ms: NBDs 
Dynamic (D) 
235K, LmrA resting state  12.3±1  - 
260K, LmrA resting state  14.4±0.7  - 
280K, LmrA resting state  20.4±1.5  28.5±2.2 
280K, ATP/ADP-Vanadate trapped  17.5±2.0  36.0±2.7 
 
Table 4.1: The spin-lattice relaxation values obtained at different temperatures in two protein states: the resting 
state and trapped with ATP-ADP-Vanadate. 
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Figure 4.3: Experimental (---) and simulated (——) 
2H spectra at (A) 235K and (B) 280K. At 280K the 
simulated spectrum is a sum of dynamic and rigid components. The dynamic component corresponds mostly to 
mobile NBDs and rigid mostly to TMDs. The calculated rigid spectrum has the quadrupolar coupling constant 
of 49 kHz and the dynamic component subsequently 159 Hz. Additionally, the width at the half height of 150 
Hz was determined for the dynamic component at linebroadening of 0 Hz. The line broadening of 1500 Hz was   118
applied during simulation and on compared experimental spectra. 
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Figure 4.4: 
2H spectra of 
2H alanine selective labelled membranous LmrA domain obtained with proteinase K 
cleavage procedure (B) and LmrA-MD (C). Both, LmrA proteolysed and truncated, are E. coli liposomes 
reconstituted. The spectrum of powder alanine CD3 is shown for comparison (A). The spectra were recorded at 
280K.  
 
To isolate the membrane-embedded domain of LmrA, proteoliposomes containing reconstituted full-
length LmrA was treated with proteinase K. This procedure allows selectively removing of the 
cytoplasmic domain and leaves intact the membranous domain and vesicles interior parts of the 
protein. Figure 4.1 shows that no band of the intact protein is observed after the proteolysis as well as 
of other peptides associated with protein or lipids. Van Veen and co-workers who were the first to 
apply this procedure to LmrA, have blotted the 35 kDa membranous LmrA domain on a PVDF 
membrane, sequenced and proved that this peptide is the six transmembrane helices and the loops 
connecting them according to the protein predicted model (Grimard et al., 2001). 
2H NMR spectrum   119
of the LmrA was recorded at 280K and compared to powder pattern alanine CD3 (Figure 4.4). The 
spectra comparison reveals that quadrupolar splitting of proteolysed LmrA is narrowed from 38 kHz 
(d3-alanine) to 35 kHz and the isotopic component is dramatically reduced when compared to full 
length LmrA (Figure 4.2).  
 
LmrA-MD 
Truncated LmrA-MD (36 kDa) was detected at SDS-PAGE (Figure 4.1). The spectrum of LmrA-MD 
was recorded at 280K and compared to powder alanine CD3 (Figure 4.4). The spectra comparison 
reveals that that quadrupolar splitting is narrowed from 38 kHz to 36 kHz and the isotopic component 
is dramatically reduced when compared to full length LmrA (Figure 4.2). However, this reduction is 
slightly less pronounced, than the one observed for proteolysed LmrA. This slightly smaller reduction 
of an isotropic component can be associated with the fact that LmrA-MD (36 kDa) has longer, 
suppositively mobile, intracellular domain connecting the TMDs and NBDs, than proteolysed LmrA 
(35 kDa). Interestingly, both LmrA-MD and proteolysed LmrA run at SDS-PAGE on approximately 
the same level (Figure 4.1). It can be explained by `low´ resolution of SDS-PAGE and possible 
differences in electrophoretic behaviour of both proteins (Venter et al., 2002).  
 
2H-MAS NMR 
The contribution from the natural abundance water can be approximated from deuterium MAS NMR 
experiment which allows clearly resolving the water and the protein components. Figure 4.5 shows 
the 
2H MAS NMR spectra of LmrA in a resting state, and trapped with AMP-PNP. For all cases at 
280K the water peak is clearly separated from the protein peak and its contributions is not dominant. 
Interestingly, for all cases we did not observe expected improvement in spectra intensity when 
compared to 
2H static spectra and in addition observe loss of spectra intensity with increasing 
temperatures (Figure 4.2 and 4.5). It could mean that the particular LmrA domains are in an 
intermediate motion regime (μsec), at which that the sidebands broaden significantly and as a result 
2H MAS NMR loses its advantage of high resolution and sensitivity.  
Another interesting feature of 
2H MAS spectra is sidebands pattern in each spectrum at 280K. The   120
sidebands are significantly reduced in all cases at 280K when compared to the subsequent spectra 
recorded at 235K and 260K but less for LmrA AMP-PNP trapped state (Figure 4.5). This more 
pronounced sidebands pattern of LmrA trapped with AMP-PNP deuterium spectra could be correlated 
with subsequent static deuterium spectra, showing reduced NBDs mobility (Figure 4.2 and 4.5).  
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Figure 4.5: 
2H MAS NMR spectra of E. coli liposomes reconstituted LmrA in a resting state (A), and with 
AMP-PNP bound (B). The temperature was set at 235K, 260K and 280K. 
 
31P NMR 
One of the possible origins of the central component is fast tumbling protein associated with non-  121
bilayer lipid complexes or with small unilamellar vesicles (Herzfeld et al., 1987; Jelinski et al., 
1980a). To exclude this possibility, the 
31P NMR was used to monitor changes in the phase behaviour 
of the phospholipids bilayer upon interaction with the protein (Ravault et al., 2005). Figure 4.6 shows 
a comparison of 
31P spectra of E. coli liposomes reconstituted LmrA and E. coli lipid unilamellar 
liposomes prepared in the same way as for reconstitution, including detergent destabilization and 
detergent removal with bio-beads. All spectra are clearly dominated by the chemical shift anisotropy 
of the phosphate groups averaged by fast axial rotation of lipid molecules. This confirms that the lipid 
systems remain in the liquid crystalline lamellar phase when it contains reconstituted LmrA in full and 
truncated form. Additionally, the freeze-fracture micrographs presented in Chapter 3 (Figure 3.8) 
clearly demonstrate that the systems used here were liposomal. Nonliposomal or amorphous structures 
were not seen. 
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Figure 4.6: The 
31P NMR spectra of E. coli liposomes reconstituted LmrA in (A) a resting state (B) with AMP-
PNP bound, (C) LmrA-MD, (D) free liposomes prepared in a way like for LmrA reconstitution. The 
temperature was set at 300 K. 
 
Comparison of 
2H NMR spectra of LmrA in a resting state and a state when AMP-PNP bound 
In the next step the static spectra of alanine CD3 labeled LmrA in complex with AMP-PNP at the 
most representative temperatures, 235K, 260K and 280K, were recorded. Figure 4.2 shows a 
comparison of 
2H alanine CD3 spectra in the LmrA resting state and in complex with AMP-PNP. 
From the visual inspection it is clear that at the temperature as high as 280K the difference between 
the spectra of both protein states is in the size of a central component. It is considerably reduced when 
AMP-PNP is bound to LmrA. The quadrupolar splitting of both spectra are equal to the one of the 
resting state LmrA at every measured temperature. However, the powder pattern of the protein with   122
AMP-PNP bound exhibit severe spectra distortions at 235K, and 260K, when compared to spectra of 
LmrA in a resting state. 
 
Comparison of 
2H spectra and T1 relaxation for LmrA in a resting state, and ATP/ADP-
Vanadate trapped state 
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Figure 4.7: 
2H NMR spectra of 
2H alanine selective labelled LmrA reconstituted E. coli liposomes in a resting 
state in a state trapped with ATP/ADP-Vanadate. The spectra recorded at increasing temperatures 235K, and 
280K. The spectra arise from the 48 alanines in the LmrA (~ 147 deuterons). 
 
To investigate the dynamics behaviour of LmrA in post-hydrolysis state, LmrA was trapped with 
ATP/ADP-Vanadate in a state when one ATP molecule is hydrolysed and product ADP still bound to 
nucleotide binding site and another ATP is waiting to be hydrolysed. The comparison of spectra of 
full-length LmrA in a resting state and in ATP/ADP-Vanadate trapped state at 280K revealed that the 
central component is reduced for ATP/ADP-Vanadate trapped state in a way similar to the one 
observed for LmrA trapped with AMP-PNP. Interestingly, in contrast to AMP-PNP trapped LmrA, no   123
differences were observed between the spectra of LmrA in a resting state and in ATP/ADP-Vanadate 
trapped state recorded at 235K. The direct comparison of deuterium NMR spectra of LmrA trapped 
with AMP-PNP and ATP/ADP-Vanadate could cause error because these two samples belong to 
different preparation batches and these two different preparation batches might slightly differ in 
deuterium natural abundance water content, which could be estimated for each case only qualitatively. 
In addition, the T1 values have been obtained for both rigid and dynamic part of ATP/ADP-Vanadate 
trapped LmrA state spectra and compared to values obtained for LmrA resting state (Figure 4.8 and 
Table 4.1). 
It was found that the T1 values for rigid part of 
2H spectrum are not significantly changed, the 
difference is in the ratio of experimental mistake. In contrast, the T1 values for the dynamic 
component are clearly different for two protein states. Although quantitative analysis of deuterium 
spin-lattice relaxation is straight forward, it has to be done with care if multiple motions are present. 
Therefore, even having the whole set of T1 values, it is not possible to deduce a correlation time of 
CD3 group motion in LmrA.  
 
free state
ATP/ADP/Vanadate trapped state
05 0 1 0 0 1 5 0 200
-0.5
0.0
0.5
1.0
N
o
r
m
a
l
i
z
e
d
 
i
n
t
e
n
s
i
t
y
 
(
a
.
 
u
.
)
mses
0 50 100 150 200
-1.0
-0.5
0.0
0.5
1.0
msec
free state
ATP/ADP/Vanadate trapped state
AB
free state
ATP/ADP/Vanadate trapped state
05 0 1 0 0 1 5 0 200
-0.5
0.0
0.5
1.0
N
o
r
m
a
l
i
z
e
d
 
i
n
t
e
n
s
i
t
y
 
(
a
.
 
u
.
)
mses
0 50 100 150 200
-1.0
-0.5
0.0
0.5
1.0
msec
free state
ATP/ADP/Vanadate trapped state
AB
 
Figure 4.8: The comparison of the spin-relaxation rates for LmrA TMDs and loops (A) and NBDs (B) in the 
protein resting state (black line) and ATP/ADP-Vanadate trapped state (blue line). 
 
 
4.4. Discussion 
Due to the necessity to study membrane proteins in membrane embedded form, structural and 
dynamic information is extremely difficult to obtain. Recently, the most precise structures of ABC   124
family members were obtained for MsbA and BtuCD transporters (Locher et al., 2002; Chang and 
Roth, 2001). However, it provides no information about the overall macromolecular proteins 
dynamics as well as about dynamics of these proteins particular domains.  
 
Labelling 
Here we exploit the deuterons as a spin-spy probe of molecular dynamics of the ABC transporter 
LmrA transmembrane and ATP binding domains. For this purpose, deuterium labelled (CD3 group) 
alanine was incorporated in the LmrA, using the procedure adopted from Cai (Cai et al., 1998). The 
alanine methyl groups were chosen because of their direct attachment to the α-carbon what allows to 
look at the backbone dynamics (Leo et al., 1987). Thus, any motions influencing the line shape, other 
than threefold methyl reorientation about the Cα-Cβ bond axis, must arise from the protein backbone 
(Leo et al., 1987). Moreover, non-methyl deuterons suffer from severe difficulties of signal detection 
(Jones et al., 1997). 
Alternative ways to incorporate the deuterium probes into the protein of interest have been used for 
egg white lysozyme and gramicidin A. All exchangeable groups in hen egg white lysozyme were 
labeled with deuterium by mild thermal denaturation in 
2H2O. Using this approach via T1 
measurements the correlation times for a fully hydrated crystalline protein was determined. The spin-
lattice relaxation measurements at different NMR fields indicated the presence of additional slow 
motions in the range of 10
-7 – 10
-6 sec (Mack et al., 2000). Another example is the indole ring protons 
of the gramicidin A tryptophan residues, which were deuterated via exchange in deuterated 
trifluoroacetic acid. From the experimentally determined quadruple echo decay time, the rotation 
correlation time was obtained which was consistent with formation of the peptide dimer (Macdonald 
and Seelig, 1988). Both methods, however, is not suitable for membrane transporters in general, and 
LmrA in particular, because the conditions for reversible renaturation for these proteins are not 
known.  
 
Examination of 
2H static LmrA in a resting state 
At low temperatures the spectra of selectively alanine methyl group deuterated LmrA in a resting state   125
has the powder pattern typical for crystalline form of CD3 alanine with asymmetry parameter of η ~ 0. 
It has a featureless line shape indicative of slow molecular dynamics with the quadrupolar coupling 
constant of 49.0 kHz, corresponding to a powder width of 37.5 kHz. At higher temperatures together 
with the rigid component the second central isotopic component appears in the spectra (Figure 4.2). 
The quadrupolar splitting of the rigid component at higher temperatures does not differ from the one 
at low temperatures. This indicates that particular domains in LmrA remain almost immobilized at 
low as well as at high temperatures whereas other LmrA domains exhibit high level of motion at 
increasing temperature. It implies that the alanine methyl groups in the LmrA domains corresponded 
to the rigid component in 
2H spectra exhibit no reorientation in addition to 3-fold rotation. Similar no 
change in quadrupolar splitting of the 
2H spectra rigid component recorded between -85 and 75
oC has 
been shown previously for 
2H5 Trp labeled bR (Kinsey et al., 1981). Therefore, it was concluded that 
bR Trp residues undergo no large amplitude motions on a time scale below < 10
-5 s below 75
oC 
(Kinsey et al., 1981). 
 
Central component 
The central isotopic component similar to the one we observed at increasing temperatures has been 
reported in the literature before. There can be multiple reasons for this central component to appear. 
Firstly, it can originate from deuterium natural abundance in water. Although prior to NMR 
measurements the protein reconstituted into proteoliposomes was extensively washed with buffer 
prepared on deuterium depleted water, the water containing natural abundance (0.015 %) 
concentration of deuterium can not be completely washed from the vesicles interior. Therefore, one 
could expect certain intensity in the isotopic central peak originating from deuterated water in natural 
abundance. For the unlabelled collagen it has been shown that approximately one-third of the sharp 
peak in the center of the spectrum is due to deuterium natural abundance in water, whereas two-third 
of the central component intensity comes from the alanine residues residing in the nonhelical termini 
of the molecule (Jelinski et al., 1980b). Using 
2H MAS NMR we have made a rough estimation of 
natural deuterium abundance water content in our samples. How it can be seen from Figure 4.5, this 
contribution is not significant.   126
Secondly, the central component can originate from partly degradated protein, which lost its 
connection with the proteoliposomes or from soluble proteins which associated with the membrane 
and were not removed during the purification procedure. This possibility can be excluded as the SDS-
PAGE analysis and gel filtration (Figure 4.1 and Figures 3.2 and 3.3, Chapter 3) reveal that the 
procedure we use for the samples preparation yields pure protein without contaminations from soluble 
proteins. Additionally, the ATPase assays performed on those samples as well as substrate induced 
intrinsic tryptophan fluorescence quenching experiments had concentration-dependent character. This 
proves the function state of the protein reconstituted E. coli liposomes and allows us to exclude the 
presence of aggregated protein in our samples (Chapter 3, 5). 
Thirdly, using 
31P NMR we have excluded the possibility that this component comes from fast 
tumbling protein attached to non-bilayer lipid complexes or small unilamellar vesicles (Figure 4.6). 
Alternatively, in some cases, this central isotopic component has been assigned to the amino acids 
located on the protein surface (Keniry et al., 1984a). Similar reduction of the spectral width (in our 
case to 150 Hz width at the half height for a resting state LmrA measured at 280K) has been reported 
for the protein in solution. Here, it has been addressed to free rotation of the molecules about its long 
axis (Jelinski et al., 1980a). However, in the same study it was proposed that the sharp component 
may be due to some alanine Cα- Cβ bond axes which make the ‘magic angle’ with respect to the helix 
axis, or corresponds to residues residing in non-helical termini of the molecule (Jelinski et al., 1980a).  
In addition, very strong argument comes from the deuterium NMR measurements of LmrA-MD and 
proteolysed LmrA. So, it has been clearly shown that this central component can be almost removed 
from the spectrum if the NBDs are cleaved or if LmrA is expressed in truncated version without 
NBDs (LmrA-MD) (Figure 4.4).  
Taking all together, it can be concluded that this central isotopic component originates from the 
residues located in NBDs. The NBDs are not embedded into lipid matrix, so the overall motion 
characteristics of NBDs can be quite different from the motion characteristics of the TMDs and even 
resemble the motion behaviour of the protein in solution. The central isotopic component has a 
dramatically reduced quadrupolar constant of 159 Hz (from 49.0 kHz of a rigid part). Such a 
quadrupolar constant reduction can be associated with (1) three-fold methyl hops or rotations, which   127
are not limited by the membrane in cytoplasmic domain, as well as by (2) additional rotation motions 
about the protein long molecular axis, (3) rotation about the Cα-Cβ and Cβ-Cγ bond axes, (4) librational 
motions corresponded to wobbling of methyl groups, and (5) by backbone mobility (Tiburu et al., 
2004). Similar two components 
2H spectrum for deuterated fd coat protein was obtained. The rigid 
spectrum part was assigned to immobile alanine residues whereas dynamic part to alanine residues of 
experiencing isotropic motions (Leo et al., 1987). At that time the structure of fd coat protein in the 
lipid bilayer was not available (McDonnell et al., 1993). So it was not possible to complete the picture 
and associate different alanine amino acids dynamic characteristics with their membrane buried and 
surface location (Leo et al., 1987).  
The relative integrals of rigid and dynamic parts in deuterium static spectra of LmrA in a resting state 
were calculated to be approximately 1 to 1 (Figure 4.2). This ratio is well matched to the number of 
residues in TMDs/loops LmrA part and LmrA NBDs, which is subsequently 27 to 21. However, it is 
known that the intensities in the 
2H quadrupolar echo experiments are not proportional to the number 
of spins except for the slow and fast limit regimes due to substantial intensity loss of groups 
undergoing intermediate rate (≈ 10
5 s
-1) (Siminovitch, 1998). Therefore, a relation between the 
integrated intensities of the two spectra components may not reflect a relation between numbers of 
amino acids contributing to them, and have to be interpreted with caution. 
 
2H static spectra of LmrA in a resting state and in a state when LmrA is trapped with AMP-
PNP and ATP/ADP-Vanadate 
To investigate the effect of AMP-PNP binding on LmrA overall dynamics, deuterium NMR spectra of 
CD3 alanine labeled LmrA in complex with ANP-PMP were recorded at 235K, 260K, and 280K. 
Figure 4.2 shows a comparison of LmrA spectra at 235K, 260K, and 280K for both protein states. 
Interestingly, the AMP-PNP binding to LmrA leads to the clear changes in the LmrA spectra at all 
studied temperatures. The difference in the deuterium spectra at 235K and 260K evidences changes in 
the protein mobility which is difficult to address to particular LmrA domains. In contrast, at 280K, at 
which the rigid spectra component was assigned to mostly TMDs and dynamic component to NBDs, 
the only difference is that the spectrum of LmrA in complex with AMP-PNP has considerably   128
reduced central component. It may indicate the reduced mobility of NBDs.  
In the next step the spectrum of ATP/ADP-Vanadate trapped LmrA were compared to a resting state 
LmrA spectrum (Figure 4.7). Interestingly, at a temperature as high as 235K the spectrum of 
ATP/ADP-Vanadate trapped LmrA resembles the one of a resting LmrA state, whereas at 280K the 
one for AMP-PNP trapped LmrA (Figure 4.2 and Figure 4.7). This interesting spectra behaviour 
points out that motionally ATP/ADP-Vanadate trapped LmrA state is neither equal to LmrA resting 
state nor to AMP-PNP trapped state.  
 
T1 measurements 
In general T1 measurement is a useful mean to investigate the protein dynamics (Allerrini et al., 1985; 
Keniry et al., 1984b; Opella, 1982; Jelinski et al., 1980a). The spin-relaxation measurements are 
extremely sensitive to internal motions of proteins side chains in the range 10
-7 to 10
-10 s. It is possible 
to determine a unique correlation time from a single set of relaxation spectra and often to discriminate 
among possible models of motion (Torchia, 1984). In our case the T1 measurements contain limited 
information because there too many probes in the protein, 48 deuterated alanines (~147 deuterons). 
Each of them might be motionally inequivalent and the resulting T1 values might be an average of 
many of different values. However, T1 values comparison for different protein states can certainly add 
to a qualitative understanding of dynamic process occurring in the protein under AMP-PNP and 
ATP/ADP-Vanadate binding.  
The spin-relaxation was investigated as a function of temperature. For LmrA resting state, it is shown 
(Table 4.1), that the T1 values increase with the temperature. Similar increase of T1 values with a 
temperature has been observed before for myoglobin (Keniry et al., 1983). It has been suggested that 
for methyl groups in L-amino acids methyl rotation dominates the relaxation at low temperatures. In 
contrast, at higher temperatures an additional large-amplitude motions occurs that effect the relaxation 
and often 
2H NMR line shapes. At 280K the T1 values were obtained separately for two spectra 
components, the rigid and the dynamic, corresponded respectively to TMDs and loops and to NBDs. 
The obtained spin-lattice relaxation vales for TMDs and loops was 20.4±1.5 ms and for NBDs was 
28.5±2.2 ms. To compare, the motional characteristics of membrane spanning domains and nucleotide   129
binding domains during the LmrA transport cycle the T1 values for LmrA in the resting protein state 
and in the state where LmrA is trapped with ATP/ADP, and vanadate were obtained (Figure 4.8, 
Table 4.1). The spin-lattice relaxation values indicated that in the ATP/ADP-Vanadate trapped state, 
the LmrA has motional characteristics clearly different from the resting state. Moreover, it was shown 
(Figure 4.8, Table 4.1) that the major dynamic changes effecting the dynamics occur not in membrane 
spanning region, but in nucleotide binding region.  
 
Summarizing to say, at 280K temperatures the deuterium spectra of LmrA in a resting state and 
trapped with AMP-PNP and ATP/ADP-Vanadate had two components: the rigid with a quadrupolar 
splitting of powder CD3 labeled alanine and central isotropic part. Usage LmrA-MD and LmrA 
proteolysed allowed us to correlate the central component with NBDs and the rigid with TMDs and 
loops. Examination of deuterium static spectra of LmrA trapped with AMP-PNP and ATP/ADP-
Vanadate revealed that NBDs in both protein states have reduced mobility when compared to LmrA 
resting state. In addition, LmrA trapped with AMP-PNP is more motionally restricted then LmrA 
trapped with ATP/ADP-Vanadate. 
 
Relation with the ABC transporters transport cycle 
Strong evidence exists that ABC transporters NBDs dimerization occurs under ATP binding, and 
subsequent ATP hydrolysis leads to opening of NBDs dimer (Lu et al., 2005). Such a dramatic 
structural rearrangement (Figure 4.9) may lead to altering of the overall protein dynamics 
characteristics what may have direct influence on deuterium spectra lineshapes in a way we detected. 
Interestingly, we have observed that all the LmrA state: resting, pre-hydrolysis, and post-hydrolysis 
are not motionally equivalent. In past, conformational non-equivalence between those three protein 
conformations have been reported for PGP on 2D crystals and by cross-linking studies and on LmrA 
by mass spectroscopy (Ecker et al., 2004; Rosenberg et al., 2003; Loo and Clarke, 2002).  
Concerning the ABC transporters transmembrane domain, it is well established that the 
transmembrane helices exhibit conformation rearrangements under substrate and/or ATP binding 
(Vigano et al., 2002; Rosenberg et al., 2001b; van Veen et al., 2000a). However, limited structural   130
data do not allow to reliably conclude on a nature of these rearrangements. The fact that changes in 
the dynamics characteristics of LmrA transmembrane helices were not detected on 
2H static spectra 
recorded at 280K and by T1 measurements at 280K (Figure 4.2) in the presence of AMP-PNP and 
ATP/ADP-Vanadate subsequently does not imply that no conformation changes occur in TMDs under 
ATP and ATP/ADP binding. We can speculate that rotation or translation movements of the a-helices 
which may be involved in restructuring of the membrane embedded domain do not affect the overall 
dynamics of TMDs in a way to be detected by low resolution 
2H NMR (Figure 4.9). Biochemical 
evidences of such transmembrane helices movements have been reported previously for LmrA and 
PGP (Vigano et al., 2002; Rosenberg et al., 2001b). 
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Figure 4.9: Proposed LmrA conformation changes affecting the protein dynamics under ATP binding and 
hydrolysis. 
 
 
Approach advantages and limitations 
The work presented in this chapter is the first attempt to study the dynamic behaviour of full-length 
ABC transporter LmrA in three protein states: resting, pre-hydrolysis and post-hydrolysis. This 
approach has its advantages and limitations.  
While it does not allow for studying the internal dynamics of individual sites within the protein, this 
approach has several advantageous features. It allows associating particular signals with the protein 
TMDs, loops and NBDs and in parallel following the dynamics changes under ATP binding and 
hydrolysis separately for the membrane spanning and ATP binding domains. Similar results would be 
difficult to obtain with the smaller number of probes. In the absence of the high resolution structure 
and in the presence of limited biochemical data on LmrA, we would not be able to speculate on the 
dynamic changes in the whole system. However, such a study could potentially make analysis of 
2H   131
NMR spectra lineshapes more quantitative.  
The results reported in this Chapter would be difficult to obtain by means of solution state NMR, 
because the internal motion of interest would be most likely superimposed by the overall protein 
tumbling, which is the dominant effect in determining T1 and other relaxation parameters (Mack et 
al., 2000). In contrast, in solid-state NMR no significant overall molecular motions occurs on the 
NMR time scale and relaxation is induced by internal motions alone (Mack et al., 2000).  
In addition to high sensitivity towards motional changes in the protein, the approach we used here is 
free of necessity to perform the signal assigning and the low natural abundance of deuterium (0.015 
%) virtually eliminates background signals due to unlabelled material in natural abundance. 
 
Conclusions 
2H static NMR studies thus demonstrated that the dynamic behaviour of LmrA domains is complex. 
The deuterium LmrA spectra at 280K had two components: the rigid with a quadrupolar splitting of 
powder CD3 labeled alanine and central isotropic part. The rigid spectra part was related to TMDs and 
loops and isotopic to NBDs. The comparison of spectra at several temperatures 235K, 260K, and 
280K allows to conclude that the LmrA TMDs are relatively immobile on NMR time scale; in 
contrast NBDs are quite dynamic. The comparison of deuterium lineshapes of LmrA in a resting state 
and trapped with AMP-PNP and ATP/ADP-Vanadate revealed that the protein is motionally non-
equivalent at each state. Concerning motion of certain LmrA domains, it has been observed that under 
ATP binding and hydrolysis, TMDs remain relatively immobilized on a time scale of NMR 
measurement, in the same time, NBDs experience considerably reduced mobility. 
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5. Ligand binding to LmrA as observed by fluorescence and solid-state 
NMR spectroscopy 
 
Abstract  
Having optimized the protocol for reconstitution of LmrA into E. coli liposomes at a high protein lipid 
ration, the experiments aiming to shed light on drug protein interaction and conformation changes 
occurring in the protein under substrate binding can be performed. In the first step the binding of 
TPP
+, fluoroquinolone drug, norfloxacin and vinblastine were probed using tryptophan intrinsic 
fluorescence quenching approach. TPP
+ and norfloxacin both contain NMR active nuclei, respectively 
31P and 
19F, in their structure. It is give the possibility to assess these drugs binding to LmrA by 
SSNMR without expensive isotope labelling. Finally, effect of leupeptin, an effective PGP inhibitor, 
on Hoechst-33342 transport and ATPase activity of LmrA reconstituted into proteoliposomes was 
investigated.  
 
5.1. Introduction 
As one of the major causes of MDR is the overexpression of MDR transporters, the goal of modern 
pharmaceutical science is to find effective modulators of MDR transporters for clinical application. 
Therefore detailed knowledge on drug-protein interaction is needed. Numerous studies have been 
performed to gain insight into the physicochemical aspects of substrate interaction with different types 
of MDR transporters (Murakami et al., 2002; Zheleznova et al., 2000; Seelig, 1998). However, the 
substrate interactions and translocation by the MDR proteins family is not well understood.  
To observe the drug binding to LmrA and conformation changes in the protein occurred under 
substrates binding, the tryptophan intrinsic fluorescence quenching with three drugs, TPP
+, 
norfloxacin, and vinblastine were performed (Figure 5.1). Two of them, TPP
+ and vinblastine, are 
known LmrA substrates (van Veen et al., 2000a; van Veen et al., 1996). Binding of fluoroquinolone 
drug, norfloxacin to LmrA, in contrast, has never been shown before. Although rapidly emerging   134
bacterial resistance to this type of agents including resistance through expression of MDR membrane 
pumps is shown (Blondeau, 2004b; Poole, 2000). 
Fluorescence spectroscopy has been very fruitful over the past years in exploration of membrane 
transporters structure and function (Eckford and Sharom, 2005; Elbaz et al., 2005; Lugo and Sharom, 
2005a; Vigano et al., 2002; Liu et al., 2000; Sharom et al., 1999a; Sharom et al., 1999b). 
Fluorescence measurements can be performed using fluorescent dyes, MDR substrates, using the 
extrinsic fluorophore 2-(4-maleimidoanilino)naphthalene-6-sulfonic acid (MIANS) at Cys residues or 
by taking advantage of intrinsic fluorescence of proteins provided by their aromatic acids, tyrosine, 
tryptophan and phenylalanine (Sharom et al., 2001; Sharom et al., 1999b). These measurements have 
provided unique information suggesting that the drugs are extracted from the membrane cytoplasmic 
leaflet and allowing to monitor changes occurring in the transmembrane and cytosolic regions in the 
presence of drug (Sharom et al., 2001; Mitchell et al., 1999).  
 
 
 
Figure 5.1: The chemical structures of (A) vinblastine, (B) TPP
+, and (C) norfloxacin. 
 
The intrinsic tryptophan fluorescence of PGP is shown to be highly sensitive to the drugs and   135
nucleotide binding and can be used to asses the drugs affinity of known substrates and screen the drug 
library to identify new substrates and modulators (Sharom et al., 2001; Liu et al., 2000; Sharom et al., 
1999a; Sharom et al., 1999b). Experiments aiming to determine the Kd values for known MDR 
substrates are extremely important because substrate Kd values are highly correlated with their ability 
to inhibit. Fluorescence quenching approach application to LmrA has been reported to our knowledge 
only once (Vigano et al., 2002). In this case, Trp fluorescence quenching by acrylamide has been 
carried out in the presence and absence of the substrate daunorubicin and ATP. The experiments 
shows that drug binding influences the structure of cytosolic regions of LmrA and a conformational 
change is transmitted from the TMDs to NBDs (Vigano et al., 2002). 
As an alternative technique, NMR has been successfully applied in recent years to identify and 
characterize a number of compounds in drug discovery process (Wyss et al., 2002; Glaubitz et al., 
2000; Spooner et al., 1994). It is a rather useful tool for obtaining site specific information concerning 
membrane protein drug recognition, binding and transport, because it allows the protein to be studied 
in the native environment (Boland and Middleton, 2004; Middleton et al., 2004; Patching et al., 
2004b; Middleton et al., 2000a; Watts et al., 1998). In addition, NMR is able to determine the 
structure of bound ligand (Luca et al., 2005).  
Solid-state NMR spectroscopy can be applied not only to observe bound ligands, but also to 
investigate the binding quantitatively by studying CP build-up curves and analyzing binding 
stoichiometry (Patching et al., 2004a; Xu et al., 2000). The most relevant substrates for this kind of 
studies are weakly bound substrates. Strongly bound ligands undergo slow dissociation from the 
membrane receptor and their kinetic is not manifested on NMR time scales. Additionally, resonances 
of tightly bound ligands experience linebroadening due to chemical shift anisotropy and dipolar 
interactions. However, strongly bound ligands can be detected by means of CP MAS NMR, because 
MAS average chemical shift anisotropy and dipolar interactions (Patching et al., 2004b).  
Among examples of such investigations are experiments performed on a nucleoside transporter, 
NucP, and a glucuronide transporter, GusB. For these two transporters not only the binding affinities 
of 
13C-labeled substrates have been determined but, additionally, a novel approach allowing to 
eliminate signal from non-specific binding by means of a cross-polarization/polarization inversion   136
recovery NMR has been presented (Patching et al., 2004b). This method might be of interest 
especially if the chemical shifts of specifically and non-specifically bound ligands overlap or if the 
signal from non-specifically bound ligand is much stronger than that of specifically bound ligand. 
The application of solid-state NMR methods allows structural insight into ligand binding to large 
membrane proteins to be obtained, which is extremely difficult by other biophysical methods (Zech et 
al., 2004). An example of such an investigation is a solid-state NMR investigation of glycosides 
binding to Na
+/K
+ ATP-ase. Here, a 
19F/
13C REDOR NMR strategy was used to determine the 
structure of an inhibitor in its binding site (Middleton et al., 2000a).  
An alternative way to study ligand-protein interactions by SSNMR is through the observation of a 
labeled protein followed by analysis of chemical shift differences between the drug bound and 
unbound protein state. This approach is potentially free of difficulties associated with non-specific 
substrates binding to the membrane in case of membrane reconstituted protein samples, especially in 
case of weak substrate binding often observed for membrane transporters (Spooner et al., 1998). 
Using this approach, the ligand binding to the anti-apoptotic protein Bcl-xL has been observed (Zech 
et al., 2004). 
The observation of ligand bound to protein requires isotope labeled ligand or protein. However, 
examples of isotope labeled drugs are rare and protein labelling is often expensive. Another way to 
observe bound ligand by NMR spectroscopy is to observe ligands naturally containing NMR active 
nuclei, such as 
31P or 
19F (Patching et al., 2004b; Middleton et al., 2000a). 
31P (100 % abundance) and 
19F (100 % abundance) nuclei are spin half nuclei and are characterized by high sensitivity, which 
makes them convenient for NMR spectroscopy. In addition, the protein itself does not contain any 
fluorine or phosphorous nuclei (unless protein is phosphorylated), which makes assignment and 
removal of background, in case of phosphorous, straight forward (Xu et al., 2000). Two LmrA 
substrates TPP
+ and norfloxacin meet these requirements, containing respectively 
31P and 
19F in their 
structure. 
There are several ways to inhibit the drug transport in MDR proteins. Among them is designing 
modulators which have affinity for the drug binding site high enough to win the competition for this 
binding site with other substrates, occupy the binding site, and block the protein function. Another   137
way to modulate the drug resistance phenomena is to design compounds perturbing interactions 
between the cytosolic and membrane–embedded domains. Concerning, PGP, up to date numerous 
compounds have been identified as MDR-reversing agents (Dantzig et al., 2001). There is growing 
evidence that many hydrophobic peptides are also P-glycoprotein substrates (Lam et al., 2001; 
Sharom et al., 1998; DiDiodato and Sharom, 1997). Several of them have been seriously investigated 
with respect to their Kd values, ATPase activity modulation, and ability to block drug transport 
(Sharom et al., 1998; Sharom et al., 1996). These peptides display a relatively low overall toxicity to 
intact MDR cells, and inhibit drug transport at concentrations below the toxic range. Therefore, it is 
suggested that hydrophobic peptides should be given serious consideration for development as clinical 
chemosensitizing agents (Sharom et al., 1998). Among those peptides are leupeptin, pepstatin A, 
valinomycin, cyclosporin A. However, despite the growing evidence of hydrophobic peptides ability 
to modulate MDR, their interaction with LmrA has never been reported. Therefore, we have examined 
the influence of leupeptin on Hoechst-33342 transport by the multidrug transporter LmrA and on 
LmrA ATPase activity.  
 
 
Figure 5.2: The chemical structure of leupeptin (acetyl-Leu-Leu-Arg-al), linear peptide, which was shown to be 
an effective blocker of colchicine transport for PGP (Sharom et al., 1998). 
 
The present work uses a fluorescence approach to provide insight into the binding of three drugs, 
norfloxacin, TPP
+, and vinblastine, to LmrA. So, the binding affinities for three drugs are determined 
and the nature of their binding to the protein is discussed. The binding of norfloxacin and TPP
+ to 
LmrA was additionally assessed by solid-state NMR spectroscopy. The real-time fluorescence assay 
is used to monitor the Hoechst-33342 transport and the transport collapse by LmrA modulator, 
peptide, leupeptin.   138
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5.2. Materials and Methods 
 
Materials 
TPP
+, leupeptin, norfloxacin, and vinblastine were obtained from Sigma. All other materials were 
reagents of analytical grade. 
LmrA purification and reconstitution into E. coli liposomes by detergent liposome destabilization 
method was done as described under Materials and Methods in Chapter 2 and 3. 
 
5.2.1. LmrA tryptophan intrinsic fluorescence quenching by various substrates 
Fluorescence quenching experiments were carried out in suspensions of 1 μM LmrA reconstituted 
into  E. coli liposomes by the detergent destabilized method described above. The necessary 
proteoliposomes dilutions were performed in 100 mM Tris, 50 mM KCl buffer, pH 7 buffer. Working 
solutions of drugs were prepared in ethanol (TPP
+ and norfloxacin) and in DMSO (vinblastine) of 
highest available purity. The final concentration of solvent in the fluorescence cuvette was always 
kept to 1 % (v/v). Both solvents alone in such concentration showed negligible effect on intrinsic Trp 
fluorescence. Quenching experiments were performed by adding 1 µL aliquots of different drug 
concentrations to 99 μL LmrA reconstituted proteoliposomes in 0.5 cm quartz cuvette. After each 
addition, the sample was exited at 290 nm and the steady-state fluorescence emission was measured at 
340 nm. Fluorescence intensities were corrected for ethanol, DMSO, and drugs effect by subtracting 
the emission spectra of the same drug dilution in appropriate buffer collected in parallel for each 
sample. Artifacts originating from scattering were corrected by using polarizing filters. 
Experimental data showing monophasic quenching behavior were computer-fitted to the following 
equation (Liu et al., 2000): 
 [5.1]     
 
where Fo is the initial value of florescence intensity, ΔF is the value of fluorescence intensity at a 
given point in the titration, ((ΔF/Fo)·100) is the percent quenching (percent change in fluorescence 
relative of the initial value); [S] is the substrate concentration, and Kd is the dissociation constant.   139
Fitting to a one or two site model was carried out using a nonlinear regression algorithm with Origin 
7.0 (Microcal Software Inc., Northampton, MA), the Kd value for monophasic quenching behavior 
and Kd1, Kd2 for biphasic were extracted.  
 
5.2.2. 
19F and 
31P SSNMR measurements of substrates bound to LmrA 
All experiments were performed on a Bruker Avance 600 spectrometer equipped with a 4 mm MAS 
DVT probe. The measurements were performed at 242.9 MHz for 
31P and 564.5 MHz for 
19F. For 
31P 
and 
19F observation a CPMAS pulse program employing an 80-100% ramped Hartmann-Hahn 
condition with two pulse phases modulated (TPPM15) heteronuclear 
1H decoupling was used. For 
31P 
observation the acquisition time was set to 49 ms, CP contact times and recycle delay times were 
respectively 1.5 ms and 2 s. For 
19F observation the acquisition time was set to 20 ms, CP contact 
times and recycle delay were respectively 1 ms and 4 s. Spectra were zero filled to 16k points and 
exponential line broadening of 50 kHz and 100 kHz were applied during processing respectively  for 
31P and 
19F. The spinning rate was set to 10 kHz for all 
19F experiments and 8 kHz for all 
31P 
measurements. Spectra were referenced externally to phosphoric acid (85 %) at 0 ppm (
31P), and to 
trifluoacetic acid at 0 ppm (
19F). The temperature was regulated by a Bruker temperature control. 
Observations were made in both the Lα (liquid crystalline) and Lβ (gel) phase of E. coli lipids at 25
oC 
and -20
oC respectively. Spectra were analyzed using Topspin (Bruker). Deconvolution of 
19F spectra 
was performed using PeakFit (SeaSolve Software Inc). 
For 
31P NMR experiments 0.65 μM TPP
+ was added to 5 ml suspension of E. coli proteoliposomes 
reconstituted LmrA (about 0.15 μM of protein) in 100 mM Tris, 50 mM KCl, pH 7 buffer or to 20 mg 
E. coli lipid free liposomes. The mixtures were incubated on a rocking table for 20 minutes and then 
pelleted for 40 minutes with 50000 rpm. 
For 
19F NMR experiments the same sample preparation procedure was used, however 10 fold excess 
of norfloxacin (about 2 μM) was added to the reconstituted protein (approximately 0.2 μM) to ensure 
efficient protein concentration in the lipid phase. 
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5.2.3. Modulation of Hoechst-33342 LmrA transport and ATPase activity by leupeptin 
 
Hoechst-33342 transport inhibition 
The Hoechst-33342 transport assay was performed essentially in the way described under Materials 
and Methods in Chapter 2. The only alteration is that Hoechst-33342 pumping under ATP hydrolysis 
was perturbed by addition of 20 μL 10 mM leupeptin solution in DMSO. In a control measurement, 
pure DMSO was added place to leupeptin dissolved in DMSO.  
 
The ATPase activity modulation 
The ATPase assay was performed as described under Materials and Methods in Chapter 3. Leupeptin 
was dissolved in DMSO so that 1 μL added to reaction mixture provided leupeptin concentrations of 1 
mM and 10 mM subsequently for two experiments. For control measurement 1 μL of pure DMSO 
was added to reaction mixture.  
 
 
5.3. Results 
 
5.3.1. Tryptophan intrinsic fluorescence quenching with norfloxacin and vinblastine 
LmrA contains 5 tryptophan residues distributed thought out the LmrA polypeptide chain. 
Accordingly to the proposed topology (van Veen et al., 1996), two of them are located in the NBD 
and three in loops connecting TM helices (Figure 5.11). Fluorescence quenching studies with the 
fluoroquinolone norfloxacin, and Vinca alkaloid vinblastine were carried out accordingly in 1 μM 
LmrA containing proteoliposomes suspension.  
The emission spectra of reconstituted LmrA exhibited a maximum at 344 nm, indicating that the 
tryptophan residues are located in a relatively non-polar environment buried within the protein 
structure as indicated by their emission spectrum when compared to solubilised Trp, which has an 
emission maximum at 360 nm (Figure 5.3) (Liu et al., 2000). Two Trp residues are non membrane-
embedded and located in nucleotide binding domain. Therefore, they potentially can be accessible to   141
aqueous surroundings. However, we observe only one emission maximum at 344 nm. This shows that 
Trp residues in NBD domain are possibly hidden from the aqueous environment and located in the 
NBD vicinity.  
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Figure 5.3: Fluorescence emission spectra for LmrA reconstituted into E. coli liposomes (1 μM protein) in 
buffer containing 100 mM Tris, 50 mM KCl, pH 7. The black spectrum is control fluorescence emission 
spectrum of standart proteoliposomes/buffer mixture containing 1 % (v/v) of pure ethanol. The red spectra show 
the fluorescence emission for Trp solubilised in 100 mM Tris, 50 mM KCl buffer, pH 7. Fluorescence emission 
was recorded at 25
oC following excitation at 290 nm. 
 
The Trp intrinsic fluorescence quenching for both drugs was measured in the concentration range of 0 
– 50 μM. Further titration was limited by low drugs solubility. The usage of ethanol and DMSO in 
amounts higher then 1 % v/v had to be avoided, as this could potentially lead to the protein 
degradation. For both drugs, high fluorescence quenching showed the concentration dependent 
binding of drugs to protein and it was possible to estimate the binding constants for both drugs. In 
both cases, the data were fitted to a one site binding model. For norfloxacin the binding constant was 
determined 0.3 μM ± 0.03 μM and for vinblastine 3.79 ± 0.4 μM (Figure 5.4). The control quenching 
of solubilised Trp analogue N-acetyl-L-tryptophanamide (NATA) by number of substrates including 
vinblastine has been performed previously and was shown to be fully aqueous (Liu et al., 2000). 
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Figure 5.4: Binding of norfloxacin (A) and vinblastine (B) to LmrA reconstituted E. coli lipids liposomes as 
assessed by tryptophan intrinsic fluorescence quenching. The continuous lines represent the best computer-
generated fit of the data points (shown by the symbols) to an equation describing interaction of drug with a 
single type of binding site. The determined affinity constants are 0.3 ± 0.03 μM for norfloxacin and 3.79 ± 0.4 
μM for vinblastine.  
 
For both drugs the quenching in percent appears to be relatively mild (less then 50 %). This indicates 
limited indirect effect of drugs binding on LmrA domains containing Trp residues. Otherwise higher 
quenching effect would be expected (Sharom et al., 2001). For the residues directly involved into drug 
binding the typical degree of quenching is much higher, up to 100 % (Sharom et al., 2001). The 
specificity of the interaction between the drugs and the protein was further confirmed, since neither 
norfloxacin, nor vinblastine showed any concentration-dependent Trp intrinsic fluorescence 
quenching when LmrA was thermally denaturated at 100 
oC for 20 minutes. 
 
5.3.2. 
19F SSNMR on norfloxacin bound to LmrA 
As we have clearly demonstrated that fluoroquinolone drug, norfloxacin, binds to LmrA and since 
little is known concerning its interaction with PGP and LmrA, a solid-state NMR experiment was 
designed to obtain structural insight in norfloxacin binding to the protein. CPMAS 
19F spectrum of 
norfloxacin bound to LmrA (Figure 5.5B) is compared with control measurement performed on the 
protein free liposomes incubated with an equal proportion of drug (Figure 5.5A). The significant 
spectrum overlap hampers the differentiation of drug bound to the protein from the drug residing in 
the membrane. The observation of bound to protein ligand is further complicated the limited solubility   143
of norfloxacin. Low norfloxacin solubility leads to the presence of three different peaks from non 
bound drug molecules associated with presence of different norfloxacin conformers in solution. 
Nevertheless, by deconvoluting the spectrum containing the signal from substrate bound to protein 
(Figure 5.5B, box) it was possible to filter out the resonance we are interested in. Figure 5.5B (box) 
shows deconvoluted 
19F spectrum of norfloxacin, where the resonance of ligand bound to the protein 
is slightly shifted to -42.50 ppm when compared with the signal of unbound ligand at -46.00, -41.20, 
and -38.46 ppm (norfloxacin conformers). 
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Figure 5.5: 
19F MAS spectrum of (A) free liposomes incubated with norfloxacin at a room temperature for 30 
minutes, (B) proteoliposomes reconstituted LmrA with added norfloxacin (LmrA : norfloxacin = 1:5 mol/mol). 
The deconvoluted spectra for both free and protein reconstituted liposomes are shown in the boxes. The 
resonance signal from ligand non specifically interacting with the membrane is assigned to -46.00, -41.20, and -
38.46 ppm, the signal from the substrate bound to LmrA is assigned to -42.50 ppm and marked with a star. The 
experiment was performed at 245K, at spinning frequency of 10 kHz. Approximately 8 K scans were 
accumulates per each spectrum. 
 
 
5.3.3. LmrA tryptophan intrinsic fluorescence quenching with TPP
+ 
In the next step using tryptophan fluorescence quenching and solid-state NMR approaches TPP
+ 
binding to LmrA was probed. Figure 5.6 shows that Trp intrinsic fluorescence quenching of LmrA 
with TPP
+ has the concentration dependent manner. The Trp intrinsic fluorescence quenching curve   144
was fitted with a two-site binding model. The determined affinity constants are 9.3 ± 3.9 nM for a 
high affinity binding site and 22.0 ± 3.8 μM for a low affinity binding site. The massive TPP
+ binding, 
manifested in non concentration dependant Trp intrinsic fluorescence quenching, was observed when 
the titration was prolonged up to concentration of 0.05 M. However, it is obvious that at lower ligand 
concentrations significant binding to lipids occur as well. This obviously interferes with the results. 
Therefore, the results must be interpreted with caution. 
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Figure 5.6: Binding of TPP
+ to LmrA reconstituted E. coli lipids liposomes as assessed by tryptophan intrinsic 
fluorescence quenching. The continuous lines represent the best computer-generated fit of the data points 
(shown by the symbols) to an equation describing interaction of drug with two-site type of binding model. The 
determined affinity constants are 9.3 ± 3.9 nM for a high affinity binding site and 22.0 ± 3.8 μM for a low 
affinity binding site. The massive TPP
+ binding was observed when the titration was prolonged, which can 
interfere with the results. Therefore, the results must be interpreted with caution.  
 
 
5.3.4. 
31P SSNMR on TPP
+ bound to LmrA 
In the next the 
31P CP MAS spectra were recorded on protein free E. coli liposomes and 
proteoliposomes reconstituted LmrA both containing 0.65 μM TPP
+, 5 fold excess in relation to total 
LmrA amount (Figure 5.7). The spinning speed was set to as 8 kHz, but it was not enough to average 
chemical shift anisotropy, so the spectra contain spinning sidebands together with the isotropic 
chemical shift. At temperature as high as 253K the TPP
+ resonance is observed at 23.2 ppm, the 
chemical shift is consistent with values reported in the literature (Glaubitz et al., 2000). TPP
+ is a   145
substrate for LmrA, and expected to bind to the protein under conditions used in the experiment (van 
Veen et al., 1996). The bound drug molecules might be placed in different environment. In this case, 
the resonance position from the bound TPP
+ molecules might be shifted from the non-bound 
molecules. However, no second peak from TPP
+, which could correspond to bound drug molecules, 
was observed. 
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Figure 5.7: 
31P MAS NMR spectra recorded using cross polarization. Spectra A and C correspond to free 
liposomes, with (C) and without TPP
+ (A). Spectra B and D correspond to E. coli liposomes reconstituted 
LmrA, with (B) and without TPP
+ (D). The isotropic lines are labeled with TPP
+ (23.2 ppm) and E. coli 
liposomes (0.1 ppm). The experiment was performed at 253K, at spinning frequency of 8 kHz. Approximately 
100 k scans were accumulates per each spectrum. 
 
Knowing that under the experimental conditions used here, the substrate binds to LmrA with high 
affinity, we hypothesized that it was not possible to differentiate between bound and unbound ligands 
by NMR methods because they have the same chemical shift. However, even if bound and unbound   146
ligands have the same chemical shift they might have different mobility characteristics. So, limited 
mobility might be expected for tightly bound ligands. It is possible to selectively detect relatively 
immobile species by applying cross polarization at increasing experimental temperatures. For 
effective cross polarization to occur 
31P nuclei have to be surrounded by relatively immobile protons 
as when ligand is tightly bound in the protein binding site. Subsequently, direct polarization allows 
observing all nuclei independent of their dynamics properties. The increasing experimental 
temperatures is required because in a frozen state the dynamics difference between more and less 
mobile molecules might not be manifested. This way, by comparing the spectra recorded under cross 
polarization and under direct polarization conditions it is potentially possible to differentiate between 
tightly bound ligands and ligands resided in the membrane or bound non-specifically to the protein.  
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Figure 5.8: 
31P MAS spectrum of liposomes reconstituted LmrA with added TPP
+ recorded using direct 
polarization (A) and cross polarization (B). The isotropic lines are labeled with TPP
+ (25 ppm) and E. coli 
liposomes (1.8 ppm). The experiment was performed at 277K, at a spinning frequency of 8 kHz. Approximately 
100 k scans were accumulates per each spectrum. 
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Figure 5.8 shows the 
31P spectra of E. coli proteoliposomes with 5 fold mole excess of TPP
+ recorded 
under direct polarization and cross polarization conditions at temperatures as high as 25
oC. The 
number of scans was doubled in case of cross polarization (Figure 5.8B), however the spectrum 
intensities obtained using cross polarization are much lower when compared to direct polarization 
(Figure 5.8A). This is not surprising because at 277K cross polarization is not efficient because there 
is a lot of mobility taking place in the membrane at temperatures close to physiological.  
 
5.3.5. Modulation of Hoechst-33342 LmrA transport and ATPase LmrA activity by leupeptin 
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Figure 5.9: Real-time fluorescence measurement of Hoechst-33342 transport blockage by leupeptin. The assay 
has been performed on the membrane ISOVs prepared for L. lactis cells. Fluorescent dye Hoechst-33342 was 
added after 1 minute of incubation. When the intensity of fluorescence reached plateau, ATP or ADP was 
added. Leupeptin was added when Hoechst-33342 transport was clearly observed (about 2 minutes after 
Hoechst-33342 addition). The experiment was performed at a room temperature.  
 
The MDR can be reversed by the action of a group of compounds known as chemosensitizers. This 
group includes several linear and cyclic peptides. One of them is leupeptin, a small linear peptide. It 
consists of two leucine and one arginine residues (Figure 5.2). Leupeptin was shown to be an effective 
PGP modulator with a binding constant of 77.6 μM. In addition, it was been shown that this peptide is   148
able to block colchicine transport in PGP (Sharom et al., 1998). As it was not known before if LmrA 
can bind such peptides, the series of experiments was designed to look if leupeptin can block substrate 
(Hoechst-33342) transport of LmrA and to find out if leupeptin influence LmrA ATPase activity. 
In our experiment Hoechst-33342 fluorescence exhibited enhancement upon interaction with lipid 
bilayers. Then upon ATP addition a slow decrease in Hoechst-33342 fluorescence is observed. This 
decrease is an average between active inward pumping of drug by LmrA and outward passive 
diffusion through the membrane (Lu et al., 2001). The ATP dependant pumping of Hoechst-33342 by 
LmrA was interrupted by addition of leupeptin. After leupeptin addition, the Hoechst-33342 
fluorescence exhibited a slow but stable increase during the measurement period (Figure 5.9). From 
this experiment it is difficult to conclude whether the Hoechst-33342 transport is completely 
abolished by leupeptin addition or just inhibited.  
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Figure 5.10: The colorimetric ATPase assay performed on the membrane ISOVs prepared for L. lactis cells 
compares inorganic phosphate turnover with increasing amounts of LmrA over 10 minutes. The black line 
presents linear fit of non simulated ATPase LmrA activity (49 nmole/min per mg of protein), whereas the red 
and green line show respectively the linear fit of 10 mM (56 nmole/min per mg of protein) and 1 mM (33 
nmole/min per mg of protein) leupeptin simulated ATPase LmrA activity.  
 
It was found that PGP substrates and inhibitors can modulate the protein ATPase activity (Sharom et   149
al., 1999b). The LmrA ATPase activity was examined in basal state (49 nmole/min per mg of 
protein), and in presence of two different concentrations of leupeptin, 1 mM and 10 mM (Figure 
5.10). Interestingly, at lower concentration leupeptin has inhibiting effect on LmrA ATPase activity 
(33 nmole/min per mg of protein), whereas at higher concentration it has stimulating effect (56 
nmole/min per mg of protein).  
Experiments similar to real-time fluorescence measurements of Hoechst-33342 transport blockage by 
leupeptin, has been performed by Sharom and co-workers for PGP reconstituted into proteoliposomes 
(Lu et al., 2001). In this case the real-time fluorescence measurement of TMR (tetramethylrosamine) 
transport by P-glycoprotein was inhibited by the MDR modulators cyclosporine A, and verapamil (Lu 
et al., 2001). 
In addition tryptophan intrinsic fluorescence quenching of LmrA (1 μM) reconstituted in E. coli 
liposomes (1 μM LmrA) was performed with increasing increasing concentrations of leupeptin (0 to 
50 μM). No concentration dependant tryptophan fluorescence quenching was observed. The possible 
reason for that is that only low concentrations of leupeptin are accumulated in lipid phase, whereas 
high concentrations of leupeptin are needed for efficient binding. 
 
5.4. Discussion 
 
5.4.1. Tryptophan intrinsic fluorescence quenching with norfloxacin and vinblastine 
The fluoroquinolones present a diverse class of bacterial agents and are effective against gram-
positive and gram-negative organisms, including Streptococcal and Staphylococcal species with 
multiple applications in variety of infection diseases (Fukuda et al., 2001). Their mechanism of action 
is to target bacterial DNA synthesis (Walsh, 2003). Recently, rapidly emerging bacterial resistance to 
this type of agents through expression of MDR membrane pumps, such as MdfA from E. coli (Edgar 
and Bibi, 1999), NorA from S. aureus, PmrA from S. pneumoniae, Bmr and its regulator BmrR 
together with Blt from B. subtilis, and LfrA from M. smegmatis (Poole, 2000) have been observed 
(Blondeau, 2004a).  
The tryptophan fluorescence quenching approach was used to determine whether fluoroquinolones in   150
general and norfloxacin (Figure 5.3C) in particular can be transported by LmrA and characterize the 
binding if it takes place. Figure 5.3 and 5.4A shows that LmrA intrinsic tryptophan fluorescence 
quenching occurs under titration of proteoliposomes reconstituted LmrA mixtures with increasing 
concentrations of norfloxacin. The experiments on Trp intrinsic fluorescence quenching by 
vinblastine, a known substrate for PGP and LmrA (Wiese and Pajeva, 2001; van Veen and Konings, 
1997), was performed in parallel (Figure 5.3A). 
Addition of both drugs resulted in saturable, concentration-dependent quenching of Trp fluorescence 
(Figure 5.3, 5.4). Tryptophan intrinsic fluorescence quenching with both substrates gave clear 
monophasic curve, interpreted as evidence of existence of only one binding site, or two with equal 
affinities, which is unlikely.  
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Figure 5.11: Location of tryptophan residues in LmrA. 
 
There are 5 tryptophan residues in the LmrA amino acid sequence. Three of them are located in the 
predicted loops connecting TM helices 2 and 3, 3 and 4, and 4 and 5, one in extracellular (W172), and 
two in intracellular (W112 and W201) loops. The other two are found in the predicted NBD (W421 
and W457) (Figure 5.11). The indole group of Trp can serve as an intrinsic fluorophore in proteins. 
Since the emission spectrum is highly sensitive to solvent polarity, it can also reveal information   151
about its environment, conformation changes in the protein, and/or direct interactions with substrates. 
The Trp emission spectrum of LmrA reconstituted E. coli liposomes has a maximum at 344 nm, much 
lower then that of the buffer-solubilised Trp, 357 nm, suggesting that all Trp residues are exposed to a 
relatively hydrophobic environment (Figure 5.3). During the substrate binding the concentration-
dependant Trp intrinsic fluorescence is observed but not the shift to the lower wavelength. Moreover, 
the observed quenching efficiency is less then 50 %. Therefore, it seems more likely that all Trp 
residues are indirectly involved in the conformation changes within the protein occurred during the 
binding event. These conformation changes do not include exposing of Trp residues to a polar 
environment. The results of fluorescence quenching experiments performed by Sharom and co-
workers on MIANS labeled PGP led to similar conclusion. The MIANS labels in their experiments 
were placed in both NBD (Qu et al., 2003). Quenching of the Trp intrinsic fluorescence by drugs 
occurs in the absence of ATP, clearly indicating that prior binding of ATP is not necessary for drug 
interaction with LmrA. 
The obtained binding affinity constant for norfloxacin to LmrA was 0.3 ± 0.03 μM and for vinblastine 
3.79 ± 0.4 μM. The vinblastine binding constant obtained in our measurements was compared to the 
one known for PGP. It is important to note, that for PGP this binding constant has been obtained using 
the same approach, Trp intrinsic fluorescence quenching (Liu et al., 2000). So, for PGP the Kd is 0.5 
μM, which is about 10 times higher when compared to the value obtained in our measurement. 
However, the same author reported the Kd of 1.08 μM for PGP with two MIANS labels, which is only 
3 times different from the value obtained in our measurements and a Kd of 2.32 μM which is 
comparable to our Kd 3.86 μM for PGP containing 1 MIANS label and vanadate (Qu et al., 2003). To 
emphasize the difficulties in comparison of Kd obtained using different approaches it is worth 
mentioning the example of Kd for [
3H] vinblastine obtained by a filtration method by Callaghan and 
co-workers. Their Kd value was estimated to be 80 nM, which is more then 10-fold higher then the all 
Kd values obtained by fluorescence quenching approach (Qu et al., 2003; Martin et al., 2001). The 
main difficulty for measuring drug binding in proteoliposomes is that often the concentration of drug 
in lipid bilayers is not known. 
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5.4.2. 
19F SSNMR on norfloxacin bound to LmrA 
Norfloxacin binding to the LmrA was further assessed by means of solid-state NMR. The 
19F CP 
spectrum of the proteoliposomes reconstituted LmrA incubated with norfloxacin is shown in Figure 
5.5. Presence of different norfloxacin conformers as well as high 
19F chemical shift anisotropy 
resulted in severe signals overlap (Figure 5.5). Nevertheless, applying deconvolution method on the 
spectrum of norfloxacin added to LmrA reconstituted in to E. coli liposomes, it was possible to 
differentiate the signal from unbound and bound to protein substrate (Figure 5.5). The substrate bound 
to the protein exhibited the shift of -42.5 ppm when compared to unbound -46.00, -41.20, and -38.46 
ppm (norfloxacin conformers). Such a shift might be caused by the ring currents of neighboring 
aromatic residues which are suggested to be involved in the substrate binding (Scrutton and Raine, 
1996). The line broadening characteristic for norfloxacin molecules bound to the protein (Figure 
5.5B) from one side hamper spectrum analysis, but from the other side it gives information on binding 
character. Namely, it indicates immobilization of bound ligand. Hence, the observed line broadening 
can be an indication of the rapid exchange between two ligand states, bound and unbound. However, 
taking into account that the experiment was performed at temperature as low as 253K, the rapid 
exchange between bound and unbound ligand states is questionable. In addition, our measurements do 
not allow us to exclude the possibility that the substrate binding to protein is partly or fully 
nonspecific. A good way to prove specificity of binding is to titrate proteoliposomes containing 
reconstituted LmrA and norfloxacin with another known LmrA substrate and follow reduction of 
signal from bound norfloxacin. However, such fine-tuned experiments are complicated by the fact that 
signal from unbound norfloxacin is dominant and differentiation of bound norfloxacin from unbound 
needs spectra deconvolution. 
 
5.4.3. LmrA tryptophan intrinsic fluorescence quenching with TPP
+ 
In the next step, TPP
+ binding to the LmrA reconstituted proteoliposomes was studied by the 
tryptophan intrinsic florescence quenching (Figure 5.6). The intrinsic tryptophan fluorescence 
quenching revealed that TPP
+ is bound to LmrA reconstituted under experimental conditions. Two 
binding site for TPP
+ were found, one TPP
+ molecule is bound to LmrA with high affinity (9.3 nM ±   153
3.8) and one with relatively low affinity (22 μM ± 3.8). Previously, it has been found by two 
independent measurements that for another MDR transporter from SMR family, EmrE, the binding 
constants for TPP
+ were 10 nM and 1.9 nM (Elbaz et al., 2005). These values are close to the value 
obtained for LmrA. The titration of proteoliposomes reconstituted LmrA with higher concentration of 
TPP
+ showed that massive binding of TPP
+ to membrane lipids. This complicates all experiments and 
the results must be interpreted with caution.  
 
5.4.4. 
31P SSNMR on TPP
+ bound to LmrA 
Detection of ligand bound to target by solid-sate NMR is based mostly on the observation of the 
difference in chemical shifts between bound and unbound ligand (Zech et al., 2004). The difference in 
chemical shifts comes from the fact that bound and unbound ligands are in different chemical 
environments meaning that bound and unbound ligand nuclei experience different chemical shift 
shielding. Here, no chemical shift difference was observed between bound and unbound TPP
+ 
molecules (Figure 5.7). In a similarly designed experiment (Glaubitz et al., 2000), where TPP
+ 
binding was probed to EmrE, the MDR transporter from the small multidrug resistance family, the 
peak from bound TPP
+ appeared shifted from the unbound TPP
+ 4.2 ppm to lower frequency. It 
should be taken into account that for all MDR proteins similar binding mechanism is proposed 
(Zheleznova et al., 1999). Similar binding mechanism implicates similar influence from the 
distribution of electrons around the TPP
+ phosphorous atom and as a result similar chemical shifts. 
There can be multiple reasons why it was not possible to observe a second peak from TPP
+ bound to 
LmrA. In case of solid-state NMR measurements signal from massively bound to liposomes TPP
+ and 
intensive resonance peak from lipid phosphorous can hide small resonance peak of TPP
+ bound to 
LmrA. Moreover, lipids might compete with LmrA in TPP
+ binding, therefore not all TPP
+ binding 
sites on protein can be occupied, making signal from bound TPP
+ even weaker and more difficult to 
observe. We have hypothesized that cross polarization performed at 253K might not be suitable for 
this type of measurements, because at these temperatures with CP all ligand fractions, tightly bound 
and unbound are observed. To check this possibility, the spectra of proteoliposomes reconstituted 
LmrA with 5 fold mole excess TPP
+ recorded at 25
oC under cross polarization and direct polarization   154
were compared (Figure 5.8).  
Expected significant reduction in intensity was observed under CP condition. The TPP
+ resonance 
was visible only under direct irradiation conditions but not under cross polarization conditions. It 
shows that both TPP
+ molecule fractions bound to protein and unbound are highly immobile on NMR 
time scale and can not be cross polarized at this temperature.  
So, the observation of ligand bound to the protein is limited. It is possible only if the bound and 
unbound ligand fractions experience different chemical shift or if their dynamic properties are on time 
scales accessible for NMR measurements.  
Apart from complicated TPP
+ behavior another interesting feature appears while looking at the CP 
spectra of free E. coli liposomes and liposomes reconstitutes LmrA at high mole per mole protein 
lipid ration (about 300:1) recorded at 253K. This feature is significant increase in chemical anisotropy 
of lipid resonance of proteoliposomes reconstituted LmrA when compared to free liposomes (Figure 
5.7). This difference is almost vanished when the spectra of liposomes reconstituted LmrA obtained 
under cross polarization and direct observation were recorded at temperature as high as 277K (Figure 
5.8). To our opinion high chemical shift anisotropy of lipids resonance in the spectra recorded under 
CP conditions may correspond to tightly bound to protein lipids. In the same time, lipid signal on the 
spectrum obtained under direct irradiation originates from all lipids bound and unbound. This way it 
can be concluded that the lipid moiety in the liposomes reconstituted LmrA has at least two different 
fractions. One of them might correspond to tightly bound to the protein and therefore relatively 
immobile lipids and another to bulk free lipids from which membrane is composed. Alternatively, this 
phosphorous spectra behavior can be related to change in the lipids phase transitions in liposomes 
containing reconstituted protein when compared with free liposomes. Because the phase transition 
temperature is a measure of the stability of the packed gel state relative to the fluid state, these 
changes might indicate that protein incorporation interferes with phospholipids packing. 
 
5.4.5. Modulation of Hoechst-33342 LmrA transport and ATPase LmrA activity by leupeptin 
There are two main ways to deal with MDR resistance, to modify the drugs to avoid their interaction 
with the transporters, and to find relatively non-toxic compounds, which can interfere with the drug   155
extrusion, somehow blocking the MDR proteins activity. A large number of compounds 
(chemosensitizers) has been identified for PGP, which are capable of restoring the cytotoxity of 
chemotherapeutic drugs. Chemosensitizers appear to compete for substrate binding site in a poorly 
understood way. Peptides, like leupeptin (Figure 5.2), are of particular interest for pharmaceutical 
science, because they are relatively non-toxic for cells, and their increased size might enhance their 
interaction with the transporter, and their synthesis by classical peptide synthetic methods is expected 
to be relatively low costly (Sharom et al., 1998). 
The Hoechst-33342 transport assay has been used before to determine ATP dependent drug pumping 
in LmrA (van Veen et al., 2000a). We tested the effect of leupeptin, a hydrophobic peptide, the 
modulator for P-glycoprotein, on Hoechst-33342 transport in inside-out vesicles containing over 
expressed LmrA. It was shown that leupeptin affected the Hoechst-33342 transport in inside-out 
vesicles (Figure 5.9). From our experiment it was not possible to conclude whether the Hoechst-
33342 transport is blocked or allosterically inhibited by leupeptin addition. The analysis of the kinetic 
parameters of substrate transport could not be carried on, because the dye concentration in the lipid 
phase is unknown. In the next step, the ATPase activity of ISOVs vesicles containing overexpressed 
LmrA was assayed in the presence of different leupeptin concentrations and compared with non-
stimulated, basal LmrA ATPase activity (Figure 5.10). In was observed that at 1 mM leupeptin 
concentration, the peptide inhibit the LmrA ATPase activity, whereas at 10 mM it stimulates the 
LmrA ATPase activity. The bimodal stimulation profile has been observed before for several PGP 
chemosensitizers (Sharom et al., 1999b). This bimodal behavior can be caused by interaction of a 
particular compound with the stimulatory site followed by the interaction with the inhibitory site. This 
suggestion, however, is speculative because the knowledge of LmrA substrate binding is limited at 
present.  
 
Conclusions 
Tryptophan intrinsic fluorescence quenching experiments were performed on LmrA reconstituted into 
E. coli proteoliposomes. For the first time it was shown that norfloxacin, the antibacterial agent from 
fluoroquinolones family, is a substrate of LmrA. The binding constants for norfloxacin, vinblastine 
and TPP
+ have been obtained by fitting the concentration dependant Trp intrinsic fluorescence   156
quenching (Table 5.1). 
By analyzing the LmrA fluorescence emission spectra, a relatively nonpolar localization in the protein 
interior was concluded for all five tryptophan residues. Moreover, it was shown that under the 
substrates binding conformation changes are transmitted from transmembrane helices to cytosolic 
domain. However, these conformation rearrangements do not increase NBDs Trp accessibility 
towards the solvent. Moreover, we suggest that drug binding initiated Trp intrinsic fluorescence 
quenching can be used as a binding assay to probe the protein activity. 
 
Binding affinity for interaction of drugs with LmrA reconstituted into proteoliposome of E. coli
Norfloxacin,  TPP,  Kd1 and Kd2 (µM)
0.0093 ± 0.0039
22.0 ± 3.8
Kd (µM) Vinblastine, Kd (µM)
3.79 ± 0.4
Norfloxacin,  TPP,  Kd1 and Kd2 (µM)
0.3 ± 0.03
Kd (µM) Vinblastine, Kd (µM)
Binding affinity for interaction of drugs with LmrA reconstituted into proteoliposome of E. coli
Norfloxacin,  TPP,  Kd1 and Kd2 (µM)
0.0093 ± 0.0039
22.0 ± 3.8
Kd (µM) Vinblastine, Kd (µM)
3.79 ± 0.4
Norfloxacin,  TPP,  Kd1 and Kd2 (µM)
0.3 ± 0.03
Kd (µM) Vinblastine, Kd (µM)
 
 
Table 5.1: Binding affinities for interaction of drugs with LmrA reconstituted into proteoliposomes of E. coli.  
 
A challenge faced while studying the ligand binding to the proteins reconstituted in the liposomes by 
SSNMR is to distinguish between specific interaction of ligand with the protein and non-specific 
interaction of ligand of interest with the surrounding lipids. Taking the advantage of high 
19F 
sensitivity and applying the deconvolution method to the spectrum of norfloxacin titrated into the 
proteoliposomes containing reconstituted LmrA, it was possible to observe the ligand binding to the 
protein.  
The experiments aiming to observe TPP
+ bound to LmrA have ambiguous results. It allowed better 
understanding of the limitations in ligand observation by solid-state NMR and showed possible ways 
to overcome these limitations. 
In the present study for the first time it was demonstrated that the real-time Hoechst-33342 transport 
by LmrA containing inside-out vesicles can be collapsed by addition of leupeptin to the vesicles 
exterior. Similar experiments can be used to carry out as high-through real-time fluorescence assay 
aimed to screen the drug library for potential ABC transporters substrates and modulators. In   157
principal, this real-time approach can be extended to other LmrA fluorescence substrates, like for 
example, verapamil derivate. The LmrA ATPase was examined at different leupeptin concentrations. 
Leupeptin gives bimodal ATPase modulation, suggesting existence of LmrA inhibitory and 
stimulatory sites and leupeptin subsequent interaction with both of them.    158
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6. The localization of multidrug resistance transporters substrates within 
the model membrane by 
1H MAS NMR 
 
Abstract 
Recognition and binding of substrates by LmrA and PGP must be associated with a preferred 
substrates membrane location, determined by molecular properties and lipid interactions. Therefore, a 
systematic study on the interaction between seven PGP and LmrA substrates (phenazine, doxorubicin, 
cephalexin, ampicillin, chloramphenicol, penicillin G, quercetin) and two modulators (quinidine, 
nicardipine) with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) model membranes has been 
performed. The location profile of these molecules across the membrane has been determined by 
1H-
NOESY MAS NMR based on 
1H-
1H cross peaks between their aromatic finger print region and lipid 
resonances.  
The results of this Chapter are partially published: Siarheyeva A., Lopez J., Glaubitz C.: The 
localization of P-glycoprotein substrates within model membranes, Biochemistry, 2006 in press. 
 
6.1. Introduction 
Cells over-expressing PGP and LmrA have been shown to posses an increased resistance to at least 
eight classes of clinically relevant broad-spectrum antibiotics, including aminoglycosides, 
lincosamides, macrolides, quinolones, streptogramins, teracyclines and chloramphenicol, which are 
neutral or positively charged hydrophobic compounds (Chapter 1, Table 1.2) (Poelarends et al., 2000; 
Ambudkar et al., 1999). It is difficult to define common specific chemical features for these MDR 
ABC transporters substrates, but most of them are characterized by a high hydrophobicity, and planar 
aromatic groups; they frequently contain a basic nitrogen atom especially within non-aromatic rings, 
and an oxo group bonded to an aliphatic carbon (Ojjima, 2005; Onishi Y., 2003; Seelig, 1998; 
Klopman et al., 1997; Ueda et al., 1997; Chiba et al., 1996; Scrutton and Raine, 1996).  
It has not been quite understood yet how a multidrug efflux pump recognizes and translocates a range 
of chemically diverse molecules. The translocation of drugs could either be accomplished by a   160
transporter acting as a ‘classical pump’, as a ‘flippase’ or as a ‘hydrophobic vacuum cleaner’. A 
flippase mechanism requires the drugs to enter the inner membrane leaflet, where they bind to the 
protein, which subsequently flips the compounds to the outer leaflet. From there, they could diffuse 
into the extracellular space as proposed for phosphatidylcholine transport (Higgins and Gottesman, 
1992). The ‘vacuum cleaner’ model suggests that drugs diffuse into the lipid phase from where they 
enter the protein which expels them through a proposed central channel (Poelarends and Konings, 
2002; Rosenberg et al., 1997). Both models require a substrate accumulation within the membrane in 
contrast to the classical pump mechanism. A ‘classical pump’, where the transporter takes up drugs 
from the aqueous phase and translocates them into extracellular space, seems unlikely, as it has been 
clearly demonstrated that substrates enter the protein from the membrane as outlined in Chapter 1. 
To map the PGP binding sites, multiple amino acids substitutions, cystein mutagenesis coupled with 
cross-linking, and photo-affinity labelling have been carried out (Loo and Clarke, 2005; Peer et al., 
2005; Pleban et al., 2005b; Loo et al., 2004a; Loo et al., 2004b; Loo and Clarke, 2001; Ueda et al., 
1997). These experiments identified residues in trans-membrane helices 4, 5, 6, 8, 9, 10, 11, and 12, 
as well as in the ATP binding cassette and loops to be important for substrate binding and/or 
transport. Based on these data, it has been suggested that the PGP drug-binding domain is a large, 
flexible ‘funnel’ which narrows at the cytoplasmic side. The drug binding according to this ‘pocket’ 
model occurs through a substrate-induced fit mechanism (Pleban et al., 2005a; Ambudkar et al., 2003; 
Loo et al., 2003; Loo and Clarke, 2001). From the other side, several experiments using fluorescent 
PGP substrates (for example, TMA-DPH and Hoechst-33342) map the binding sites locations close to 
the membrane boundary of the cytoplasmic leaflet (Lugo and Sharom, 2005a; Qu and Sharom, 2002; 
Shapiro and Ling, 1998; Bolhuis et al., 1996c; Bolhuis et al., 1996b). This controversy drug binding 
site/sites location makes difficult to hypothesize on the ABC MDR transporters transport cycle. 
Therefore, knowledge about location of substrate binding sites is required.  
The nature of drug binding to some extent could also be influenced by drug-lipid interactions. The 
membrane-based location of a binding pocket is consistent with the hydrophobicity of many 
substrates which has been commonly determined from their n-Octanol-water partition coefficient. 
However, phospholipids bilayers are not homogeneous hydrophobic two dimensional solvents, but   161
contain partially ordered hydrocarbon chains between highly ordered, charged headgroup regions. It is 
not known if PGP substrates have a preferable location within lipid bilayers. This knowledge could be 
essential for the understanding of drug-protein interactions. If structurally diverse molecules show a 
similar interaction pattern within membrane lipids, a common binding site could be envisaged as all 
substrates could be located in the same region within the membrane. In contrast, if each substrate 
behaves differently, a larger, less specific binding pocket within the membrane would be required.  
The lack of information on substrate-membrane interactions was a motivation to perform a systematic 
study to determine the location of a set of PGP substrates and modulators within phospholipid 
bilayers. 
 
MAS-NOESY NMR 
Magic angle spinning nuclear Overhauser enhancement spectroscopy (MAS-NOESY) has been 
shown to be a powerful tool for studying substrate distributions within model lipid bilayers in 
multilamellelar dispersions (Huster et al., 1999).  
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Figure 6.1: Energy levels for a pair of spin -1/2 nuclei I and S, showing the six possible relaxation pathways. 
W2
I and W0
IS are cross relaxation pathways, the others are the spin-lattice relaxation processes.  
 
The NOE cause the change in intensity of one resonance (spin I) when the spin transitions of another 
are perturbed from their equilibrium populations (spin S). This change in intensity of spin I resonance   162
occurs if spins I and S are dipolar coupled via cross relaxation process. The perturbation occurs by 
either saturating a resonance that is equalizing the spin population differences across the 
corresponding transitions or by inverting the population differences across the transitions. On a 
diagram showing energy levels for a pair of spin ½ nuclei I and S (Figure 6.1) the cross relaxation 
processes are defined by αIαS ↔βIβS (both spins flipping in the same direction at rate W2
IS) and by 
αIβS↔βIαS (I and S flipping in opposite directions at rate W0
IS). If both transitions of one nucleus (S) 
are saturated, spin system may reach equilibrium state by so called ‘cross relaxation’. The saturated 
spin S transfers magnetization to its dipolar coupled partner I. The change in intensity of the I 
resonance can be positive (an increase), or negative (a decrease). In an attempt to return to 
equilibrium, W2
IS and W0
IS relaxation pathways are competing. When the W2
IS pathway dominates, 
the population difference across the two I transitions increases, causing on enhancement of the I spin 
resonance intensity; this is then positive NOE. In contrast, when W2
IS dominates, the population 
difference across the two I transitions decrease; this is then negative NOE. Which relaxation pathway 
is dominating is determined by molecular motional characteristics of the studied system.  
The NOE enhancement is negative for large molecules with an average tumbling rate τ c
-1 much less 
than ωo (Larmor frequency), and positive for small molecules with an average tumbling rate τc
-1 much 
greater than ωo. The magnitude of the NOE between I and S can be quantified by a parameter η, 
defined in terms of ι the perturbed NMR intensity of spin I, and ιo its normal intensity: 
η = (ι – ιo)/ιo. 
The NOE magnitude contains direct information on internuclear separation, so the r
-6 dependence of 
the cross relaxation rates in principle gives internuclear distances directly (Claridge, 1999; Hore, 
1995). Alternatively, NOEs are often used semiquantitatively to decide whether two nuclei are close 
to one another or not. Gawrisch and co-workers have shown that NOESY MAS NMR is a powerful 
tool for studying substrate distribution within model lipid bilayers in multilamellelar dispersions. It 
was found that NOE cross peaks between lipid resonances arise mainly from inter- rather than intra-
molecular interactions due to the anisotropic nature of molecular motions in membrane bilayers 
(Huster et al., 1999). Therefore, NOEs between substrate and lipid resonances could serve as a 
measure for substrate-lipid distances which could be converted into substrate distribution with respect   163
to the lipids which act as a molecular ruler across the membrane. 
The correct interpretation of lipid-lipid NOEs as intermolecular interactions was verified by analyzing 
the full cross relaxation rate from a series of cross peak built up curves from DPMC/nicardipine 
MAS-NOESY spectra taken at a range of mixing times (50 to 900 ms), while for substrate-lipid 
interactions, a simplified single mixing time approximation was used (Huster et al., 1999).  
Using this approach, the distribution of ethanol in model lipid membranes (Holte and Gawrisch, 
1997), the location of anesthetics and hydrophobic ions in liposomes (Peng et al., 1995; Yokono et al., 
1989; Ellena et al., 1987), the preference of flavonoids and tryptophan for the membrane interface 
(Scheidt et al., 2004; Yau et al., 1998), the interaction of a peptide (Huster et al., 2003b) and, the 
location and dynamic reorientation of two fluorophores (Huster et al., 2003a) have been investigated.  
Here, we used the aromatic protons of all nine molecules as molecular reporters to determine the 
drugs preferable location within the membrane. The substrates were prepared in a complex with 
DMPC and DMPC/DMPG liposomes. The DMPC lipids was chosen to be a model membrane 
because in these lipids PGP binds substrates more effectively than in egg PE for example (Romsicki 
and Sharom, 1999). 
 
 
6.1. Materials and methods 
 
Materials  
The phospholipids 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) and 1,2-dimyristoyl-sn-
glycero-3-phospho-ras-(1-glycerol) (DMPG) were obtained from Sigma. Penicillin G was obtained 
from Fluka, BioChemika, ampicillin from Roth. All other reagents were purchased from Sigma. 
 
Sample preparation  
Drugs and DMPC (25 mg) were dissolved separately in 2 ml of chloroform and methanol 1:1 and 
mixed. The drugs/lipids molar ratios were follows: 0.28 phenazine, 0.22 doxorubicin, cephalexin, 
quinidine, penicillin G, and quercetin, 0.18 ampicillin, 0.26 chloramphenicol, 0.27 nicardipine. The   164
solvent was removed under stream of nitrogen. The lipid film was re-dissolved in 2 mL cyclohexane, 
frozen in liquid nitrogen and freeze-dried in a vacuum overnight. Multilamellar vesicles were 
prepared by hydrating the lipid/drug sample with approximately 20 µL of D2O. The samples were 
further homogenized by 5 freeze-thaw cycles. The pellet was transferred to a 4 mm MAS rotor. 
Before acquiring data, the sample was spun at 8 kHz in the MAS rotor for 15 min to allow for 
homogeneous sample distribution and equilibration. 
 
NMR measurements 
NMR experiments were performed on a Bruker Avance 400 equipped with a 4 mm MAS probe at 
temperatures 300K and 313K which maintains DMPC lipids in the liquid crystalline phase. All 
1H 
experiments were carried out at a resonance frequency of 400.131 MHz with spectral width of 8 kHz. 
Inserts made of Kel-F were used to keep the samples centered within the 4 mm zirconia MAS rotor. 
Two-dimensional NOESY experiments were acquired in the phase sensitive mode with 90° pulses of 
3 µs was used (Figure 6.2). A total of 256 complex data points were collected in the indirect 
dimensions with 16 transients per increment at a relaxation delay of 4 s between scans. A square sine-
bell window function was applied in both dimensions before processing.  
 
Figure 6.2: NOESY pulse sequence. 
 
All 
1H spectra were referenced with respect to the terminal methyl group of the lipid chains at 0.89 
ppm of a DMPC sample in the absence of drug molecules. 
Data processing was carried out with XWIN-NMR (Bruker Instruments, Karlsruhe). Assignment and 
integration of the NOESY crosspeaks were carried out using the software packages Sparky (T. D. 
Goddard and D. G. Kneller, SPARKY 3, University of California, San Francisco).  
In order to assess the cross relaxation rates (σij) between the nuclei of the ligand and the lipid matrix, 
the approximations, which take into account the interactions between just two nuclei whilst ignoring   165
the effect of other nuclei within dipolar coupling range was used [6.1]. For the diagonal peak 
volumes: 
[6.1a]    i(tm) = [Aii(0)/2] [1 + exp/(-2σijtm)] exp(-tmTii)]       
and for the cross peak volumes: 
[6.1b]     (tm) = [Ajj(0)/2] [1 - exp/(-2σijtm)] exp(-tmTij)]         
where Aii(tm) i and Aij(tm) are the respective diagonal peak and the crosspeak volumes at mixing time 
tm, Aii(0) and Ajj(0) are the diagonal peak volumes at a mixing time zero. The values 1/Tii and 1/Tij 
define a rate of magnetization leakage toward the lattice. By simplifying the spin pair approach it is 
possible to calculate the cross relaxation with the use of equation [6.2] (Huster et al., 1999): 
[6.2]     σij = Aij(tm)/Ajj(tm)tm 
The cross relaxation rate σij is estimated by dividing the crosspeak volume Aij by the diagonal peak 
volume Ajj, multiplied by the mixing time tm of the NOESY spectrum.  
In order to ensure the validity of the approximation for our experiments, results using [6.2] were 
compared with those obtained by using the spin pair interaction model for DMPC-nicardipine H9-
proton [6.1]. For these purpose, the NOESY spectra for this ligand, prepared with DMPC liposomes, 
were obtained at 9 mixing times, ranging between 50 ms and 900 ms.  
 
 
6.2. Results  
The nine substrates used in this study are listed in Table 6.1 and their chemical structures are shown in 
Figure 6.3. They have been shown to act either as substrates or modulators for PGP and LmrA 
(Alqwai et al., 2003; Ambudkar et al., 2003; Varma et al., 2003; Poelarends et al., 2000; Ambudkar et 
al., 1999; van Veen et al., 1998b; VanVeen et al., 1996) and belong to distinct drug classes such as 
Ca
2+ channel blockers, antracyclines, cytotoxic agents, antihypertensives or bacteriostatics. Their 
lipophilicity is estimated in form of the octanol/water partitioning coefficient (log P) as shown in 
Table 6.1. Its high value indicates that fast drug equilibration within the model membrane can be 
expected. However, no indication about their detailed location within the lipid bilayer can be derived 
from the partitioning coefficient.   166
Drug Category  log P 
A phenazine  miscellaneous  2.8±0.3 
B doxorubicin  antracyclines  2.3±0.7 
C cephalexin  bacteriostatic  0.6±0.3 
D ampicillin  bacteriostatic  1.3±0.3 
E quinidine  Antimalarial  3.4±0.4 
F chloramphenicol  Bacteriostatic  1.0±0.3 
G nicardipine 
Calcium channel 
blockers 
5.2±0.6 
H penicillin  G  bacteriostatic  1.7±0.2 
I quercetin  bacteriostatic  2.2±1.0 
 
Table 6.1: PGP and LmrA substrates used in this study and their octanol/water partition coefficients (logP) 
(calculated using Advanced Chemistry Development (ACD/Labs) Software Solaris V4.67 (1994-2005 
ACD/Labs)). 
 
Although varying in molecular size and structure, a common feature of all drugs in this study is the 
occurrence of aromatic moieties in each molecule (Figure 6.3), which seem to be directly involved in 
protein binding (Varma et al., 2003; Van Bambeke et al., 2000). The NMR signals of the aromatic 
protons are well resolved and well separated from dominating lipid resonances, as shown in Figure 
6.4 for all nine molecules, a fact which makes these groups ideal probes for substrate-lipid 
interactions. The 
1H chemical shift assignments of substrates and synthetic lipid DMPC have been 
determined before and are shown in Figure 6.3 and 6.8 (Garipova and Silnikov, 2003; Zolek et al., 
2003; Lindholm et al., 2002; Tung et al., 2000; Calzolai et al., 1997; Gaggelli et al., 1992) 
The feasibly of one mixing time approach was checked by comparing the results obtained for one 
mixing time approach and two spin pair approximation. A comparison of the distribution profiles of 
nicardipine proton 9, 21, 21' within the lipid matrix, calculated with two spin approximation, and 
single mixing time equation, showed only marginal differences (Figure 6.5). 
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Figure 6.3: Chemical structures of PGP substrates used in this study: (A) phenazine, (B) doxorubicin, (C) 
cephalexin, (D) ampicillin, (E) quinidine, (F) chloramphenicol, (G) nicardipine, (H) penicillin G, (I) quercetin, 
and (J) DMPC. The drug categories and partition coefficients are given in Table 6.1.  
 
To ensure the reproducibility of two spin-pair approximation, the 2D MAS NOESY spectra of 
cholesterol 40 % (w/w) in DMPC were obtained and the cross relaxation rate for 23 proton of 
cholesterol (Muhl et al., 1996) and the G3 group of DMPC group was fitted by using eq. 6.1b. Figure 
6.6 shows the 2D MAS NOESY spectrum of cholesterol 40 % (w/w) in DMPC and the dependence of 
cross peak volumes for the 23 proton group of cholesterol and the G3 group of DMPC fitted to two 
spin-pair approximation. The calculated cholesterol cross relaxation rate is 0.00158 ms
-1. This number 
is comparable with the values obtained earlier for the cross relation rates between the saturated sn-1 
chain methylene groups of PC, PE, and PS and the cholesterol C18 methyl resonance (Huster et al., 
1998). Additionally, the comparison of the cross relaxation rates obtained by using the full relaxation 
matrix method, two spin pair, and one mixing time approximations for quinidine also confirm the   168
correctness of one mixing time approach (Siarheyeva et al, in press 2006). Therefore, for the 
remaining samples, cross relaxation estimates were obtained by acquiring NOESY spectra at the 
mixing times 400 ms and by performing calculations using equation [6.2]. 
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Figure 6.4: 400 MHz 
1H MAS NMR spectra of DMPC/D2O dispersions containing nine different substrates 
taken at a spinning rate of 8 kHz and T = 300 K. Lipid resonances 1-10 are labeled according to the assignment 
shown in Figure 6.3. The aromatic region is shown from 6 – 9 ppm, with the assignment for all substrates used 
here: (A) phenazine (Van't Land et al., 1993), (B) doxorubicin (Pinciroli et al., 1997), (C) cephalexin (Tung et 
al., 2000), (D) ampicillin (Bartzatt and Malesa, 2003; Tung et al., 2000), (E) quinidine (LIndholm et al., 2002), 
(F) chloramphenicol (Zolek et al., 2003), (G) nicardipine (Calzolai et al., 1997), (H) penicillin G (Tung et al., 
2000), (I) quercetin (Scheidt et al., 2004).  
 
Two-dimensional MAS NOESY spectra for quinidine/DMPC and penicillin G/DMPC at mixing time 
of 400 ms are shown in Figure 6.7. Cross peaks indicating intermolecular drug-lipid interactions are 
highlighted. Interactions are found with almost every lipid resonance, which agrees with the expected 
drug penetration into the lipid bilayer.    169
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Figure 6.5: The comparison of cross relaxation rate for 9, 21, 21' nicardipine group obtained using spin-pair 
interaction approach (A) and one mixing time approach (B). Assignment for nicardipine and DMPC is kept as in 
Figure 6.3 and 6.8.  
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Figure 6.6: (A) The cross peak volumes as a function of mixing time in a 40 % (w/w) cholesterol in DMPC. 
The solid line represents a fit according to the spin-pair interaction model (σlipid-chol = 0.00158 ms
-1) as described 
in the text, (B) cholesterol, (C) 
1H MAS NOESY countor plot of a 14:0 DMPC/cholesterol 40% mixture 
recorded at a mixing time of 300 ms. The 23 proton of cholesterol and the G3 group of DMPC are highlighted 
with boxes. 
 
In the single mixing time approximation, cross relaxation rates are proportional to normalized cross 
peak volumes. By plotting these values for each cross peak between drug and lipid resonance as a 
function of the corresponding lipid proton location within the membrane, a distribution function of the 
drug across the membrane is obtained. The results of our measurements are shown in Figure 6.8,   170
plotted from the hydrophobic core of the membrane to the headgroup region from left to right, 
respectively. None of the substrates shows a strong correlation with the hydrophobic core region. 
There is a general pattern of preferred equilibrium location of the aromatic groups of all studied 
molecules in a layer located below the head group phosphate and above the first segments of the lipid 
acyl chain. 
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Figure 6.7: Examples for two-dimensional 
1H MAS NMR NOESY spectra of quinidine (A) and penicillin G 
(B) DMPC dispersions in D2O recorded with a mixing time of 400 ms and at a temperature of 300 K. Both 
spectra show intense cross peaks between drugs and DMPC resonances. 
 
Interestingly, in almost all molecules most resolved protons show a similar location profile indicating 
that they do not take up a preferred orientation within the bilayer  
In some cases (Figure 6.8), we observe discontinuities of relative cross peak volumes for contacts 
around the G1 lipid protons. The α resonance coincides with one of the proton signals of G1 (Figure 
6.4) (Holte and Gawrisch, 1997). Therefore, the number of lipid protons by which the volumes of 
cross peaks have to be corrected do not necessarily reflect the number of lipid protons actually 
contributing to the lipid-drug interaction.    171
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Figure 6.8: Following the single mixing time analysis as discussed in the text, normalized DMPC–substrate 
cross peak volumes according to the 
1H assignments in Figures 6.3 are plotted in the order of increasing distance 
from the hydrophobic core of the membrane. All aromatic protons in all nine substrates show a similar 
interaction profiles indicating a similar location of all aromatic groups within the membrane interface ((A) 
phenazine, (B) doxorubicin, (C) cephalexin, (D) ampicillin, (E) quinidine, (F) chloramphenicol, (G) nicardipine, 
(H) penicillin G, (I) quercetin). On the right side, the DMPC proton assignment used for 
1H-NOESY MAS 
NMR is shown. The labelling corresponds to: N(CH3)3 (α), N-CH2-CH2 (β), CH2-CH2-O (γ), O-CH2-CH (G3), 
CH2-CH-CH2 (G2), CH-CH2-O (G1), CH2-CH2-COO (C2), CH2-CH2-COO (C3). 
 
The main purpose of this work was to investigate the membrane interaction of the neutral form of all 
drugs in pure D2O. Control experiments on doxorubicin which bears a single positive charge in its 
daunosamine moiety at pH 7.4 and an additional experiment at pH 8.5 did show a very similar 
location profile as shown in Figure 6.10. We have also altered surface charge and temperature in order 
to investigate their effect upon membrane distributions of chloramphenicol, nicardipine, penicillin G, 
and quinidine. Charged model membranes were prepared by mixing anionic DMPG with DMPC   172
(3:7). At this DMPG/DMPC ratio, the membrane is almost saturated with negative charges (Wiedmer 
et al., 2001). Our measurements show that the addition of anionic lipids to the model membrane 
causes no significant change in the overall location probability for all studied (Figure 6.9). 
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Figure 6.9: Using the single mixing time analysis as discussed in the text, normalized DMPC/DMPG–substrate 
cross peak volumes are plotted in the order of increasing distance from the hydrophobic core of the membrane. 
All aromatic protons in all four substrates show similar interaction profiles indicating a similar location of all 
aromatic groups within the membrane interface ((E) chloramphenicol, (F) nicardipine, (G) penicillin G, and (H) 
quinidine).  
 
Further experiments at a higher temperature of 313K on chloramphenicol, nicardipine, penicillin G, 
and quinidine DMPC/DMPG lipid mixtures were carried out. The higher temperature causes shorter 
lipid and drug correlation times and influences the motional characteristics of lipid-drug interactions. 
As expected, the relative cross peaks volumes dramatically decreased as correlation times are reduced 
at higher temperatures (Holte and Gawrisch, 1997). A smoothed drug distribution might be expected 
as membrane fluidity also rises with temperature, thus facilitating drug diffusion within the lipid 
matrix. Experiments at 313 K also present a more physiological situation. However, we observed no   173
change in the resulting drug location probability within the membrane. 
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Figure 6.10: Comparison of chemical shifts and location profiles of proton 3 in doxorubicin (A) and proton 2 in 
chloramphenicol (B) buffered at pH 7.4 and pH 8.5 (10 mM TRIS, 50 mM KCl) and in pure deuterated water.  
 
 
6.4. Discussion 
Our data clearly indicate that all tested drugs accumulate within the membrane, in accord with their 
high octanol/water partition coefficients (Table 6.1). The relative lipid-drug cross peak volumes 
shown in Figure 6.8 offer direct evidence for the preferred interfacial location of the aromatic groups 
of all nine drugs, although their distribution across the hydrophobic core region is less well defined: 
Protons from each CH2 chain segment have the same chemical shift but could contribute differently to 
each cross peak volume due to different contacts to the substrate. A better spatial resolution is offered 
by other NMR approaches such as 
2H-NMR on selectively chain deuterated lipids or 
13C-MAS NMR, 
as demonstrated for the antidepressants desipramine and imipramine (also PGP substrates). They have 
been found to show contacts down to the sixth out of fourteen carbons on the lipid acyl chain (Santos 
et al., 2004; Meadows, 1979). However, there is no doubt that the aromatic groups of all nine tested 
drugs shown in Figure 6.3 have a preferred equilibrium location within the interface region, i.e. within 
a narrow layer between upper segments of the lipid acyl chain and below the phosphate of the lipid 
head group (Figure 6.8).   174
Drug-membrane interactions  
The main reason for this distribution is a balanced interplay between hydrophobic and electrostatic 
effects. Lipid membranes are characterized by a steep hydrophobicity profile with dielectricity 
constants ranging from 80 at the aqueous phase to 2 inside the hydrocarbon phase (Subczynski et al., 
1994) as well a strong electric dipole potential (Clarke, 2001). The drugs used in his study contain 
both hydrophilic and hydrophobic groups. They are weak bases or acids which remain mainly 
uncharged under the conditions used here (Ferte, 2000). Therefore, only their π-π electron systems 
and to a lesser extent electric dipole- and quadrupole moments would weakly contribute to 
electrostatic interactions with the dipole of the zwitter-ionic DMPC lipid headgroup (Yau et al., 
1998). In addition, the formation of hydrogen bonds between the lipid carbonyls and drug molecules 
supports a preferred location within the membrane interface (Castaing et al., 2005; Clarke, 2001). 
Therefore, hydrophobic substances would have a preference for the membrane core region, while 
electrostatic interactions would cause a preference for the lipid headgroups. Theses effects could 
compensate each other in the interface region.  
Four of the drugs (doxorubicin, quinidine, penicillin G, ampicillin) used here have already been 
investigated with respect to their interaction with lipids. Studies on quinidine and its optical isomer 
quinine have shown that it interacts with both neutral and charged lipids. However, penetration into 
the bilayer has only been observed in the presence of charged lipids (DMPG) (Porcar et al., 2003). 
Ampicillin (Casa et al., 1992) and penicillin G (Suwalsky et al., 1996) have been found to interact 
with model membranes as well, but spatially resolved details could not be obtained. 
Anthracyclines, and especially doxorubicin, have been subjected to an especially intense scrutiny by a 
variety of methods in both neutral and anionic lipids (Parker et al., 2001). Membrane binding involves 
a complex interplay of both hydrophobic and electrostatic interactions. Using NMR, it was found that 
it interacts with both surface and buried sites in DMPC/cardiolipin containing bicelles (Parker et al., 
2001), while monolayer studies showed no penetration into the hydrophobic region of the membrane. 
It has been shown that the presence of anionic lipids increases the binding of doxorubicin to the 
bilayers (Dewolf et al., 1991) but decreases passive transport through the membrane (Speelmans et 
al., 1994). Interestingly, some fluorescence studies have suggested two binding environments in   175
PC/cardiolipin bilayers (Karczmar and Tritton, 1979). While our studies have focused on the detailed 
location of the neutral form of doxorubicin within zwitter-ionic lipids, our data also show a preferred 
interaction with the interface region. Doxorubicin does not penetrate deeply into the hydrophobic 
core. Indeed, Figure 5.8 indicates two maxima for the location probability, one more exposed between 
water and lipid headgroup and a second between lipid headgroup and hydrophobic core region of the 
lipids.  
At physiological pH 7.4, 94% of the doxorubicin molecules bear a positive charge at the daunosamine 
group (pKa 8.4) leading to strong electrostatic binding to anionic lipids. However, it is the uncharged 
form of the drug which is transported via passive diffusion across the membranes (Frezard and 
Garniersuillerot, 1991) and it has also been shown that it is transported better by PGP than charged 
doxorubicin (Frezard et al., 2001). Our data show a very similar location profile of neutral 
doxorubicin compared to data acquired at pH 7.4 and pH 8.5 (Figure 6.10). This is consistent which 
fluorescence studies which did show that drug incorporation in the bilayer does not depend on the 
presence of a positive charge nor on anionic lipids but on the hydrophobicity of  the molecule (Gallois 
et al., 1996).  
in
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in
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Figure 6.11: Drugs are proposed to enter the protein from the membrane interface region.  
 
Comparison with physiological conditions 
Under physiological conditions, the total lipid to drug ratio in cell membranes is significantly lower 
than the ratios used in our measurements. Our use of higher ratios was a requirement due to the low   176
signal-to-noise ratio of the observed drug resonances. However, line-width and chemical shifts of 
lipid resonances did not change significantly compared to drug-free liposomes, indicating an intact 
bilayer structure. Indeed, we note that previously published studies used comparable drug-lipid ratios 
(Scheidt et al., 2004; Yau et al., 1998). Although our major goal was a comparative study of the 
interaction of nine PGP substrates or modulators with neutral/zwitter-ionic lipids, the effect of 
charged lipids (DMPC/DMPG 7:3) on the drug distribution within the membrane was additionally 
studied, due to the importance of charged lipids for drug-membrane interactions. The locations of 
chloramphenicol, nicardipine, penicillin G, and quinidine within the DMPC/DMPG membrane were 
evaluated. No qualitative change was observed when compared with DMPC membranes. This result, 
and the fact that substrate-PGP binding affinity has been shown to be higher in DMPC than in PS or 
PE, indicates that DMPC is a good choice as a model system (Romsicki and Sharom, 1999).  
 
Relevance of our findings for passive uptake models  
Due to their mainly lipophilic nature, most drugs “dissolve” and accumulate within the membrane. In 
contrast to active efflux, drug uptake takes place by passive diffusion across the membrane along the 
drug concentration gradient. The high substrate concentration in the interface region found here 
supports the model of a three step process for the drug to cross the membrane: (i) Substrate 
accumulates in the interface of the outer leaflet, (ii) it flips over to the interface of the inner leaflet and 
(iii) is found to be in equilibrium with the intracellular space. Therefore, our findings support the 
previously suggested flip-flop model for passive drug uptake (Eytan, 2005; Eytan et al., 1996).  
 
Relevance of our findings for efflux 
Although the binding sites for hydrophobic substrates are assumed to be in the transmembrane region, 
their exact location is not yet known despite a number of studies using mutagenesis, photo-affinity 
labelling, and fluorescence spectroscopy (Lugo and Sharom, 2005a; Loo et al., 2004a; Loo et al., 
2004b; Loo et al., 2003; Loo and Clarke, 2001; Seelig and Landwojtowicz, 2000; Dougherty, 1996). 
An important role of aromatic residues for substrate binding has been suggested (Ambudkar et al., 
2003; Pawagi et al., 1994), and indeed a common building block of the rather diverse set of substrates   177
are aromatic ring structures (Seelig and Landwojtowicz, 2000). In this case, drug binding could take 
place via π-π cation and stacking interactions with aromatic and polar amino acids present in the 
transmembrane domain of PGP and LmrA (van Veen, 2001; Seelig and Landwojtowicz, 2000; 
Dougherty, 1996). .   A Ar ro om ma at ti ic c   r re es si id du ue es s   i in n   m me em mb br ra an ne e   p pr ro ot te ei in ns s   a ar re e   l li ik ke el ly y   t to o   b be e   e ex xp po os se ed d   t to o   t th he e   m me em mb br ra an ne e   
i in nt te er rf fa ac ce e    r re eg gi io on n    ( (v vo on n    H He ei ij jn ne e, ,    1 19 99 92 2) ), ,    w wh he er re e    t th he e    s su ub bs st tr ra at te es s    s st tu ud di ie ed d    h he er re e    h ha av ve e    t th he ei ir r    h hi ig gh he es st t   
c co on nc ce en nt tr ra at ti io on ns s. .   Interestingly, the relatively low binding affinity of many PGP substrates (μM) 
increases with increasing membrane partition coefficient (Sharom et al., 1999a). This means that 
increasing substrate concentration in the membrane is needed for efficient binding. T Th he er re ef fo or re e, our 
data support a model in which drug binding sites are located within or accessible from the membrane 
interface (Figure 6.11) (Lugo and Sharom, 2005a; Lugo and Sharom, 2005b). 
We have included in our study not only PGP substrates (Table 6.1) but also the two modulators 
nicardipine and quinidine (Ambudkar et al., 2003), which have been found to decrease PGP activity 
(Wang et al., 2000). Interestingly, we have found no differences in the membrane location for 
substrates and modulators. This could indicate that substrates and modulators enter the proteins via 
similar pathways or that substrate and modulator binding sites are both accessible from the membrane 
interface. The high similarities in structure, partition coefficient and membrane interaction between 
substrates and modulators may make it very difficult to define molecular properties needed to 
eventually design a potent inhibitor. 
Existing transport models imply that bound substrates are taken up from the inner leaflet, moved 
across the membrane and released either into the outer leaflet (flippase model) or directly into extra 
cellular space (hydrophobic vacuum cleaner model). Although substrate-lipid interactions and their 
well defined membrane location found here can be related to drug uptake and binding, it is difficult to 
draw any conclusions about their translocation and release. Their preference for the interface region 
makes a flippase model likely. In this case, the transporter would have to flip drugs at a higher rate 
than flip-flops observed during passive uptake. In contrast, the existence of an aqueous 
transmembrane chamber open to extracellular milieu as suggested for PGP or LmrA could also serve 
to release bound substrates directly (Loo et al., 2003; Poelarends and Konings, 2002; Rosenberg et 
al., 1997).   178
 
Conclusion 
The location of seven PGP substrates and two modulators within neutral phospholipid bilayers have 
been determined by NOESY-MAS-NMR. Although structurally rather diverse, all molecules show a 
very similar behavior within the membrane and are found predominantly within the membrane 
interface region, but are less likely to penetrate into the membranes hydrophobic core region. 
Furthermore, both substrates and modulators show a rather similar membrane location profile. 
Therefore, substrate and modulator binding sites in PGP are most likely accessible from within the 
interface region. These findings might also have relevance for the understanding of secondary 
multidrug efflux pumps due to their partially overlapping substrate specificity and their ability to bind 
substrates from within the membrane as shown for example for LmrP (Bolhuis et al., 1996a). 
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Outlook 
 
Nuclear magnetic resonance spectroscopy is unique among the methods available for structure 
determination (Wüthrich, 2002). In general, although not yet widely used for membrane proteins, 
solid-state NMR methodology is rapidly developing into a method for protein structure determination.  
In this thesis a procedure for preparation of selective amino acids isotope labeled ABC MDR 
transporter LmrA from Lactococcus lactis for solid-state NMR investigations as well as first solid-
state NMR experiments on this protein have been demonstrated. This opens a door to apply advanced 
SSNMR techniques not only to the ABC MDR transporter LmrA but to the whole ABC family.  
In future MAS SSNMR experiments can be performed using 
13C/
15N uniformly and selectively 
labeled LmrA reconstituted into E. coli liposomes as well as in a variety of synthetic lipids. These 
experiments can potentially allow detecting conformational changes in LmrA during its catalytic 
cycle. This can be done via following chemical shift changes in 
13C/
15N MAS SSNMR spectra of 
LmrA in a resting state and in states where LmrA is trapped with either substrates, or ATP and ADP.  
In addition, the distance constrains of LmrA ATP-binding domain can be investigated through variety 
of correlation type 2D 
13C/
15N MAS SSNMR experiments taking advantage of LmrA NBDs high 
mobility by utilizing J-coupling under MAS-NMR conditions. Alternatively distance constrains can 
be obtained from dipole-dipole interactions between two spins. Example of distance constrains 
determination is measuring of the internuclear distance in specifically labeled (
15N-Leu37, 
13C-Leu39) 
phospholamban peptide (Middleton et al., 2000b). 
Experiments could be planned to detect 
2H/
13C/
15N/
19F isotope labeled substrates bound to LmrA via 
static and MAS SSNMR. Moreover, 
13C/
15N 1D and 2D MAS SSNMR experiments can be performed 
firstly to detect 
13C/
15N labeled ATP bound to LmrA and secondly to shed light on the conformation 
changes occurring in the LmrA NBDs under ATP binding and hydrolysis. Deuterium static SSNMR 
can be used to add to understanding of the protein-lipids interactions.    180
 
Appendix 1 
 
Trifluroacetyl cysteine labelling of bacteriorhodopsin 
Attaching 
19F labeled groups to cysteins allows selective labelling of membrane proteins for 
19F MAS 
NMR. The aim is to make use of long range of 
19F dipolar coupling and of high 
19F sensitivity. Here, 
19F labelling of M163C bacteriorhodopsin is demonstrated. Such an approach could be used for LmrA 
in the future. 
 
Materials and Methods 
Purple membrane (PM) (10.5 mg, 0.4375 µM) was resuspended in 50 mM Tris, 25 mM KCl, pH 7.5 
buffer to final concentration 7 mg/mL. Ten fold diluted 97 % 3-bromo-1, 1, 1-trifluoroacetone 
(BTFA) solution was added to PM suspension to final BTFA concentration of 5 mM. After 30 
minutes incubation at room temperature on a rocking table, trifluoroacetyl cysteine labeled 
bacteriorhodopsin (bR) was pelleted by ultracentrifugation at 50.000 rpm for 40 minutes. To remove 
excess of labelling reagent, PM pellets was washed twice in low salt buffer (Brauer and Sykes, 1986; 
Huestis and Raftery, 1978; Milett and Raftery, 1972). 
19F CPMAS NMR experiments were performed 
essentially as described in Chapter 5. 
 
Results 
Trifluoroacetyl bR M163C mutant labelling was performed using adapted protocols from (Getmanova 
et al., 2004; Brauer and Sykes, 1986; Huestis and Raftery, 1978; Milett and Raftery, 1972). Figure 1 
shows a comparison of 
19F CPMAS NMR spectra of PM M163C mutant labeled with TFA and of 
control  E. coli lipids resuspended in BFTA solution and spinned down. PM mutant M163C 
19F 
spectrum has only one resonance at -5.2 ppm corresponding to TFA labeled cysteine. The absence of 
any other peaks shows that BTFA side reactions with threonine, lysine and histidine have low 
efficiency and are not significant on NMR scales. Control 
19F CPMAS measurements, performed on   181
BTFA incubated with lipids, revealed no non-specific TFA binding to lipids. 
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Appendix 1 Figure 1: 
19F CPMAS of A) purple membrane M163C mutant labeled with 3-bromo-1, 1, 1-
trifluoro-aceton (BTA), B) control lipid vesicles resuspended in BTA and spinned down for NMR measurement. 
Spectra recorded at 7 kHz MAS spinning frequency and 255K. Spectra were referenced externally to 
trifluoacetic acid at 0 ppm. 
 
 
Disscusion 
19F NMR has been proven to a powerful technique in the study of protein structure and dynamic 
because 
19F nucleus provides a relatively nonperturbing and extremely sensitive probe (the 
19F 
chemical shift range is 100-fold larger then that of 
1H) with no background signals (Danielson and 
Falke, 1996a). Biosynthetic approach often fails to directly introduce fluorinated amino acids into a 
protein sequence because they are toxic for majority of bacterial strains (Gerig, 2001; Danielson and 
Falke, 1996a). We tried to incorporate 
19F tryptophan into LmrA by substitution of unlabelled 
tryptophan with its 
19F labeled analogue in CDM. However, the bacterial growth as well as the protein 
production was dramatically limited. Another way to introduce a fluorine labels into a biological 
macromolecule is by means of a chemical reaction in which a covalent bond is formed between a 
functional group of the molecule and some exogenous, fluorine-containing reagent. The most often 
target for such experiments is the sulfohydryl group of cysteine residues because of the high 
nucleophilicity of the side chain sulfhydryl group. There are usually relatively few cysteines in   182
proteins what makes this modification specific. Apart from cysteines, BTFA can react with the amino 
groups of lysine and of the peptide N-terminus, or the hydroxyl group of a serine or threonine but 
these reactions have very low yield, so on NMR scale their products are not visible (Gerig, 2001). A 
number of recent works showed applicability of TFA cysteine labelling approach for studying of such 
a large macromolecules as mammalian rhodopsin (Getmanova et al., 2004; Loewen et al., 2001; 
Thomas and Boxer, 2001). Trifluoroacetyl labelling was not tested first on LmrA but on bR because 
of several reasons. Among them are questionable accessibility of cysteines in LmrA mutants for 
labelling reagent and dimeric nature of LmrA. These could potentially initiate a wrong interpretation 
of labelling results if cysteines are not accessible or if each half of LmrA dimmer gives separated 
peaks. For these reasons trifluoroacetyl cysteine labelling was first probed on PM M163C mutant. 
Figure 1 shows 
19F CPMAS spectrum of trifluoroacetyl labeled bR. The peak at -5.2 ppm corresponds 
to TFA labeled cysteine. The same labelling approach can be used in future for LmrA.   183
 
Appendix 2 
 
Alignment of LmrA reconstituted into PC/PG liposomes  
Solid-state NMR on aligned membrane proteins is an alternative to solid-state MAS NMR. The main 
problem however is to prepare well aligned samples of large membrane proteins. Here, first results of 
alignment tests on LmrA are reported. 
 
Materials and methods 
The preparation of the aligned free and leupeptin reconstituted PC/PG liposomes (the molar ration of 
PC to PG were 3 to 1 for all cases) was accomplished by the procedure outlined by (Hallock et al., 
2002). The procedure basically involves co-dissolving lipids, and peptide when necessary, in the 
chlorophorm-methanol mixture (3:1) to a lipid concentration of 4 mg/ml, depositing the mixture onto 
glass cover slips, subsequent drying of the cover slips on the air and under vacuum for at last 4 hours, 
and finally hydrating the samples with H2O and aligning the lipids or lipid-peptide deposits.  
The preparation of aligned LmrA reconstituted PC/PG proteoliposomes were accomplished by two 
approaches, and simple drying and hydrating on the glass cover slips and by the isopotential 
centrifugation (Grobner et al., 1997). The first approach included depositing of the suspension of 
LmrA (4 mg/mL) reconstituted into PC/PG on the glass plates, drying the plates on the air for 
approximately 20 minutes and hydrating in sealed plates in 93% (93 % KCl) hydration atmosphere for 
several days. The isopotential centrifugation was performed how it was described in (Grobner et al., 
1997). 
Prior to alignment the cover slips were pre-washed with in methanol and chlorophorm, dried on the 
open air. The remaining solvent was removed by evaporation under vacuum for at least 3 hours.  
For NMR measurements about 15 cover slips were stacked one on top of the other, sealed with 
paraffin to prevent rehydratation and measured in at 0
o with respect to the magnetic field direction at 
303K. 
31P static NMR experiments were performed essentially as described in Chapter 4. 
LmrA purification and reconstitution was performed as described in Chapter 2 and 3.   184
Results 
Figure 2 shows proton-decoupled 
31P NMR spectra of fully hydrated mechanically aligned PC/PG 
liposomes: free (Figure 2A), reconstituted with leupeptin (Figure 2B), and non aligned PC/PG 
proteoliposomes reconstituted with LmrA (Figure 2C) at 25
oC. The presence of single intense peak at 
29 ppm in Figures 2A and 2B indicates that the PC/PG bilayer normal is aligned parallel to the 
external magnetic field. In contrast, the presence of a powder pattern indicates that the liposomes 
reconstituted LmrA are not oriented in magnetic field. The PC/PG lipids’ mixture was chosen as 
preferable lipid matrix for LmrA when compared with total E. coli lipids extract, because liposomes 
made of mixture of E. coli lipids in total extract are not well suitable lipids for alignment experiments. 
Additionally, how it was shown in Chapter 3, LmrA can be reconstituted into several synthetic lipids, 
including PC/PG lipids mixture. 
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Appendix 2 Figure 2: The 
31P spectra of PC/PG liposomes (A) free, (B) reconstituted leupeptin, 3 amino acid 
long peptide, and (C) reconstituted LmrA. For all oriented samples, the glass plates are oriented such that the 
bilayer normal is parallel to magnetic field. The temperature was set at 25
oC.  
 
Disscusion 
Keeping in mind, that the chief advantage of solid-state over solution state NMR is that orientaional 
parameters are analytically related to angles of the reporter group relative to the applied magnetic 
field, efforts were made to prepare oriented sample. The examples of solid-state NMR studies on   185
peptides and proteins aligned on the glass plates are rare (Prosser and Davis, 1994a). However, we 
tried to align LmrA reconstituted into PC/PG liposomes on glass covers. Several alignment methods 
were probed, namely isopotential centrifugation and sequential proteoliposomes drying on glass plates 
followed by their slow rehydratation. However, it was not possible to align the LmrA reconstituted 
proteoliposomes on the glass plates. In Figure 1 shows the comparison of aligned PC/PG liposomes 
free and containing small tripeptide, leupeptin, and non aligned PC/PG proteoliposomes reconstituted 
LmrA.  
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Zusammenfassung 
 
Festkörper NMR Experimente an dem ABC Transporter LmrA 
Multidrug Resistenz ist ein wachsendes Problem bei einer Anzahl von infektiösen Erkrankungen und 
Krebs. Das Phenomen der Multidrug Resistenz (MDR) basiert auf dem synergetischen 
Zusammenspiel von verschiedenen Mechanismen; Proteindeaktivierung, Proteinveränderung, 
Prevention von Wirkstoffinflux sowie aktiver Ausstoss des Wirkstoffes aus der Zelle. Dieser zuletzt 
genannte Mechanismus wird durch die Überexpression von Multidrug Effluxpumpe bewirkt. Die 
zuerst entdeckte und bis heute am besten charakterisierte Multidrug Effluxpumpe ist der menschliche 
MDR Transporter P-glycoprotein  (Ambudkar et al., 2003). Es ist ein Mitglied der Familie der ATP 
Bindekassetten (ABC) Superfamilie und fungiert als aktiver Transporter für eine Reihe von Antitumor 
Wirkstoffen unter Verwendung der Energie der ATP Hydrolyse (Higgins, 1986b). 
ABC Transporter haben vier Hauptdomänen. Zwei Transmembrandomänen (TMD) jede bestehend 
aus multiplen membranspannenden α-Helices die zusammen den Substratkanal durch die Membran 
formen. Zwei Nukleotidbindedomänen (NBD) formen die ATP Bindetasche und koppeln 
Konformationsänderungen, die von ATP-Bindung, -Hydrolyse und ADP-Abgabe hervorgerufen 
werden, an den Substrattransportprozess. Diese vier Domänen sind entweder als separate Polypeptide 
kodiert oder als Multidomänenprotein fusioniert (Higgins, 1986b). 
Die ABC Transporterfamilie ist gross und vielseitig. Die Gemeinsamkeit der Familie beruht auf den 
streng konservierten Motive der ABC-Kassetten, die sowohl in der Bindung als auch in der Hydrolyse 
von ATP involviert sind (Geourjon et al., 2001). 
The konservierten Motive sind P-Schleife oder Walker A Motiv, Walker B Motiv, ein Glutamat in der 
Q-Schleife sowie ein Histidine in der Schalterregion. 
Zusätzlich besitzen ABC Kassetten grundsätzlich eine D-Schleife mit (..LSGG..), die auch als ABC –
Signatursequenz bezeichnet wird (Ambudkar et al., 1999). 
Membranproteine sind äuβerst schwierig aufzureinigen und zu kristallisieren. Trotzdem gab es 
erhebliche Fortschritte in der Strukturanalyse von ABC Transportern. In den letzten fünf Jahren     215
wurden mehrere ABC Transporter Strukturen von MsbA (Reyes and Chang, 2005; Chang, 2003a; 
Chang and Roth, 2001) und die Struktur vor BtuCD aus E. coli (Locher et al., 2002) gelöst. Der 
Mechanismus von ABC Transportern ist trotz einer Vielzahl von ausführlichen Untersuchungen 
biochemischer und struktureller Natur immernoch ungeklärt. Aufgrund der Ähnlichkeiten zwischen 
den NBDs verschiedener Transporter wird allgemein angenommen, dass derselbe Mechanismus zum 
Substrattranport genutzt wird (van der Does and Tampe, 2004). Unser Verständnis des Mechanismus 
der ABC Transporter beruht auf  PGP Strukturen mit geringer Auflösung in verschiedenen 
Konformationen, unterstützt von biochemischen Daten. Diese Daten zeigen, dass die 
Hauptkonformationsänderung der TMD bei der Bindung des ATP stattfindet, sich dabei die Affinität 
für Wirkstoffe reduziert und eine zentrale Pore geöffnet wird. Diese Konformationsänderungen 
können möglicherweise das Eintreten von Wirkstoffen von der Lipidmembran in die wassergefüllte 
Pore des Transporters erleichtern (Rosenberg et al., 2003; Rosenberg et al., 2001b). 
Obwohl eine grosse Menge an strukturellen und funktionellen Daten in Bezug auf verschiedene 
Aspekte der ABC MDR Transporter im Allgemeinen und PGP im Besonderen existieren, gibt es noch 
viele offene Fragen. 
Ein Teil dieser offenen Fragen sind 1) wie das Substrat an das Protein gebunden wird, 2) wieviele 
ATP Moleküle pro Substrattransport hydrolisiert werden, 3) wieviele Konformationsänderungen von 
NBD auf TMD übertragen und umgekehrt werden, 4) wie der Transportzyklus abläuft, 5) wie der 
Transportzyklus reguliert wird. Kristallstrukturen von ABC MDR Transportern in offener und 
geschlossener Konformation , sowie mit und ohne gebundenem Substrat müssen noch gelöst werden.  
Wie schon erwähnt ist einer der am besten charakterisierten MDR ABC Transporter sicherlich P-
glycoprotein und als solches wird es als Modellprotein für die ganze ABC MDR Familie angesehen. 
Das strukturell und funktional ähnlichste Protein in Bakterien ist LmrA aus Lactococcus lactis. 
Motivation 
Es ist oft schwierig mit Proteinen aus Säugetieren zu arbeiten und diese in ausreichender Menge nicht 
nur für Kristallisationsansätze sondern auch für biochemische Versuche zu produzieren. Daher ist 
LmrA ein praktisches Modellsystem für strukturelle und funktionale Analysen. 
Die Hauptziele dieser Arbeit sind die Etablierung einer selektiven Isotopenmarkierungsmethode für   216
LmrA in Lactococcus lactis, Optimierung von LmrA für Festkörper NMR und erste Festkörper NMR 
Experimente, die die Substratbindung und den katalytischen Zyklus von LmrA untersuchen sollen. 
Lange Zeit wurde Festkörper NMR in den Biowissenschaften fast ausschliesslich für die 
Untersuchung kleiner Moleküle genutzt. Nun konnte gezeigt werden, dass Festkörper NMR auch für 
Struktur- und Funktionsuntersuchungen grosser Membranproteine und deren Liganden geeignet ist. 
Jedoch wurde nach unserem Wissen bis jetzt weder ein ABC Transporter aminosäureselektiv mit 
Isotopen markiert noch ein kompletter ABC Transporter mit Hilfe von NMR untersucht. Für 
Festkörperexperimente an Membranproteinen müssen diese aufgereinigt werden und hochkonzentriert 
in Lipide rekonstituiert werden. Weiterhin müssen das Protein oder ein Ligand isotopenmarkiert 
werden. Daher wurden grosse Mengen an Protein hergestellt, in hoher Konzentration rekonstituiert 
und in dieser Form auch auf Funktionalität untersucht. 
Kapitel 1: Einleitung 
Kapitel 1 gibt einen Literaturüberblick. Es beginnt mit einer Erläuterung des Phänomens der 
Multiwirkstoff-Resistenz und Multidrug Transportern. Im zweiten Teil werden MDR ABC 
Transporter, insbesondere P-glycoprotein und LmrA sowie deren Funktionsweise besprochen. Der 
dritte Teil der Einleitung führt allgemein in die Festkörper NMR ein und zeigt Anwendungen für 
membranständige Transportproteine auf. 
Kapitel 2: Entwicklung eines Definierten Mediums für Isotopenmarkierung von LmrA in 
Lactococcus lactis. 
Kapitel 2 dieser Dissertation beschreibt die Etablierung einer kosteneffizienten aminosäureselectiven 
Methode der Isotopenmarkierungs Methode für LmrA in Lactococcus lactis. Es wurde ein chemisch 
definiertes Medium zur selektiven Aminosäuremarkierung im ABC Transporter LmrA in Lactococcus 
lactis für NMR Anwendungen etabliert. Die ersten Spektren von inside-out Vesikeln mit circa 30% 
LmrA Überexpression  und 
13CO Glycin/Tyrosin Markierung bestätigen eine erfolgreiche 
Isotopenmarkierung. Die neue Lactococcus lactis Methode benötigt lediglich die Hälfte der 
ursprünglich  benötigten Menge an isotopenmarkierten Aminosäuren. Die Funktionalität des, in 
diesem System überexprimierten LmrA wurde mit Hilfe von dem Hoechst-33342 Fluoreszenzassay 
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Kapitel 3: Herstellung von in verschiedenen Lipiden rekonstituierten LmrA für Festkörper 
NMR Versuche. 
In Kapitel 3 dieser Dissertation wird gezeigt, dass LmrA in E.coli Lipiden und einer Reihe von 
künstlichen Lipiden (PE/PG, und PC/PG/cardiolipin) mit Hilfe der Detergenz basierten   
Liposomendestabilisationsmethode in einem hohen Protein:Lipid Verhältnis von 1:300 mol:mol 
rekonstituiert werden kann. Die Qualität der Rekonstitution und Proteinfunktionalität sind mit Hilfe 
von Gefrierbruchelektronenmikroskopie, Sukrose Gradienten, Gel Filtration, ATPase 
Aktivitätsnachweis, und Hoechst 33342 Transport untersucht worden. Die ersten Spektren von 
13C 
und 
15N Tyrosin markiertem LmrA, welches in E. coli Liposomen rekonstituiert wurde, zeigte ein 
gutes Signal zu Rauschen Verhältnis und bestätigten, dass die Menge an selektiv isotopenmarkiertem  
LmrA ausreichend ist für Festkörper NMR Experimente. Zum ersten Mal sind jetzt ein 64kDa 
Membranprotein LmrA und damit die Klasse der ABC Transporter Superfamilie für NMR Analyse 
zugänglich gemacht worden. Nach Etablierung der Prozedur zur aminosäureselektiven Markierung 
von LmrA in Lactococcus lactis und Rekonstituierung in E. coli Lipiden in einem hohen Protein Lipid 
Verhätnis konnten wir nun Untersuchung zur Ligandenbindung und Dynamik des Proteins während 
der ATP Bindung und Hydrolyse durchführen. 
Kapitel 4: Dynamik von LmrA untersucht mit Deuterium-Linienformanalyse und 
Relaxationsmessungen. 
Unter Benutzung der in Kapitel 2 beschriebenen Methode für die selektive Aminosäurenmarkierung  
wurde LmrA mit deuteriertem Alanin hergestellt und in E. coli Liposomen rekonstituiert. Statische 
Deuterium NMR Experimente zeigen, dass die Dynamik von LmrA Domänen komplex ist. Während 
ein Teil der LmrA Domänen sehr immobil auf der NMR Zeitskala ist sind andere sehr dynamisch. Der 
Vergleich von Deuteriumlinienform in LmrA im Ruhezustand zu den AMP-PNP und ATP/ADP-
Vanadate gebundenen Zuständen zeigt, dass das Protein in diesen Fällen unterschiedliche 
Bewegungsmodi besitzt. Im Zustand der ATP Bindung und Hydrolyse bleiben die TMD von LmrA 
während der NMR-Zeitskala relativ immobil. In der gleichen Zeit wird die Mobilität der NBDs durch 
ATP-Bindung und – Hydrolyse stark eingeschränkt. 
Kapitel 5: Untersuchung der Ligandenbindung an LmrA durch Fluoreszenzspektroskopie und   218
Festkörper NMR 
Experimente zum Quenching der intrinsischen Fluoreszenz von Tryptophan in LmrA wurden an in E. 
coli Lipiden rekonstituierten Proben vorgenommen. Zum ersten Mal konnte gezeigt werden, dass 
Norfloxacin ein antibakterieller Wirkstoff aus der Fluoroquinolon Familie ein Substrat von LmrA ist. 
Die Bindungskonstante von Norfloxacin, Vinblastine und TPP
+ wurden aus der 
konzentrationsabhängigen intrinsischen Tryptophan Fluoreszenz erhalten. Die Analyse der 
Fluoreszenz Emissionspektren von LmrA deutet auf eine relativ unpolare Umgebung für alle fünf 
LmrA Tryptophane hin. Zusätzlich wurde gezeigt, dass durch Substratbindung induzierte 
Konformationsänderungen von den Transmembran Helices zur zytosolischen Domäne übertragen 
werden. Jedoch erhöhen diese Konformationsänderungen der NBD nicht die Tryptophan 
Zugänglichkeit zur Lösung. Ausserdem kann das Quenching von der intrinsische Fluoreszenz von 
Tryptophan als Test für Substratbindung und Proteinaktivität benutzt werden.  
Die Untersuchung von Ligand/Protein Wechselwirkungen an Protein rekonstituiert in Liposomen 
wird erschwert, da die Unterscheidung zwischen einer spezifischen Interaktion von Ligand/Protein, 
jedoch nicht einer spezifischen Interaktion von Ligand/Lipid erzielt werden muss. Am Beispiel von 
Norfloxacin und unter Nutzung der hohen 
19F Sensitivität und Dekonvolution konnte 
Ligandenbindung an LmrA beobachtet werden. Experimente, die die Bindung von TPP
+ an LmrA 
untersuchen sollten, erzielten zweideutige Ergebnisse. Jedoch konnte ein besseres Verständnis der 
Limitationen der Ligandenobservation mittels Festkörper NMR erreicht werden, und es zeigten sich 
Möglichkeiten diese zu überwinden. In der hier vorliegenden Studie wurde zum ersten Mal gezeigt, 
dass der Echtzeit Hoechst-33342 Transport von LmrA in inside-out Vesikeln mit Hilfe einer 
Leupeptin Zugabe unterbrochen werden kann. Ähnliche Experimente können für Hochdurchsatz 
Echtzeit Fluoreszenz Experimente zur Untersuchung einer Wirkstoffbibliothek nach potentiellen ABC 
Transporter Substraten und Modulatoren benutzt werden. Im Prinzip kann diese Echtzeit Methode 
auch mit anderen fluoreszierenden LmrA Substraten wie etwa Verapamil Derivaten benutzt werden. 
Die LmrA ATPase wurde bei verschiedenen Leupeptin Konzentrationen untersucht. Leupeptin 
erzeugt eine bimodale ATPase Modulation und suggeriert damit die Existenz von inhibierenden und 
stimulierenden Bindungstaschen in LmrA und Leupeptininteraktion mit beiden.   219
Kapitel 6: Die Lokalisierung von Multidrug Transporter Substraten in einer Modellmembran. 
Die Lokalisierung von sieben P-glycoprotein und LmrA Substraten sowie zwei Modulatoren 
innerhalb einer neutral geladenen Phospholipidmembran  wurde mit Hilfe von NOESY-MAS-NMR 
bestimmt. Obwohl strukturell divers zeigten alle Moleküle ein ähnliches Verhalten in der Membran. 
Die Moleküle sind überwiegend in der Membran/Lösungs Region zu finden und kaum im 
hydrophoben Kern der Membran. Zusätzlich zeigen sowohl Substrate als auch Modulatoren ein 
ähnliches Membranlokalisationsprofil. Es folgt, dass PGP Substrate und Modulatoren die Bindestellen 
von der Membran/Lösungsregion aus erreichen können. Dieses Ergebnis könnte relevant sein für das 
Verständnis von sekundären Multidrug Effluxpumpen. Diese zeigen eine partiell überlappende 
Substratspezifität und haben die Möglichkeit Substrate aus der Membran heraus zu binden, wie 
bereits für LmrP beschrieben (Bolhuis et al., 1996a).  
   220
 
E R K L Ä R U N G  
 
Ich erkläre hiermit, dass ich mich bisher keiner Doktorprüfung unterzogen habe. 
 
Frankfurt am Main, den.................................... 
 
............................................................................ 
(Unterschrift) 
 
 
Eidesstattliche Versicherung 
 
 
Ich erkläre hiermit an Eides Statt, dass ich die vorgelegte Dissertation über ``Solid-state NMR 
investigations of the ATP binding cassette multidrug transporter LmrA`` selbständig angefertigt 
und mich anderer Hilfsmittel als der in ihr angegebenen nicht bedient habe, insbesondere, dass aus 
Schriften Entlehnungen, soweit sie in der Dissertation nicht ausdrücklich als solche mit Angabe der 
betreffenden Schrift bezeichnet sind, nicht stattgefunden haben. 
 
 
Frankfurt am Main, den.......................................                ..........................................                                      
      (Unterschrift 
  221
 
Lebenslauf 
 
 
 
 
Name  Alena Siarheyeva 
Geboren am  4 April 1979 in Minsk 
 
Ausbildung 
 
 
Schule   1986 -1996 Höhere Schule, Minsk,  
 
Studium 
 
 
 
 
Promotion 
1996 – 2001 Studium der Strahlenbiologie und Medicinische Ökologie 
an der International Sakharov Ökologisch Üniversität, Minsk 
Thema der Abschlussarbeit: “Investigation of pharmacokinetic and 
pharmacodynamic properties of new bloodsubstitute solution Microdez”  
Betreuer: Prof. V. N. Gapanovich 
 
Februar 2003 – in der Abteilung von Prof. Dr. Glaubitz am der Institut 
für Biophysikalische Chemie, Johann Wolfgang Goethe Universität in 
Frankfurt am Main 
Thema der Dissertation: “Solid-State NMR Investigations on the ATP 
Binding Cassete Multidrug Transporter LmrA” 
Betreuer: Prof. C. Glaubitz 
 
  
  222
 
Publications 
 
Siarheyeva A., Lopez J., Glaubitz C.: The localization of P-glycoprotein substrates within model 
membranes, Biochemistry, in press 2006. 
 
Siarheyeva A., Glaubitz C.: Deuterium solid-state NMR investigation of LmrA dynamic changes 
under ATP binding, in preparation. 
 
Lorch M., Lehner I., Siarheyeva A., Basting D., Pfleger N., Manolikas T., Glaubitz C.: NMR and 
fluorescence spectroscopy approaches to secondary and primary active multidrug efflux pumps, 
Biochem. Soc. Trans.; 33 (Pt 4):873-7 August 2005.  
 
Mason A.J., Siarheyeva A., Haase W., Lorch M., van Veen H., Glaubitz C.: Amino acid type selective 
isotope labelling of the multidrug ABC transporter LmrA for solid-state NMR studies, FEBS Letters, 
568 (1-3): 117-121 June 18 2004. 
  
  223
 
List of Conferences Contributions and Talks 
 
CONFERENCES 
 
March 2006  “A systematic approach to study the multidrug ABC transporter LmrA substrate 
binding by solid-state NMR” at FEBS special meeting: ATP-binding cassette (ABC) 
proteins: from multidrug resistance genetic diseases, Innsbruck, Austria 
 
March 2005   “First solid-state NMR Experiments on ABC multidrug transporter LmrA” at 1
st Joint 
German/British bioenergetics meeting, Wilhelm-Kempf-Haus, Wiesbaden, Germany 
 
September 2004   “Solid-State NMR investigations on ABC-transporter LmrA” at Annual 
 Meeting of the German Biophysical Society, Freiburg, Germany 
 
TALKS 
 
 
October 2005  “Solid-State NMR investigations on ABC-transporter LmrA” at Forschungsinstitute 
für Molekulare Pharmakologie, Berlin, Germany 
 
June 2005  “Solid-State NMR investigations on ABC-transporter LmrA” at the International 
School of Structural Biology and Magnetic resonance, 7
th Course Structure and 
Biophysics New Technologies for Current Challenges in Biology and beyond, Erice, 
Sicily 
 
May 2004  “Solid-State NMR investigations on ABC-transporter LmrA” at Summer school 
Membrane proteins, Bioinformatics and Proteomics, Spetses, Greece 
 
WORKSHOPS 
 
 
March 2006  Workshop on Computational Biophysics `Hands-on`, giving by K. Schulten, MPI of 
Biophysics, Frankfurt (M), Germany 
 
June - July 2005    The International School of Structural Biology and Magnetic resonance, 7
th Course 
Structure and Biophysics New Technologies for Current Challenges in Biology and 
beyond, Erice, Sicily 
  
  224
November 2004  Workshop 'Scientific presentation skills', Saarbücken, Germany 
 
May 2004  Summer school 'Membrane proteins, Bioinformatics and Proteomics',  
Spetses, Greece 
 
April 2004  Workshop 'Membrane protein biophysics', Aalborg, Denmark  
 
   
   
 